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ABSTRACT
Restenosis remains a common problem affecting the patency of endovascular
intervention such as balloon angioplasty and stent placement as treatments for
atherosclerosis. Denudation of the endothelial layer and the increased injury from
balloon deployment can cause phenotypic changes in surrounding vascular smooth
muscle cells (SMCs) in vivo. The presented work modeled this mechanical environment
in vitro to investigate the role of the altered mechanical environment on the phenotypic
response of SMCs. Through the system design and CFD channel characterization, a sixindependent-channel system providing low oscillating wall shear stress (WSS) was
manufactured to apply concurrent shear and tensile forces with uniform strain and WSS
profiles over the cell location. The project hypothesis that balloon angioplasty
endovascular intervention exposing vascular smooth muscle cells to an altered
mechanical environment would evoke a cell phenotype change. The exposure of SMCs
to concurrent shear and tensile forces following balloon angioplasty resulted in a more
synthetic phenotype behavior marked by such characteristics as increased synthetic
morphology, increased proliferation, increased apoptosis and decreased expression of
contractile markers.
Clinical implications for this work suggest that physiological dynamic regimens
should be incorporated into in vitro studies. We simulated balloon angioplasty through
increased strains and a clinical heparin bolus administration, both of which evoked
different SMC responses compared to controls. SMC response triggered by exposure to
the injury model resembled in vivo reactions following balloon angioplasty. Therefore,
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dynamic concurrent shear and tensile forces should be incorporated in vascular in vitro
testing to possibly lead to better treatment and prevention of restenosis following
endovascular intervention.
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-CHAPTER 1INTRODUCTION
1.1 Clinical Significance
Cardiovascular disease is an ongoing problem facing healthcare systems.
Atherosclerosis is the leading cardiovascular disease which causes problems of
thickening in arteries and a decrease in lumen size. When a severe atherosclerotic lesion
forms, clinical intervention is required such as arterial bypass or a less invasive
endovascular procedure percutaneous transluminal angioplasty (PTA). Unfortunately,
following PTA, endothelial cells that comprise the lumen of the artery are denuded and
arterial smooth muscle cells are exposed to normally unseen blood flow. Under normal
conditions, arterial smooth muscle cells are in direct contact with tensile forces from the
expansion of the blood vessel, but following PTA, they are exposed to concurrent shear
and tensile forces. In vivo response of smooth muscle cells following angioplasty include
increased migration and proliferation, which can initiate restenosis, or the reclosing of the
artery.
Following balloon angioplasty, the denudation of the endothelial cell layer allows
the exposure of the smooth muscle cells (SMCs) to normally unseen shear forces from
blood flow. The response of the SMCs to these mechanical forces includes apoptosis,
differentiation, migration, hypertrophy and proliferation. The balloon angioplasty
induced injury can be the etiology for the SMC change from a contractile to a synthetic
phenotype [1]. Synthetic smooth muscle cells are characterized by: increased number of
synthetic organelles, such as rough endoplasmic reticulum, increased proliferation,
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decreased α-actin, increased protein secretion, loss of contraction ability, and an
increased cell volume [2-5]. In contrast, contractile smooth muscle cells are generally
spindle shaped, non-proliferative, able to contract, and contain relatively more α-actin,
calponin, and smooth muscle myosin heavy chain isoforms than synthetic smooth muscle
cells [2, 3, 5-7].
Smooth muscle proliferation is believed to be an acute response to injury and can
occur up to seven days following balloon angioplasty with most of the cells entering the
growth cycle within the first 1-3 days following injury [8]. Following the acute response,
the number of smooth muscle cells within the intima stays relatively constant up to a year
following the endovascular procedure. Due to the stability of the smooth muscle cell
population with time, further increases in intimal hyperplasia are believed to be due to the
production of extracellular matrix and connective tissue and from cellular hypertrophy
[9]. Maximum intimal thickening in humans usually occurs within 2-3 months of injury
[10]. The degree of activation of smooth muscle cells following angioplasty effects the
migration and proliferation characteristics of smooth muscle cells and directly contributes
to the degree of intimal thickening and hyperplasia. To date there have been many
studies designed to investigate the in vivo response of SMC to injury following balloon
angioplasty. Due to difficulty in maintaining concurrent shear and tensile forces to
evaluate their effect on SMC in vitro, limited studies have been performed using an in
vitro model.
In the development of an in vitro model, it is important to incorporate the vascular
mechanical forces, which is why a concurrent shear and tensile force vascular simulator

2

has been developed for use in this project. In addition, this model can also be used to
investigate the effect of increased forces during PTA. The custom designed system was
implemented to evaluate the effects of applied stress levels on vascular smooth muscle
cell response through the following aims of this project with the ultimate goal of this
project to provide a clinically relevant platform for the reaction of smooth muscle cells
that could be implemented for use in testing of pharmaceutical agents for the prevention
of restenosis.

1.2 Project Hypothesis:
It was hypothesized that balloon angioplasty endovascular intervention exposing vascular
smooth muscle cells to an altered mechanical environment will evoke a cell phenotype
change. The exposure of smooth muscle cells to concurrent shear and tensile forces
following balloon angioplasty will result in a more synthetic phenotype of the smooth
muscle cells when compared to normalized dynamic strain which was thought to
maintain the contractile behavior of the cells. The hypothesized synthetic behavior was
hypothesized to result in increased proliferation, altered cell morphology, increased
hypertrophy, increased apoptosis, and decreased expression of contractile phenotype
markers. Incorporation of a clinical administration of heparin within the dynamic injury
model was hypothesized to result in decreased SMC proliferation potentially conserve
contractile phenotype markers. Changes in protein expression due to mechanical stimuli
were hypothesized to be controlled in part by extracelluar signal-regulated kinase (ERK)
½ pathway.
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1.3 Summarized Project Aims
Aim 1- Design a six-station concurrent shear and tensile mechanical force in vitro
simulator to model clinically significant levels of physiological strain and shear stress.

The designed system consists of two Lexan vascular mechanics simulators. Six
independent channels receive fluid from multichannel peristaltic pump system which
provides fully developed laminar fluid flow to cells grown on a collagen coated flexible
silicone membrane. Cyclic tensile force to cells is applied by vacuum application which
stretches the silicone membrane containing the cells over a rigid platform. The vacuum
regimen is regulated through the FlexCell computer system and the system was
successfully calibrated to relate the programmed elongation versus the actual
experimentally determined percentages of elongation within reasonable error.

Aim 2- Computational Characterization of system using Computational Fluid Dynamics

In order to validate the shear component of the design and to investigate
alterations of the theoretical wall shear stress (WSS), Computational Fluid Dynamics
(CFD) simulations were performed using GAMBIT for the geometry construction and
FLUENT for the CFD simulations. The particular parameters of interest were the wall
shear stresses and the fluid velocity profiles at the location of the cells following suction
of the silicone membrane simulating balloon angioplasty. Steady-state deformation
simulations did not result in significant WSS changes. Simplified moving wall
deformation in unsteady demonstrated that the changes in WSS in dynamic simulations
occur due to localized increases/decreases in fluid velocity from dynamic channel
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geometry changes. Parabolic unsteady dynamic simulations confirmed this principal,
demonstrating oscillating WSS at the site of the cells with positive velocities maintained
over deformation. This analysis demonstrated that dynamic simulation is needed to
accurately model shear mechanical forces on cells in vascular mechanics simulator and
will provide insight to the actual mechanical stresses that are present at the cells.

Aim 3- Establish a vascular smooth muscle cell proliferation model using a short time
point with in vitro mechanical application and clinical intervention.
In this acute study (8 hours), rat aortic SMC demonstrated significant cell
proliferation following applied angioplasty injury and shear exposure when compared to
“normal function” tensile exposure. Low wall shear stress was applied to the cells to
simulate areas where early intimal thickening commonly occurs, such as immediately
following a stent strut where fluid profiles are dramatically altered and fluid shear
stresses are dramatically decreased.
The increased expression of the phenotypic marker SM α-actin indicated a
significant increase in synthetic behavior of the smooth muscle cells exposed to balloon
angioplasty injury and concurrent shear and tensile mechanical forces. These findings
demonstrate the efficacy of the developed model for in-vitro angioplasty and the
simulated mechanical environment to the cells.
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Aim 4- Evaluation of the Increased Synthetic Phenotype Behavior of Smooth Muscle
Cells in Response to in vitro Balloon Angioplasty 24h Injury Model
Expansion of the previous 8 hour study to 24 hour resulted in alterations in cell
responses of apoptosis, proliferation, cell hypertrophy, and phenotype behavior. The
injury model resulted in increased proliferation and apoptosis and decreased SM α-actin,
SM22α, and calponin expression of the dynamic groups (IM, BA, CT) compared to the
static group (U). Expression of the synthetic marker, vimentin, was increased in the
injury model with combined concurrent forces in comparison to the decreased expression
in those exposed to strain alone (CT). Overall, increased cell hypertrophy, decreased
contractile markers, and an increased number of cells demonstrate the highest synthetic
behavior of the SMCs within the developed injury model.

Aim 5- The Effects of Heparin Administration in Concurrent Force Injury Model

The effect of the administration of heparin on smooth muscle cells (SMCs) after 24 hours
was investigated using the developed injury model. A local administration of 100 µg/ml
was compared to a clinically relevant bolus of 10,000 units for 5 minutes prior to balloon
angioplasty followed by 100 µg/ml administration over the course of 24 hours. It was
found that the heparin bolus dynamic group resulted in a decreased number of cells while
the 100 µg/ml administration had no effect within the injury model. Additionally,
heparin was shown to significantly decrease calponin expression within the bolus injury
model and decrease calponin expression in static samples. Significant variations in

6

responses demonstrate the necessity of using dynamic clinically relevant in vitro models
for pharmaceutical agent testing.

Aim 6- Evaluating the Role of ERK ½ in Injury Model Protein Expression Response
Decreased in ERK ½ activity were confirmed in the concurrent force injury model to
similar levels as with the ERK ½ inhibitor U0126. The inhibited and uninhibited injury
models resulted in similar expressions of SM22α and SM α-actin. However, comparison
to the inhibited and uninhibited static control (U) demonstrated that the large differences
in ERK ½ activity were not attributed to inhibition. ERK ½ may be partially involved,
but other mechanotransduction pathways must be involved to evoke these SMC
responses.

1.4 Literature Review
1.4.1 Atherosclerosis
Atherosclerosis is the continually leading type of heart disease and cause of
mortality each year in the United States. Atherosclerosis is usually characterized by a
fatty streak, fibrous plaque, and resultant lesions. Fatty streaks are present in many
stages of life; however different arteries normally contain fatty streak lesions in different
stages. For example, fatty streaks are present in the aorta, in coronary arteries, and in the
cerebral arteries in the first, second, and third decades, respectively [11].
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Mechanisms of Atherosclerosis
Role of Endothelium
Endothelial dysfunction is believed to be one of the initiating factors of
atherosclerosis. Early stages of atherosclerosis consist of intimal accumulation of fatfilled cells due to endothelium dysfunction. In a normal vessel, the endothelium acts as a
non-thrombogenic surface and a selectively permeable barrier to protect the lumen and
control passage between the blood and tissues [11, 12]. Anatomically, it makes up the
intima of the blood vessel and provides a non-thrombogenic interface for contact with
blood.
At early stages of atherosclerosis, the endothelial cells are believed to express
adhesion molecules where monocytes can attach. The process begins with the rolling of
leukocytes on the endothelium mediated by adhesion molecules such as ICAM or
selectins such as P-selectin [13]. The actual adhesion of these molecules may be
mediated by molecules such as VCAM-1 on the endothelium and VLA-4 on the
monocytes and T cells [11]. The process of leukocyte transmigration across the
endothelium is demonstrated in Figure 1.

8

Figure 1.1 Endothelium Interaction with Leukocyte Adhesion

Role of Monocytes andd Macrophages
The monocytes can then turn into macrophages and transudate further into the
vessel wall [12, 14].. In atherosclerosis, increased monocyte recruitment and
macrophage proliferation also occurs. Monocy
Monocyte chemotactic protein (MCP--1) and its
receptor CCR2 have been shown to affect the number of recruited monocytes [15, 16].
The cytokine such as M-CSF
CSF has been shown to be involved in the proliferation and
differentiation of macrophages [17]. The transudated macrophages can
an then engulf
cholesterol from transudated plasma lipoproteins, becoming foam cells and secreting
growth factors and chemotactic factors which recruit more macrophages and leukocytes
from the blood plasma.
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Role of Lipoproteins
When increased levels of circulating low density lipoprotein (LDL) are present,
transport and retention in sites for atherosclerotic lesion formation are increased [11].
LDL passively diffuses through endothelial cell junctions and is retained in the vessel
wall by apolipoprotein B (apoB) and matrix proteoglycans [18]. Modification of the
trapped LDL in the forms of oxidation, lipolysis, proteolysis, and aggregation, allows for
increased uptake by macrophages in order to form foam cells and contribute to
inflammation [11]. Accumulation of minimally oxidized LDL can also stimulate
endothelial cells to produce adhesion molecules and growth factors, ultimately leading to
the recruitment of monocytes and lymphocytes as previously discussed [11]. Nitric oxide
production can be inhibited by oxidized LDL which can also contribute to atherosclerosis
due to decreased vasorelaxation function and resultant higher blood pressures [11, 14].
Atherosclerotic Lesion Classification
Atherosclerotic lesions can form from the fibrosis and cell death that occurs
within the artery wall. These are usually stable and consist of collagen and calcium.
These lesions are commonly classified using Stary’s Classification which characterized
lesions into five phases shown in Figure 2 [12].
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Figure 1.2 Stary’s Classification of Lesion Classification [12]

st phase is usually characterized by lesion types II-III
III and can occur in individuals
The first
under 30 years old. Lesion type I consists of foam cells and lipid droplets, type II
contains macrophages and smooth muscle cells with lipid deposits, and type II consists
consist
mostly of smooth muscle cells surrounded by extracellular lipid. The plaque that is
present in Phase II is high in lipid content, which can lead to rupture. The types of lesion
in Phase II are types IV and Va. Both of these contain large amounts of ex
extracellular
tracellular
lipid, but the lipid in Va is usually covered by a fibrous cap. These can evolve into more
severe lesions of Vb or Vc into Phase 3 or 4. Vb lesions contain more smooth muscle
cells, lipid, and connective tissue while Vc lesions contain larger amounts of collagen. In
Phase 4, the lesion may rupture or fissure, or a thrombus may form. Phase 5 can result in
fibrotic behavior and partial or total occlusion of the artery.
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In higher stages, the stability of the lesion tends to decrease. Plaque consisting of
extracellular lipids and macrophages may be more vulnerable to rupture, and may be
more influential than the size of the lesion. The plaque in atherosclerosis consists of both
intracellular and extracellular lipids in addition to macrophages, T-cells, smooth muscle
cells, proteoglycans, collagen, calcium, and necrotic debris [11].
Contributing Factors to Atherosclerosis
There are several factors, both environmental and genetic, which can lead to
higher risks of atherosclerosis. Environmental factors include: high-fat diet, smoking,
low antioxidant levels, lack of exercise, and infectious agents [11]. Genetic factors
include: elevated levels of LDL/VLDL, reduced levels of HDL, elevated levels of
lipoprotein(a), elevated blood pressure, elevated levels of homocysteine, family history,
diabetes and obesity, elevated haemostatic factors, male gender, systemic inflammation,
metabolic syndrome, and depression and other behavioral traits [11]. Elevated levels of
LDL can lead to accumulation and increased passage through the endothelial junctions,
ultimately resulting in the formation of foam cells as previously discussed. Low levels of
high density lipoprotein (HDL) are promoters of atherosclerosis because HDL protects
against atherosclerosis. HDL removes excess cholesterol from the surrounding tissue and
inhibits lipoprotein oxidation [11].
Clinical Assessment and Intervention for atherosclerosis
Imaging and Assessment
A growing occlusion of the blood vessel can lead to decreased blood flow to peripheral
arteries and results also in localized higher pressures since the cross-sectional area of the
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artery is decreased. These lumen decreases are generally detected with methods such as
ultrasound or angiography.
Intravascular ultrasound (IVUS) is an invasive ultrasound technique that can
provide higher resolution images and information about the blood vessel. In this method,
cross-sectional arterial images are obtained by inserting an ultrasonic transducer mounted
on a catheter. It uses an ultrasound beam at varying frequencies to form images of
surrounding objects. High frequencies are used for higher resolution while low
frequencies are used when depth of penetration are more of interest [19]. Three
dimensional images can be formed by catheter controlled advancement or contraction.
IVUS is used in both pre-operative and post-operative assessments following
endovascular intervention. IVUS can be used to examine vascular compliance and
characterize plaque through detection of differences in acoustic impedances [19, 20].
Angiography is a lower resolution imaging technique but is still important in
endovascular imaging. In angiography, a liquid iodinated contrast agent gas is injected
into the blood stream in order to image the vascular tree [19]. Angiography uses a
system of fluoroscopy and x-ray to create images of the blood flow. It is often used
during surgery for proper balloon placement and stent positioning. Following surgery, it
shows the restored patency of the artery while IVUS is better at demonstrating the
microenvironment of the artery [19]. Angiography can also be used with magnetic
resonance imaging (MRI) in the process of magnetic resonance angiography (MRA)
which is used to evaluate the vasculature or with computed topography (CT) in computed
topography angiography (CTA). Although these have increased imaging capabilities,
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angiography is still more prevalently used in part due to the increased acquisition time
and image manipulation of these other techniques. In addition, MRA may still
overestimate the amount of stenosis present within an artery. Summarized information
concerning diagnostics is provided below in Table 1.1.
Table 1.1 Comparison of Diagnostic Techniques
Duplex
Ultrasound

Intravascular
Ultrasound
(IVUS)

Angiography

Magnetic
Resonance
Angiography
(MRA)

Computed
Tomography
Angiography
(CTA)

Imaging
Dependant upon
frequency and
depth into tissue

High resolution
images used Pre-op
and post-op for
lumen area and
plaque size
-X-ray images of
2D silhouette
-Good for overall
vasculature
information
rather than
microenvironment
-Three-dimensional
images with
increased
sensitivity
-Radio signal in
multiple
orientations
-Three-dimensional
images and
surrounding soft
tissue
-X-ray technique

Invasiveness

Cost

Non-invasive

Inexpensive

-Low risk procedure
-Resolution can be a problem with
deep vasculature

Invasive

Moderately
Expensive

-Increased examination time
-Increased risk over angiography
-Acoustic shadowing

Moderately
Expensive

Invasive

Risks/Considerations

-1% Fatality
-Tissue damage
-Infection risks
-Anesthesia risks
-Allergic reaction to contrast
-Emboli hazard

Non-Invasive

Expensive in
both time and
expense

-Less risk since uses blood as own
contrast agent
-Increased risk with additional
contrast agents
-Overestimation of Stenosis

Non-Invasive
(Invasive
with contrast)

Expensive in
both time and
expense

-Requires contrast bolus, risk for
those with impaired renal function

Surgical Procedures
If the degree of occlusion is significant, surgical intervention is required. Arterial
bypass using artificial grafts or vein grafts is one possible surgical treatment. Artificial
vascular grafts can be made out of materials such as Dacron, polyester, or
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polytetrafluoroethylene (PTFE). However, arterial bypass has drawbacks that include the
need for open surgery, material biocompatibility, and differences in hemodynamic
velocity profiles. Endovascular procedures are considered minimally invasive and
require less time in the hospital and less time for patient recuperation than open bypass
surgeries.
Balloon Angioplasty
Percutaneous transluminal angioplasty (PTA), or balloon angioplasty, is an
example of an endovascular procedure that prevents the need for open surgery. During
PTA, as the balloon is expanded, plaque within the walls of the vessel is compressed.
Balloon deployment may also tear the plaque in order to enlarge the lumen area [12]. In
balloon angioplasty, a catheter is inserted usually through the artery with a deflated
polyethylene (PE) or polyethylene terephthalate (PET) balloon on the tip of the catheter
[19]. The length and diameter of the balloon is determined prior to surgery according to
ultrasound and angiography results yielding information on the length, location, and
severity of the lesion area. For large arteries such as the iliac, a balloon diameter in the
range of 5 to 10 mm in diameter is generally needed [19]. In general, balloon sizes
increased 20 to 30 percent larger than the vessel are used in PTA depending on the
compliance of the balloon [19].
The mechanics of the balloon deployment can vary between procedures. The
balloon is deployed with saline. The balloon can be deployed with an inflation device or
according to the surgeon’s discretion. During deployment, the balloon expands until the
deployment force equals the vessel wall circumferential force [19]. The circumferential
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stress that is placed on the vessel wall due to deployment is referred to as the hoop stress
which is a product of the outward fluid pressure and the balloon diameter [19]. The
pressures on the arterial wall range between 5-15 atmospheres [19]. Local differences in
pressures caused from variations in the geometry of the stenosis can result in increased
longitudinal and outward vector forces [19].
The duration of balloon deployment is generally 10-20 seconds with an average
number of two deployments [19]. Two deployments is suggested to allow for
reconfiguration of the vessel and different frictional forces which upon the second
deployment, may demonstrate increased efficacy of the balloon angioplasty [19].
Intravascular Stents
Balloon angioplasty can be performed as an individual procedure or paired with a
stent placement. A stent is a slotted metal tube designed to mechanically assist in
maintaining the lumen of the artery to maintain proper blood flow in the artery. Stents
are generally categorized as thermal, self, or balloon-expandable. Thermally expandable
stents are made of out nitinol, which is an alloy of nickel and tantalum and referred to as
a memory shape alloy [21]. During a nitinol stent deployment, the stent expands in its
austenite phase at the temperature of 37 degrees Celsius [22]. A study performed by
Carter and collaborators found that the thermal expanded nitinol stent compared to the
balloon deployed Wallstent resulted in decreased thrombus formation, infiltration of
inflammatory cells, and neointimal formation [22]. Overall, thermal expansion stents are
proposed to decrease the disruption of the arterial wall through gradual thermal expansion
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[22]. However, the methods of this study used direct stenting without balloon
“predilation” prior to stent placement which could affect the results.
Balloon expandable wire stents are crimped over the balloon to allow passage
through the arterial access. One of the first used stents implemented was the Palmaz
stent. This stent is made of stainless steel with silver soldered cross points to help resist
radial collapse [19]. The Palmaz stent is still commercially used today. During a stent
placement, balloon angioplasty is sometimes first performed to expand the lumen of the
artery, referred to as “predilation” [19]. After retraction of the catheter, another catheter
is inserted with a balloon with a crimped stent over the balloon. As the balloon is inflated
again to approximately 10 atmospheres pressure for about 10 seconds, the stent is
deployed and secured into the vessel wall [19].
Although stents can reduce the effect of negative remodeling, they can also result
in higher cases of intimal hyperplasia than angioplasty alone [23-25]. There are several
variables which could potentially affect this such as the balloon compliance, pressure of
inflation, and the distance between stent struts. Using both in vivo and finite element
analysis (FEA), Rogers and collaborators demonstrated that there are higher contact
stresses between the stent struts and a greater surface-contact area between the stent and
the artery with higher balloon inflation pressures, increased balloon compliance, and
wider stent-strut openings [26]. Understanding this relationship is important is stent
design and deployment procedure to minimize vascular injury.
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Drug eluting stents
Drug eluting stents (DES) are a recent advancement in stent technology although
long term studies are still under evaluation. In a drug eluting stent, drugs can be directly
attached to the metal stent or embedded within a polymer coating within the stent which
serves as a reservoir for drug release [27]. Local dosage tissue delivery of drug eluting
stents eliminates the risk of systemic toxicity [28]. New drugs are constantly under
evaluation for use in drug eluting stents. Anticoagulants, steroids, and antiproliferative
agents have three general categories of possible coatings applied to stents [29]. The two
most well documented and FDA approved drugs commercially are rapamycin
(Sirolomus) and taxane (Paclitaxel). Both of these drugs are commonly used but have
differing attributes. For example, arterial transmural distribution of sirolomus tends to be
evenly distributed while paclitaxel remains within the subintimal space [30]. The
mechanisms of action also differ between these two pharmacokinetic agents.
Sirolomus inhibits the mammalian target of rapamycin (mTOR) [27, 31]. mTOR
regulates protein translation and the inhibition of mTOR results in G1 arrest of the cell
cycle [27, 32]. Arresting the cell cycle in the late G1 phase does not allow DNA
replication of the cell [31]. In result, vascular smooth muscle cell migration,
proliferation, and growth are inhibited [32]. This mechanism is shown in Figure 3. In
animal studies, sirolomus has been shown to have decreased inflammatory response and
neointimal hyperplasia formation in addition to inhibited SMC migration and promotion
of a contractile SMC phenotype [33-35]. Adversely, sirolomus has also been shown to
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have increased platelet aggregation which paired with delayed re-endothelialization
results in a higher risk of subacute thrombosis [36].
Paclitaxel is an anti-proliferative agent belonging to the group of taxanes which
are commonly used in cancer treatment [27]. Paclitaxel works by disrupting the
cytoskeletal components during cell division. Specifically, paclitaxel polymerizes the α
and β units of tubulin incorporated with the microtubule structure [27]. Paclitaxel arrests
the cell in the G2/M phase of mitosis by accumulation of microtubule structures [31].
This mechanism can be seen in Figure 3. The disruption of the microtubules in mitosis is
important because the microtubules form the mitotic spindle during cell division. Similar
to sirolomus, paclitaxel has been shown to inhibit smooth muscle cell migration and
proliferation [37]. Some of the adverse effects of paclitaxel in studies have been
incomplete healing, increased number of macrophages, and fibrin deposition [38]. Direct
application of paclitaxol has demonstrated differing results than polymer coated stents
with paclitaxol within the polymer. Stents coated with poly(lactide-co-Σ-caprolactone)
have shown a more effective drug kinetic profile with high initial release but lower
controlled release within the following 10 days [39]. Stents with directly attached
paclitaxel have resulted in higher rates of sub acute thrombosis rates [27].
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Figure 1.3 Drug-eluting stents: mitosis inhibition by sirolomus and paclitaxel [40]

Other drugs including derivatives of sirolomus and paclitaxel continue to be
investigated for use in drug eluting stents, but results are still preliminary. Some of the
points of interest for potential drugs include: time to re-endothelialization, endothelial
cell function, smooth muscle cell migration, smooth muscle cell proliferation, smooth
muscle cell phenotype, vascular healing, and inflammatory response. A combinatory
drug approach to address multiple points is also a subject of interest for drug eluting
stents.
Variations of the stent and polymer coatings can also affect the response of drug
eluting stents. The ideal drug eluting stent should have appropriate radial strength,
flexibility, and a large surface area for drug loading [27]. The design of the stent should
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have struts close together to allow for complete drug coverage distributed to the lesion
and surrounding areas [27]. If the struts are too far apart, areas of the blood vessel will be
unable to gain access to the drug. One particular stent, the Conor drug delivery stent,
uses laser cut pockets to allow for a combination of different polymers and drugs within
different pockets and an optimal drug release profile with time over the affected area
[41].
The purpose of the polymer coating is to promote adequate drug adherence to the
stent. Different layers of polymers or different polymer concentrations can also be used
to vary the drug release over time [27]. Early polymeric coatings were associated with
problems of biocompatibility, inflammatory response, and neointimal proliferation [42].
Inorganic coatings are currently used to enhance the electromechanical properties and
reduce inflammatory response and platelet activation [27]. The polymer coating of the
commercially available sirolomus eluting stent Cypher contains a co-polymer system
consisting of polyethylene-co-vinyl acetate and poly n-butl methancrylate
(PEVA/PBMA). The polymer of the paclitaxel eluting stent Taxus manufactured by
Boston Scientific consists of the Translute polymer [Poly(styrene-b-isobutylene-bstyrene)]. Since long-term studies are still limited with drug eluting stents, there is some
question concerning the stability and inertness of the polymer coatings with time. For
example, Poly-methacrylate, the major component of the sirolomus-eluting stent, has
been shown to induce smooth muscle cell apoptosis in vitro [43].
The future of drug eluting stents would ideally incorporate biodegradable stents.
In theory, a biodegradable stent made out of a polymer, would be drug coated and
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implanted at the site of injury and slowly degrade over time, releasing the drug as it
degrades. Unfortunately, currently there has not been a biodegradable stent with the
required mechanical strength and surface properties like metal stents [31]. The idea of
biodegradable stents would eliminate the trauma associated with a permanent rigid
foreign body [31].
The potential of drug eluting stents decreasing the rates of restenosis is a highly
significant factor in health care systems. Although drug eluting stents currently cost
about five times more than non-coated stents, the cost and effectiveness profiles are
promising [44]. Current costs of drug eluting stents are high due to developmental and
research costs, exclusive licenses for pharmaceutical agents, and low production yield
[44]. Longer term studies and resultant reinterventions will be used for future evaluations
of cost effectiveness.
1.4.2 Restenosis
Following the endovascular procedure, restenosis, or the reclosing of the artery
can occur.

Restenosis in balloon angioplasty alone can occur in 30-60% of the

procedures [45]. Stenting reduces the rate of restenosis to 13-36%, but is still clinically
significant [12]. There are several factors that can contribute to restenosis which include
both chemical and mechanical factors. Intimal hyperplasia, injury response, elastic
recoil, and vascular remodeling are key components of restenosis.
Characteristics of Restenosis
Restenosis following stenting can differ from restenosis following balloon
angioplasty. Following stenting, restenosis occurs mostly from neointimal formation
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with only 11% cells and consists mostly of ECM, proteoglycans, and collagen [40].
Neointimal hyperplasia is mostly due smooth muscle cell hyperplasia [29]. The primary
difference between in-stent restenosis and balloon angioplasty alone is the increased
presence of cells and their proliferation in addition to inflammatory markers in the case of
in-stent restenosis [46, 47]. Neointimal proliferation surrounding a stent results from the
vascular trauma from stent wires at the time of implantation, the interaction of the blood
components and the stent material interface, and the altered fluid velocity and pressure
profiles [48-50].
Contributing Factors to Restenosis
Many factors contribute to intimal hyperplasia and potentially restenosis. As
noted, following endovascular procedures like balloon angioplasty and stent placement,
the endothelial monolayer is severely damage or completely denuded from the arterial
lumen. This removal of the protective endothelial cells can result in platelet adhesion and
aggregation due to the release of platelet-derived growth factor (PDGF) [51].
Role of Endothelial Cells
Endothelial cells are also important in their release of heparin. Studies have
shown that heparin helps to maintain the quiescent, low proliferating state of smooth
muscle cells [52]. Without the anti-proliferative effect of the heparin from the
endothelial cells, there is less control on smooth muscle cell proliferation.
However, there are limitations to the involvement of endothelial cells in intimal
hyperplasia. When a small arterial area is denuded but endothelial cells recover the area,
there is minimal intimal hyperplasia seen [53]. In contrast, when a larger area is
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denuded and endothelial coverage is incomplete, intimal hyperplasia may reach a
maximum thickness at 2 months without endothelial cells [51]. This suggests that the
acute response and following few months are important for the role of endothelial cells in
restenosis.
Role of Platelet-derived growth factor (PDGF)
Studies have shown the importance of endothelial cells but there are other factors
that could potentially play key roles in restenosis. Adherent platelets deliver PDGF to
the injured vessel wall which may be an important factor [51]. However, aggregated
platelets may play a significantly lesser role due to the rapid clearance of their released
PDGF [51]. PDGF stimulates DNA synthesis and cell proliferation by allowing the cell
to leave the arrest state (G0) and move into the cell cycle state of (G1). The release of
PDGF stimulates mitogenic and chemotactic movement of medial smooth muscle cells,
causing migration and proliferation of the smooth muscle cells toward the intima [51].
Smooth Muscle Cell Migration
Smooth muscle cell migration plays a contributing role in intimal proliferation.
Cell migration is influenced by both biochemical and mechanical influences. Endothelial
cells are important in the regulation of smooth muscle cell migration. Endothelial cells
are responsible for the secretion of autocrine and paracrine factors. There are several
factors that may inhibit smooth muscle cell migration that are associated with endothelial
cells. Some of these include: nitric oxide [54, 55], endothelial plasminogen activator
inhibitor-1 (PAI-1) [56], platelet derived growth factor isoforms (PDGF-AA and PDGFBB) [57], endothelial basic fibroblast growth factor (bFGF) [58], transforming growth
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factor-β1 secretion, and inhibition of SMC hyaluronanic secretion [59]. Denudation of
the endothelial layer and these factors allows for SMC migration.
Matrix metalloproteinases (MMPs) are a group of mechanosensitive proteases
that may be important to smooth muscle cell migration. They degrade extracellular
matrix components such as collagen, laminin, and fibronectin [60]. In addition, they
break down non-matrix substrates such as growth factors and cell surface receptors [60].
These functions make them very important in the process of vascular remodeling. In
combination with chronic strain (5%), endothelial derived MMP-2 has been shown to
mediate the down-regulation of BASMC migration [61]. The same response was not
seen in the static controls, suggesting the importance of cyclic strain. In response to
vascular remodeling stimuli, the up-regulation of MMP-2 and MMP-9 derived from
smooth muscle cells degrades the basement membrane and the surrounding extracellular
matrix, therefore facilitating smooth muscle cell migration [61].
Smooth Muscle Cell Proliferation
Smooth muscle proliferation is believed to be an acute response to injury and can
occur up to seven days following balloon angioplasty with most of the cells entering the
growth cycle within the first 2-3 days following injury [8]. Following the acute response,
the number of smooth muscle cells within the intima stays relatively constant up to a year
following the endovascular procedure. Due to the stability of the smooth muscle cell
population with time, further increases in intimal hyperplasia are believed to be due to the
production of extracellular matrix and connective tissue and from cellular hypertrophy
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[9]. Maximum intimal thickening in humans usually occurs within 2-3 months of injury
[10].

Phenotype of Vascular Smooth Muscle Cells
Normal non-diseased smooth muscle cells reside primarily in the media layer of
the blood vessel and are of a contractile phenotype. Following balloon angioplasty,
medial smooth muscle cells can change from a contractile to a synthetic phenotype [1].
These synthetic cells migrate to the intima and proliferate and excrete extracellular matrix
components such as elastin, collagen, and proteoglycans [12]. The extracellular matrix
production of synthetic smooth muscle cells is 4-5 times the amount of ECM produced by
contractile smooth muscle cells. It is estimated that 50% of the smooth muscle cells that
migrate from the media due to balloon angioplasty divide 3 times [8]. These cells make
up eight ninths of the resultant intimal smooth muscle cell population [8]. The
remaining one ninth of the resultant smooth intimal smooth muscle cell population
consist of the remaining 50% of smooth muscle cells activated from balloon angioplasty
which simply migrated to the intima without further replication [8]. Synthetic smooth
muscle cells are characterized by: increased number of synthetic organelles, such as
rough endoplasmic reticulum, increased proliferation, decreased α-actin, loss of
contraction ability, and an increased cell volume [2]. In contrast, contractile smooth
muscle cells are generally spindle shaped, non-proliferative, able to contract, and contain
relatively more α-actin than synthetic smooth muscle cells [2]. Mechanically, the
stiffness of contractile smooth muscle cells has been shown to be higher than synthetic
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smooth muscle cells [62], and suggested to be from an increased amount of actin within
the SMCs [62].
In summary, it is hypothesized that the degree of activation of smooth muscle
cells following angioplasty affects the migration and proliferation characteristics of
smooth muscle cells and directly contribute to the degree of intimal thickening and
hyperplasia.
Impact of Endovascular Intervention
The actual surgical procedure can impact restenosis. Balloon angioplasty
specifications depend on the disease state of the vasculature, surgical preference, balloon
diameter, injury length, and other contributing factors. The extent of the injury in terms
of the transmural pressure exerted on the vessel wall and on the cells within the vessel
wall can affect the cellular response to injury. Experiments in literature have shown that
a large injury without media damage initiated medial smooth muscle cell replication, but
no intimal proliferation [63]. In contrast, when a small but deeper injury was performed,
intimal proliferation occurred. In the first case, there was also platelet adhesion and late
endothelial recovery while in the second case, platelets were absent and the endothelial
monolayer was quickly recovered.
This can also be associated with the rupture of the internal elastic lamina. This
supports the theory that mechanical or possibly inflammatory activation of smooth
muscle cells is needed to initiate smooth muscle cell proliferation and that platelet
adhesion and endothelial denudation, although can contribute to proliferation, are not
strong enough stimuli to initiate smooth muscle proliferation. The injury from balloon
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angioplasty can cause several disturbances within the blood vessel including platelet
aggregation, endothelial denudation, growth factor production from injured and dead
smooth muscle cells, attraction of leukocytes and macrophages from the inflammatory
response, and mechanical sustained stretch of smooth muscle cells, which can all
contribute to cellular proliferation [51].
Composition of Atherosclerotic Lesion
The composition of the atherosclerotic lesion can indirectly contribute to intimal
hyperplasia and restenosis. With varying amounts of fibrous tissue, lipid, calcium, and
organized thrombus, the mechanical rigidity of the plaque can differ. The resultant
distensibility of the lesion area of the vessel is significantly lower than the normal vessel
wall and is not easily compressed by the tensile forces of the balloon. The plaque within
the wall is not compliant so unfortunately, the surrounding smooth muscle cells and
tissue are subject to most of the applied balloon tensile force [51]. The stiffer the plaque
composition, the more force that is necessary to expand the vessel, resulting in higher
pressures exerted on surrounding cells. The severe increase in diameter from increased
radial expansion also exposes a greater surface area of smooth muscle cells that are
exposed to shear force and subject to platelet adhesion. However, the higher the plaque
content within the blood vessel, the more likely the vessel will retain the open lumen
following angioplasty due to less elastic recoil because of the lower elastic properties of
the atherosclerotic vessel.

28

Tissue-stent reaction
The body reacts to foreign objects not normally seen, even if they are considered
to be biocompatible materials. With a stent placement, there is a reaction to the
mechanical force of the stent in addition to the material reaction. After stent deployment,
the stent is in contact with both surrounding cells and with blood flow. With any implant,
both the acute and long-term responses are important for function. In the case of a stent,
the reaction will be driven by the surface characteristics of the material such as
roughness, electrical charge, free surface energy, and wettability [64]. The roughness of
a stent can be altered by the machining process. The thrombogenicity of a material
increases with rougher materials [64]. In the case of a bare metal stent, a thin metal oxide
layer resides between the stent and surrounding tissue [64].
Immediately following stent implantation, reaction occurs. Bare metal metallic
stents have an initial positive surface charge [64]. When implanted, this surface potential
attracts plasma proteins and results in a 5-20 nm thick layer of fibrinogen surrounding the
implant within seconds of implantation [64]. After 24 hours, a layer of fibrin strands
oriented in the direction of flow is present [65]. After a few days, a fibromuscular tissue
replaces the thrombotic layer [64]. This tissue reaches a maximum thickness around
eight weeks and then replaced by collagen [66].
According to Palmaz, the embedment of the stent struts within the vessel wall can
impact the thrombogenic response. If the stent is not embedded, thrombus can be
deposited as a continuous layer and can result in delayed reendothelialization and
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therefore increased time for possible thrombus deposition and fibromyocyte proliferation
[64].
In general, the surface interaction of the stent with surrounding tissue is an
important consideration in the issue of thrombosis. Surrounding tissues can be affected
significantly by smaller scale factors such as metal ions and polymer particles at the
individual cell level due to geometries, surface energy, and electrical charge.

Drug Therapies and Restenosis
New pharmacologic approaches are continually being investigated for restenosis,
targeting different mechanisms. Three of the common categories of interest are:
•

Antiplatelet agents

•

Antiproliferative agents

•

Antimigratory agents

Although there has been limited success with antiplatelet agents reducing
restenosis in clinical studies, there is a potential for development. Animal studies have
shown that by decreasing the number of circulating platelets, smooth muscle cell
proliferation can be reduced [67]. However, this can cause complications of hemorrhage.
In addition, Cyclooxygenase inhibitors like aspirin are antiplatelet and anti-inflammatory
agents that can actually increase smooth muscle cell proliferation in vitro [68, 69].
Antiproliferative agents such as heparin can help reduce smooth muscle cell
proliferation and migration [52, 70]. It should be noted that heparin subfragments are of
interest because they do not have an anticoagulant effect, therefore bleeding
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complications are minimized. PDGF antagonists, such as triazolopyrimidine, lovastatin,
prostaglandin E1 or I2, are other antiproliferative agents that can inhibit smooth muscle
cell proliferation [69, 71-74].
Antimigratory agents could help reduce smooth muscle cell migration, and
therefore intimal proliferation. These include caffeic acid derivatives and calcium
antagonists [75-77]. Other agents that have been investigated reduce the production of
extracellular matrix and therefore reduce intimal thickening [78].
Other pharmacologic approaches investigated for restenosis include antiinflammatory agents and anti-thrombotic agents. Tissue factor pathway inhibitor (TFPI)
is an anti-thrombotic agent that has been shown to prevent thrombotic occlusion and
prevent formation of neointima in a balloon angioplasty experiments [79, 80]. It has also
been shown to inhibit smooth muscle cell proliferation in vitro [81]. TFPI is thought to
inhibit synthetic smooth muscle cell proliferation and block medial smooth muscle cell
proliferation [12].
Overall, pharmocologic agents should act before or immediately following
balloon angioplasty. As previously mentioned, intimal proliferation begins immediately
following injury and can continue for up to two weeks. Success in clinical trials with
current agents has been limited probably due to the complexity of the balloon angioplasty
injury in vivo. Injuries in stenotic arteries induce a larger injury with a greater surface
area for platelet exposure. The increased injury in clinical angioplasty induces an
increased smooth muscle response [51]. Synergistic combinations of pharmacologic
agents are current areas of interest in the treatment of restenosis.
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In addition to pharmacologic agents, there are other approaches that are being
investigated to minimize restenosis. These include: 1) minimizing smooth muscle cell
injury, 2) destruction of smooth muscle cells, and 3) improvement of blood flow.
Minimizing smooth muscle cell injury may be achieved through direct laser or ultrasonic
ablation of atheroma or linear extrusion balloon techniques [51]. The destruction of
smooth muscle cells in the lesion could reduce smooth muscle cell proliferation [51].
Blood flow can be improved with stent devices to maintain the area of the lumen;
however, these have problems associated with them as well due to alteration of fluid
mechanic forces.

1.4.3 Blood Vessel Mechanical Forces
Mechanical forces play a key role in normal vessel function, diseased vessels, and
injury response. There are several forces that can affect the blood vessel such as the
shear force from blood flow, tensile force exertion due to dilation, and hydrostatic fluid
pressure. These applied forces result in stresses in the longitudinal, radial, and
circumferential directions [82].
Fluid Forces
Flow mechanics of the arterial system are important regulators of the arterial
system. The flow rate, velocity profile, and resultant wall shear stresses directly affect
surrounding vascular components. Differences in arterial location, direction,
bifurcations, and unhealthy conditions can complicate the fluid profile characterization of
blood vessels. Small healthy sections of the vascular system are considered to be subject
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to Hagen-Poiseuille flow, or laminar flow through circular tubes [83]. Smaller vessels
which may be more prone to occlusion, such as the carotid artery have flow rates in the
range of 300-400 mL/min. In the case of atherosclerosis, several almost contradicting
fluid alterations have been considered in the past as initiating or contributing factors such
as both high and low shear stresses and both high and low pressures [84]. In actuality,
both low and high extremes for conditions could have negative results. For example,
although recently low shear stress is seen more as atherogenic and high shear stress as
atheroprotective, early studies have shown that intimal thickness results in areas of high
shear at early time points while low wall shear was associated with advanced intimal
thickening, demonstrating negative effects in both cases deviated from an optimum range
[85, 86]
Flow can be steady or unsteady in nature. In steady flow, the velocity of the fluid
at a fixed point does not change with time, while the velocity field varies over time for
unsteady flow. Three types of unsteady flow include: nonperiodic flow, periodic flow,
and truly random flow [83]. Blood flow would be considered periodic flow regulated by
the cardiac cycle. However, the pattern of blood flow depends on the location of the
artery. Large arteries such as the aorta are generally unsteady while blood flow through
small arteries and capillaries is considered almost steady in nature.
The velocity profile of a fluid can be either laminar or turbulent. If a flow is
laminar, it has a uni-directional stream-lined velocity profile. In contrast, turbulent flow
is characterized by random three dimensional vorticity [83]. The unitless characteristic
Reynold’s number of a fluid generally determines if flow is laminar or turbulent in
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nature. The formula for the Reynold’s number (Re) of a straight circular tube of constant
cross section is:
Re =

ρUd
µ

Equation 1. Reynold’s number to determine laminar or turbulent fluid behavior
Where ρ, U, d, and µ represent the fluid density (kg/cm3), velocity (cm/s), diameter (cm)
and dynamic viscosity (dyne*sec/cm2), respectively. In the general case for pipe flow,
flow is considered to be laminar if the Reynold’s number is less than 2100, and turbulent
if it is greater than 2100 [83]. However, if the Reynold’s number is close to 2100, the
fluid may be considered semi-turbulent.
In the case of arterial mechanics, variations in arterial geometry can cause areas of
localized turbulence. These could be naturally occurring due to a bifurcation or a result
of a protruding atherosclerotic lesion or stent strut effects. These areas of turbulence
result in local changes of wall shear stress behavior on the surrounding cells.
The turbulence due to atherosclerotic lesions has been used in the past to
characterize atherosclerotic arteries. The auditory frequency of the blood is different in
areas of turbulence [84]. The variation in sound could be used to estimate the lumen area
reduction due to the presence of relatively large plaque formations [87]. Within the past
twenty years or so, many improvements upon this principle have been instated in the
form of Doppler velocimetry ultrasound as a non-invasive diagnostic technique.
Shear stress is another important fluid characteristic formula when examining
blood vessels. Cells have been shown to respond to varying levels of shear stress. The
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shear stress is dependent upon the radial location. For a parabolic profile, the formula for
shear stress is given in Equation 2 where µ is the fluid dynamic viscosity
(dynes*sec/cm2), U is the velocity (cm/s), and r is the diameter of the blood vessel (cm).

τ =µ

dU
[88]
dr

Equation 2. Shear Stress Formula
With the cell location lining the arterial walls, the wall shear stress is of greater
interest. Wall shear stress of a cylinder is directly related to the volumetric flow rate
through the equation (Eq. 3) of:

τw =

4µQ
[88]
π R3

Equation 3. Wall shear stress formula
Where τw is the wall shear stress (dynes/cm2), µ is the dynamic viscosity of the fluid
(dynes*sec/cm2), Q is the volumetric flow rate (cm3/sec), and R is the radius of the blood
vessel (cm). Interestingly, despite significant differences in arterial diameter, most blood
vessels will adjust to maintain wall shear stresses of 10-20 dynes/cm2 [84]. This
compensatory adjustment brought way to an early theory of atherosclerosis presented by
Giddens and collaborators which proposed that early atherosclerotic plaque location is
initiated by an unstable arterial remodeling response to decrease the radius of the artery if
the wall shear stress is below the optimum range [84, 89].
Besides the adjustment of the parameters of the Equation 2, alterations in
geometry can cause localized area of turbulence. The normal blood flow of an artery is
considered laminar, but there are arterial areas that are exposed to turbulence and have

35

been shown to be more susceptible to atherosclerosis. Arterial bifurcations are often
susceptible to disease due to altered velocity profiles. For example, where the common
carotid branches into the internal and external carotid, an area of flow separation occurs
at the outer sinus wall, resulting in a fluctuation in the direction of the fluid velocity and a
decreased wall shear stress [90, 91]
The viscosity of blood is an important parameter to consider. Blood is a Casson
fluid, meaning the viscosity of the fluid decreases with increasing shear rate. This is in
contrast to Newtonian flow which has a constant viscosity at all shear rates. The reason
for the varying behavior of blood is due to the cellular components and proteins within
the blood that make blood a heterogeneous fluid [88]. As the shear rate increases, the
fluid starts to act as a Newtonian fluid as the aggregates of particles are broken up and the
result is a decrease in apparent viscosity of the fluid [88]. The shear rate at which blood
starts to act as a Newtonian fluid is approximately 100/sec at 37 degrees Celsius [88].
Near the walls of the blood vessel, the flow can be considered Newtonian because the
wall shear rate is greater than 100/sec [88].

Effect of Atherosclerosis on Fluid Mechanics Properties of a Blood Vessel
Although these fluid properties can be easily identified in normal healthy linear
blood vessels, alterations in these components that are of greater interest in
atherosclerotic lesion and restenosis research. Clinical autopsies have shown that early
atherosclerotic lesions were more likely to develop in areas of flow separation, low wall
shear stress, and oppositional flow [90]. Maximum plaque formation occurred at the
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outer wall, where flow separation could occur, and minimal formation at the inside
divider of the bifurcation [90]. Several in vitro studies have using glass arterial models to
study the effect of the hemodynamic forces support clinical results. For example, using
pulsatile flow with intervals of systolic and diastolic function resulted in changes in fluid
velocity and direction in a glass carotid bifurcation model, whereas these were not seen in
steady flow conditions [92].
The presence of large protruding lesions or stent struts can cause alterations in the
fluid profile. Although the Reynold’s number may indicate laminar behavior, local areas
of disturbance can occur. The flow through the stenosed area, referred to as stenotic
flow, has areas of flow separation, strong shear layers, recirculation, reattachment and
turbulence [93]. Turbulent flow within the blood vessel can have several negative effects
besides the previously mentioned effect on the wall shear stress. In addition, there are
several other physiologic events are affected such as the tensile stress on the cell
membrane of endothelial cells, mass transport between the blood and vessel wall, blood
clot formation, and the blood rheology [94].
Tensile and Pressure Relationship to Blood Vessel Properties
Blood vessels are subject to tensile forces as the blood flow is transferred from the
heart to the peripheral arterial system. In order to compensate for the large stroke volume
from the heart, large arteries will expand to compensate for the increased pressures.
Following expansion, the elastic recoil in combination with smooth muscle cell
contraction, brings the artery back to its original shape and provides pressure to maintain
proper pressure for the cardiac diastolic phase [95]. Large arteries also have high elastin
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and collagen content for delivery of the fluid to peripheral tissues [95]. In contrast, small
arteries and arterioles minimize the pressure drop by having a large lumen-to-wall
thickness ratio. At the cellular level, high pressures can result in smooth muscle cell
hypertrophy and hyperplasia. Wall stiffness can be increased by the contraction of
smooth muscle cells [96, 97].
The tension placed on the blood vessel is commonly represented using LaPlace’s
law shown in Equation 4, where T is the tension in the wall (dynes/cm), P is the blood
pressure (dynes/cm2), and r is the radius of the blood vessel (cm).
T = Pr [98]

Equation 4. LaPlace’s Law
In addition to the artery diameter and pressure as suggested in Equation 4, the tensile
stress can also be dependent upon the distance from the heart [95]. The relationship
between the tensile stress and the wall tension is that the tensile stress is equal to the wall
tension divided by the vessel wall thickness [96]. The normal tensile stress levels normal
to the vessel wall are approximately 1000-2000 dynes/cm and the wall thickness can
adjust to maintain these stress levels [91, 99].
Normal healthy blood vessels are generally characterized as being viscoelastic.
Viscoelasticity refers to the dependence of speed, magnitude, and applied force on the
elasticity of a material. In contrast, a purely elastic material returns to its original form
instantaneously following deformation and commonly referred to as a Hookean elastic
material. For other material properties, blood vessels are anisotropic and heterogeneous
in nature. The heterogeneous property of the arteries refers to the fact that the material
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properties are not the same throughout the blood vessel due to varying components
within the walls of the artery [100]. The direction of applied load matters as well,
anisotropic behavior states that the material properties depend on the direction of applied
load. In the case of blood vessels, the direction of both collagen and elastin fibers
contributes to this material property [100].
Effect of Atherosclerosis on Stiffness Properties of the Blood Vessel
In a diseased state, the stiffness of the artery can be altered. If the artery is
significantly stiffer, it is more difficult for the artery to expand, resulting in higher
pressures exerted on the walls of the artery. Plaque formation within the walls of the
artery causing protrusions can affect blood flow as previously discussed, but the presence
of plaque can also effect the compliance of the artery as well. In late atherosclerotic
lesions, the high prevalence of plaque generally stiffens the artery [101]. Within the
plaque, areas of vascular calcification demonstrate decreased elasticity and compliance
[102]. Compared to plaque consisting of cellular plaque, calcified atherosclerotic plaque
is 4-5 times stiffer [103].
The elastic modulus of the artery is not dependent upon the wall dimensions,
while the stiffness of the artery depends on both the wall dimensions and material
elasticity [101]. This is important in the case of atherosclerosis because often the arterial
wall increases in thickness, which would further alter the mechanical behavior rather than
the elasticity modulus of the material alone. The elasticity of a blood vessel will depend
on the stage of atherosclerosis, vascular location, and the species involved [101]. As
atherosclerosis progresses, the wall thickens followed by wall stiffening. Abnormal
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collagen production increases and elastin within the artery decreases causing arterial
stiffening [104]. This is of importance because collagen and elastin in the extracellular
matrix within the arteries provide mechanical integrity and the elasticity of the artery. A
summary of the contributors and locations of arterial stiffness can be seen in Figure 4.

Figure 1.4 Summary of arterial stiffness locations and causes [105]
The elastic modulus does not change until late stages when the walls have areas of high
calcification and wall hypertrophy and result in higher values of both the elastic modulus
and stiffness [101].
Plaque rupture is always a concern with atherosclerotic lesions. The stability of
plaque is determined in part by mechanical stiffness of the artery. The stability of the
plaque is affected by the degree of calcification. Higher points of failure stress, or Von
Mises stress, tend to occur at the interface between materials with varying material
properties of stiffness [106]. Biomechanically, the higher the number of interface sites,
the greater the chance of rupture [82]. As calcification increases, risk of rupture can
actually decrease as plaques coalesce and result in less material interface sites [82].
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Hypertension is commonly involved in atherosclerosis and increased rigidity of
arterial walls. Increased rigidity of the wall in part is due to increased arterial wall
thickness caused by vascular smooth muscle cell hypertrophy [107]. Vascular smooth
muscle cell hypertrophy are polyploidal in nature, with a five fold higher mass than
diploid vascular smooth muscle cells, higher levels of PDGF A, fibronectin, and collagen
III [108]. VSMC polyploidy is characteristic of abnormal smooth muscle cells that have
a malfunctioning spindle cell cycle checkpoint in the mitotic cycle which normally
prevents the exit of mitosis if chromosomal segregation cannot be complete [109, 110].
Effect of Intervention on Blood Vessel Mechanics
Mechanical forces within the blood vessel play a contributing role to the response
following endovascular procedure. Although intimal hyperplasia could contribute to
restenosis, following angioplasty the lumen diameter does not significantly change from
intimal hyperplasia. An additional contributor may result from the surrounding
mechanical forces that the vessel is exposed to. The fluid dynamics of the blood vessel in
stenotic regions can be disturbed which can disrupt normal function. Intimal thickening
is generally located in areas of low shear stress or areas of fluctuating wall shear stress
[51]. The geometry of poststenotic regions can result in areas of flow separation and
turbulent vortexes of fluid velocity as demonstrated in Figure 5.
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immersed body

Areas of flow
separation and vortex

Flow Reattachment Point
Figure 1.5 Alterations in fluid profile due to stenotic lesions

This effect is also present following a stent strut. Alterations in wall shear stress from
normal function have also been suggested to affect the endothelial monolayer recovery
which could contribute to increased intimal proliferation [111, 112].
In the blood flow, stent struts can cause a similar action to immersed bodies
depending on the level of embedment of the strut. This immersion in blood flow can
cause formation of flow separation dependant upon the Reynold’s number of the fluid.
As the Reynold’s number decreases toward zero, the streamlines of fluid flow are able to
adapt around the profile and are essentially the same as the streamlines before the object.
The larger the Reynold’s number, the greater the distance of the separated region and
increase of the importance of viscous effects [83]. The areas of separation are
characterized by local turbulence and recirculation causing times of stagnant flow and
varying wall shear stresses.
Restenosis of smaller diameter vessels is usually more common than restenosis of
larger vessels. This could partly be due to the inverse relationship of the rate of blood
flow to intimal proliferation. As the flow rate increases, the rate of intimal proliferation
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decreases. In relationship to wall shear stress, there is a direct relationship between
increasing wall shear stress and flow rate as indicated in Equation 2. Additionally, the
increased size of the lumen allows for a smaller ratio of occlusion, allowing for a
sufficient cross-sectional area of the lumen for blood flow. Generally, the vessel will
adapt with local dilation or constriction to normalize the wall shear stress. In contrast to
being controlled by the smooth muscle cells, it is believed that a sustained lumen
diameter increase is primarily controlled by the endothelium, particularly by
endothelium-derived relaxing factor (EDRF) production or release [113]. However, it
has also been shown that vessels with denuded endothelium or abnormal endothelium in
atherosclerotic arteries can still adjust lumen diameter to increased or decreased flow
rates [114, 115].
There are several possible contributing mechanical factors to restenosis.
According to Liu and collaborators, the following series of events are proposed for
coronary restenosis. Following the balloon angioplasty, intimal proliferation
immediately occurs along with a new flow pattern of the vessel. If there is a residual
stenosis, the area will be subject to areas of flow separation. Areas of flow separation
will continually be subject to low wall shear stress, which could enhance proliferation
and lead to further disrupted flow. Overall, the dilated segment after angioplasty can
narrow due to disturbed flow and low shear stress which can cause intimal growth and
wall structural changes that can decrease the lumen. Restenosis is less likely to occur if
normal levels of shear stress are maintained and intimal thickening regresses after acute
reaction [116].
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In addition to abnormal low shear stresses and flow patterns, there are other
factors that lead to increased rates of restenosis including residual stenosis greater than
30% [117]. Areas with higher flow rates with the same degree of residual stenosis, can
result in larger areas of flow separation, and therefore increased neointimal hyperplasia.

1.4.4. Vascular Cell Mechanics and Response
The field of cellular mechanics has grown significantly over the last several years
with refined techniques and increasingly lower scale measurements. There are several
cell components that determine the mechanical properties of the cells, with the most
influential being those that constitute the cytoskeleton of the cell including microtubules,
actin filaments, and intermediate filaments [118].
Cells can either be considered as continuous or discrete structures dependent upon
the application. On a whole cell scale, cells can be modeled on a continuum, but local
deformation of cells cannot due to discontinuities in the mechanical behavior [118].
Cellular biomechanics are showing to be an important method of investigation for
examining mechanical signals as interpreted and relayed by the cytoskeleton and cellECM interactions [118]. Although the work of this project is based upon the treatment of
cells as a continuum and examining whole-cell deformations in response to applied
mechanical forces, it is important to be present other approaches of cell mechanics.
Mechanotransduction
The conversion of mechanical signals to biological signals involves the important
aspect of mechanotransduction. There are several cellular components that are thought to

44

be involved in mechanotransduction. These include: cytoskeleton components, G
proteins, receptor tyrosine kinases (RTKs), integrins, mitogen-activated protein kinases
(MAPKs), and stretch-activated ion channels [119].
Cells are in contact with other cells and surrounding extracellular matrix. Cellmatrix adhesions come in the form of focal adhesions, focal complexes, fibrillar
adhesions, and three-dimensional matrix adhesions [120]. Focal adhesions are the best
characterized and largest of these interactions. Integrins link the extracellular matrix to
the cytoskeleton and regulate the formation of focal adhesions and function to regulate
signals across the cell membrane and are involved in cell functions like migration,
attachment, migration, and differentiation in addition to the recruitment of kinases for
pathways [121, 122]. The clustering of integrins causes recruitment of scaffold proteins
and trigger cytoplasmic signaling [120, 122]. With increased focal adhesion formations
due to increases in cytoskeletal tension, downstream signaling suggest a proliferative
effect on cells [123]. In part, proliferation is controlled by focal adhesions by relating to
cell spreading. Cell spreading regulates tension within the actin cytoskeleton and along
with other factors can arrest the cell cycle downstream [120, 124]. In summary, cellmatrix interactions through the relationship of focal adhesions and tension can have
downstream effects on cell responses such as proliferation and migration through
signaling in the Rho family [120].
At cell-cell contacts, there are similar mechanisms of mechanotransduction that
occur. Cell-cell adhesions can be in the forms of adherens junctions, tight junctions, and
gap junctions. These are mediated by cadherins, occludins, and connexins [125-127].
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Mechanical forces have been suggested to increase formation of adherens junctions but
determining the effect of tension is difficult since isolating effects of cell-cell contacts
can be difficult due to the simultaneous effects of cell-matrix interactions [120].
Contradicting results have been seen in response to increases in tension affecting the
morphology and permeability of adherens junctions and other cell-cell junctions [128131]. Between both focal adhesions and adherens junctions, there appears to be an
antagonistic behavior where cell-cell adhesion competes and can decrease cell-substrate
adhesion [132, 133].
Vascular Calcification
Vascular calcification plays a significant role in atherosclerosis. In atheroclerosis,
vascular calcification occurs in the intima, whereas calcification in the media occurs in
medial or Mönkeberg’s sclerosis [102]. In advanced atherosclerosis, there are calcium
deposits located throughout the vessel [102].
Vascular smooth muscle cells are involved in later stages of vascular calcification
in atherosclerosis and the formation of atherosclerotic lesions. Smooth muscle cells in
atherosclerotic lesions demonstrate a synthetic phenotype, referring in part to increased
proliferation and migration and it has been suggested that a third phenotype for smooth
muscle cells is present for a calcifying SMC phenotype which are higher prone to
calcification [134]. It is theorized that macrophages are involved in this phenotypic shift
for increased calcification [135]. Apoptotic smooth muscle cells have been shown to
crystallize calcium and apoptosis has been suggested to the promotion of vascular
calcification [136]. Macrophages have been shown to induce SMC apoptosis [137].
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Vascular calcification has been linked to share common characteristics and
components with bone calcification. Some of the calcification-regulating proteins that
overlap between the two processes include: bone morphogenetic protein 2-a (BMP2-a),
osteopontin (OPN), and bone Gla protein, which are present within atherosclerotic plaque
[138-140]. These calcification factors can be due to loss of calcification inhibition.
Contributions in atherosclerosis appear to be a combinatory event between several
factors. These involve the cell to cell interaction as with smooth muscle cells and
macrophages, increased expression of calcification-regulating proteins or decreased
calcification inhibition, cytokines and growth factors such as tumor necrosis factor (TNFα), and circulating lipids and inorganic phosphates (Pi) [102].
In Vitro Vascular Force Application and Cell Response
Physiologic conditions involve a synergistic combination of forces that can be
difficult to mimic in vitro or isolation of individual or dual force effects may be desired.
For these reasons, mechanical force systems are constructed for the purpose of
mechanical stimulation similar to what the cells may experience in vivo. The arterial
system is a system of tensile and shear force applications applied to the blood vessel as
previously established. At the cellular level, cells within the blood vessel are subject to
these forces and respond to them, causing changes within the cell. Mechanobiology
refers to how cells convert mechanical signals into biological responses [119].
Cellular response to applied mechanical stimulation has been investigated in a
variety of force applications. Some of these include compressive loading, longitudinal
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stretch, bending, Out-of-plane and in-plane substrate distension, fluid shear, and
combination of above [141].

In Vitro Compressive loading
Compressive loading can basically be divided into indirect and direct loading.
Hydrostatic pressurization is an indirect force application which utilized applied fluid
pressure to cells and is physiologically present to most cells. In terms of implementation
in the laboratory setting, its advantages include: relative simplicity, stimulus
homogeneity, multiple sample adaptation, static or transient loading, no local
compaction, independence of adhesion effects, and no impedance of transport process
[141].
The disadvantages of applied hydrostatic pressurization are that the pO2 and
pCO2 levels in the media may become elevated in the media and the fact that many cells
are under greater influence of different forces than hydrostatic pressure [141, 142].
Direct displacement models are good for direct load bearing and contact articulation
models for bone and cartilage, respectively, and for investigation of the cell/matrix
interaction [141]. Direct Platen displacement has the disadvantages of Poisson-effect
anisotropy of strain, friction effects at the interface, and impediment of nutrient transport
due to the platen [141]. These models can be seen in Figure 6.
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(a)

(b)

Figure 1.6 Compressive Loading (a) Hydrostatic Pressurization (b) Direct Platen [141]

In Vitro Tensile Applications
There are a variety of modifications of deformable devices to apply strain to a
substrate. Unidirectional or longitudinal stretch systems either directly attach to opposing
ends or function with four-point substrate bending (Figure 7a). Both of these have been
developed with mostly homogeneous strain fields but have usually been used for lower
levels of strain less than 10% [141]. Deformable substrates are also highly utilized for
bidirectional and circumferential deformation applications in the in-plane and out-of
plane distension models. Out-of plane distension models function by direct application
of positive or negative pressures, such as fluid and vacuum, respectively, or by direct
platen or prong displacement [141]. In-plane distension devices, such as that present in
the developed simulator can work through direct platen displacement, direct bidirectional stretch (Figure 7b), or a combination of vacuum and platen deformation with a
frictionless surface (Figure 7c). Often, these all can contain areas of heterogenous strain

49

but can be compensated by localized placement of cultured cells in mostly homogenous
application area.

a)

b)

c)

Figure 1.7 Tensile strain application a) Uniaxial b) Bi-axial c) Radial and Circumferential
[141]

In Vitro Shear Application
The last testing system that will be directly addressed is the fluid shear system.
There are two basic configurations, the cone and plate system and the parallel plate flow
chamber (Figure 8).
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a)

b)

Figure 1.8 Shear stress testing systems a) Cone and plate system b) Parallel plate flow
chamber [141]

The range of shear force applied in the cone and plate system (Figure 8a) depends on the
conic taper and angular velocity [141]. The applied fluid shear stress is spatially
homogeneous since the local velocity and distance between the two components varies
linearly with radial position [141]. The parallel plate configuration (Figure 8b) works on
the premise of a pressure gradient across the system through the use of gravity heads or
active pumps [141]. The applied shear of the parallel plate flow chamber is also
homogeneous in nature with additional advantages of equipment simplicity, ease of
sampling, and ease of culture [141].
As previously discussed, there are several forces involved in the natural dynamic
blood vessel. One of the purposes of in vitro testing is the isolation of factors to narrow
in on the behavior of cells in response to stimuli. For this reason, the effects of in vitro
shear force and cyclic displacement applications will be the areas of focus since they are
the primary factors in the scope of this project.
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Response to Shear
Applied shear force to vascular cells causes many changes to the morphology of
the cells, gene expression, alignment, and differentiation. Under normal conditions, the
smooth muscle cells are protected from direct exposure to shear forces by the
endothelium, but following endothelial denudation, the smooth muscle cells are placed in
direct contact with blood flow. The level of dilation of the vessel and the flow behavior
can both severely affect the smooth muscle cell response. In one clinical study, smooth
muscle cell proliferation was lower in widely dilated lesions than in insufficiently dilated
lesion areas [117].
The application of shear force to smooth muscle cells can have various effects on
the cell response. For example, the flow behaviors as laminar or turbulent can invoke
different responses along with the magnitude of the shear rate. There are numerous shear
studies which demonstrate the inhibition of in vitro VSMC proliferation with high levels
of shear stress [143]. In general, shear stress levels above 10 dyne/cm2 are considered
high and atheroprotective [144]. In contrast, areas of low shear stress (<10 dyne/cm2)
promote atherogenic response and increased smooth muscle cell proliferation [144].
Areas of low shear can result from disturbed geometry and resultant areas of turbulence
or flow separation causing decreased velocity profiles.
There have been several studies to identify the mechanisms involved in both
increased and decreased smooth muscle proliferation in response to shear. One of the
proteins that may be involved with shear stress transduction is Transforming Growth
Factor-β1 (TGFβ1), a 25-kD homodimeric protein that is produced by several cell types
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such as VSMCs [145]. TGFβ1 is a cytokine that has been shown to suppress VSMC
proliferation [143]. TGFβ1 works by causing cell cycle arrest in the G1 phase [146]. In
one study of Ueba et. al, when a high shear stress of 28 dynes/cm2 was applied using a
cone-and-plate configuration to VSMC for 24 hours, gene expression of TGFβ1 increased
twofold, and its activator tissue-type plasminogen activator (TPA) increased fivefold
[143]. Shear stress also has been shown to upregulate TPA in endothelial cells [147].
Smooth muscle cell migration has been shown to be directly dependent to the
substrate on which the cells were grown by DiMillia and collaborators [148]. The
migration of smooth muscle cells is partly regulated by the p38 MAPK pathway and
relates to actin remodeling [149]. Migration of smooth muscle cells continues to be an
important issue in restenosis. Liu and collaborators have shown that the exposure of
shear stress in a laminar velocity profile inhibts SMC migration and maximum SMC
migration occurs in areas of stagnation, flow separation, and vortexes [150].
The alignment of smooth muscle cells in vivo is normally regulated by tensile
force since smooth muscle cells are normally not exposed to shear force. When shear is
applied to smooth muscle cells to simulate conditions following endothelial denudation,
alignment of the stress fiber orientation occurs. Lee and collaborators have shown canine
vascular SMCs to align their stress fibers perpendicular to flow in response to shear with
24 hours exposure with a physiologically equivalent shear stress [151]. This is in
contrast to endothelial alignment parallel to shear. In addition, Lee and collaborators also
demonstrated that the alignment of vascular smooth muscle cells depends on the
magnitude and time of shear exposure and also showed the dependence of intracellular
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calcium for SMC alignment [151]. However, SMC alignment results have not been
consistent in literature. In addition to perpendicular alignment, both parallel and random
orientation have also been documented in bovine and human aortic cells, respectively
[152, 153]. Liu and collaborators have shown SMC alignment parallel in high shear
stress regions and perpendicular in low shear stress regions [150]. Overall, alignment of
smooth muscle cells in response to shear appears to be highly dependant upon the type of
cells used and the level of applied shear.
Response to Cyclic Tensile Force
The application of tensile force applied to cells is usually in the form of
circumferential, uniaxial, or biaxial application. The direction applied is usually adjusted
to the application. In the case of vascular cells, they are cyclically deformed from the
dilation and relaxation of the blood vessel, usually represented by either circumferential
or uniaxial testing. The cyclic strain response of vascular cells is important to both
normal and abnormal cell function. It can effect cell proliferation, migration, apoptosis,
morphology, and alignment [154].
The cell response to applied cyclic tensile forces can vary with different
parameters such as the cell type, species, vascular bed, and the extracellular matrix [154].
In terms of mechanics, the frequency, amplitude, and time exposed to tension could also
affect the response of cells. The effect of cyclic forces on both endothelial and smooth
muscle cell proliferation is inconsistent, and seems to depend highly on the species and
source of age source of cells [154].
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Apoptotic response of both endothelial and smooth muscle cells depend on the
level of applied cyclic forces. Tensile forces corresponding to low physiologic strain (510%) has been shown not to induce cell apoptosis [155-157], while higher levels (1015%) have been shown to induce cell apoptosis [157, 158]. One theory is that the high
level of applied force results in significantly higher stresses and causes cell death and
invoking an inflammatory response [159].
Smooth muscle cell alignment in vivo corresponds to the direction of applied
tensile forces. In response to cyclic tension, and in contrast to applied shear, both
endothelial and smooth muscle cells align their actin filaments perpendicular to the
applied force usually within 12-48 hours [154]. Unlike the response to shear, this is also
consistently seen in various vascular cell types and species [154]. This property has also
been shown to be magnitude dependent, with low levels of strain (0-7%) resulting in
random orientation and higher levels (7-24%) resulting in perpendicular alignment in the
case of bovine smooth muscle cells [160]. Protein kinases A and C have been shown to
play important roles in stretch-mediated alignment [160]. For smooth muscle cells, this
perpendicular alignment is contradictory to the physiologic circumferential alignment
around the blood vessel, acting parallel to the application of tensile application [161].
This could be one limitation of 2D in vitro testing.
Cell differentiation is an important issue in development and in vitro testing.
When transferred to static culture, contractile vascular smooth muscle cells tend to
change their phenotypes to a synthetic state. Cyclic tension has been shown to increase
the expression of some of the markers of the differentiated state of smooth muscle cells.
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In a study by Birukov and collaborators, in addition to h-caldesmon upregulation,
increased proliferation was seen [162], indicating a contradicting synthetic behavior, but
the level of stress on the cells was higher than physiologic stress (15%) which could
affect the proliferation behavior of the cells. Butcher and collaborators demonstrated a
phenotype shift in a 3D collagen construct of RASMC subject to tensile forces
corresponding to 10% strain at 1 Hz for 48 hours using a platen multiaxial strain system
[163]. The strained group results showed increased cell viability, decreased
morphological elongation, decreased α-actin and calponin expression, and increased
vimentin expression compared to the static control. These results suggest a shift from
contractile toward a more synthetic phenotype. In addition to synthetic versus contractile
phenotype, differentiation toward vascular calcification can be a problem with statically
grown smooth muscle cells. Bone differentiation markers as osteopontin, CFFA-1, and
alkaline phosphatase have been shown be downregulated through the application of
cyclic stress [164].
Vascular smooth muscle cell migration due to cyclic stretch has not thoroughly
been investigated in vitro although there are some well documented cases for endothelial
cells. Increased migration rates of endothelial cells have been associated with increased
cyclic strain response and is mediated by rho p21 [165]. As mentioned previously, the
application of cyclic stretch in one study to endothelial cells with strain-induced MMP-2
resulted in decreased smooth muscle cell migration using a transwell migration assay
[61]. In response to increased cyclic stretch, a key component in smooth muscle cell
migration has been shown to be protein kinase c delta (PKCδ), which plays a significant
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role in actin fiber rearrangement during SMC migration [166]. Since vascular
hypertension can create up to 30% increase in tension strain within arterial walls in vivo
[167], it is possible that this increase could result in increased activation of PKCδ and
increased activation of migratory pathways that could be important in both
atherosclerosis and restenosis.
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-CHAPTER 2AIM 1- DESIGN AND CALIBRATION
2.1 Introduction
The purpose of this project is to develop an in-vitro model to simulate the induced
mechanical forces on the blood vessel during balloon angioplasty and evaluate cell
damage and response. This model is aimed for potential implementation as a test bed for
the study of drug delivery, surface treatment systems for balloon angioplasty, and
endovascular stents and minimizing restenosis to aid in the reduction of deleterious
vascular responses. During balloon angioplasty, surrounding smooth muscle cells lining
an artery are subject to both tensile stress from the balloon deployment and shear stress
from blood flow. Balloon angioplasty increases the arterial diameter by a circumferential
stretching meant to compress the plaque within the wall of the blood vessel and
consequently irreversibly stretches the collagen fibers within the wall.
The designed system consists of two simulators. Laminar fluid flows from a
multi-channel peristaltic pump across a location of cells simulating shear stress.
Concurrently, a vacuum chamber suctions a silicone membrane where the cells are
located over a static platform, which essentially stretches the cells and simulates tensile
stress. In this system, cells are grown onto the flexible silicone membranes to simulate
the distensibility of the blood vessel. In the presented work, the design parameters are
explained further and calibration of the applied strain to the cells is further characterized.
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Membrane Plates
Bioreactor Baseplate

Figure 2.1 Vascular Mechanics Simulator System Configuration

2.2 Simulator Design
This simulator system consists of six independent channels allowing for six
independent cell populations to be assessed for increased statistical applicability and
multiple analysis techniques. The system is comprised of two apparatuses each with
three channels, as demonstrated in Figure 1. Design parameters were considered to
resemble physiological conditions with minimal compromises, including laminar flow,
developed flow at the cells, and applied shear stresses. Cells are grown on a flexible
silicone membrane which oscillates at 60 cycles/min (1 Hz) during mechanical testing.
As the vacuum from the FlexerCellTM strain unit is applied from an underneath chamber,
the silicone membrane is stretched over a circular rigid Lexan post (0.875”, or 2.22 cm
diameter), therefore applying tensile force to the cells grown on the silicone as shown in
Figure 2.
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Figure 2.2 Application of Concurrent Forces in System

A parallel plate geometry was chosen for this application for the shear component
of the system. Figure 3 provides a pictorial explanation of the designed mechanical
simulator. The entrance length of the channel to ensure fully developed flow at the site
of the cells was governed by the resultant Reynold’s number of 151 from the volumetric
inlet flow (Qin) of 350 ml/min although the flow is laminar for the majority of the range
for the fluid pumps. The Reynold’s number, Re, was determined from the equation
applying to a rectangular channel:
Re =

ρQin
[83]
µb

where b is the width of the channel (cm) , ρ is the density of the fluid (kg/cm3), and µ is
the fluid viscosity (dynes*s/cm2). The Reynold’s number was also used to establish the
channel flow as laminar. This was considered highly laminar inflow since the Reynold’s
number was much less than 2000 for this rectangular channel [83]. This equation
assumes that the fluid behaves as an incompressible Newtonian fluid.

60

Figure 2.3 Demonstration of individual channel of vascular mechanics simulator: a)
System configuration b) One of the vascular mechanics simulators during
experimentation c) Top view of individual channel with entrance length and location of
cell culture on silicone d) Side view of entrance side indicating cross-sectional area of
channel.

The minimum entrance length parameter for a fully developed velocity profile, Le
(cm), was estimated by:

Le = .05 Re [168]
where Re is the Reynold’s number. The calculated required minimum entrance length of
7.55 cm was manufactured to 13.95 cm to assure a fully developed velocity profile at the
site of the cells as shown in Figure 3 (c).
Several accessories to the system were also designed. To run tensile tests alone, a
tensile force isolation bar shown in Figure 4 was designed to provide sufficient media for
tensile testing alone. To obtain a sufficient seal, a principal of O-rings with applied
pressure was implemented and secured with four stainless steel screws paired with wing
nuts on alternating sides of the culture bar for evenly distributed pressure.
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a)

b)

c)

Figure 2.4 Tensile Force Isolation Bar a) 3D CAD design b) 3D CAD assembly with
baseplate c) Manufactured tensile bar with baseplate

Cells are grown on the surface of the silicone membranes which are held into
place by compressive force into the membrane plates (Figure 5a). This allows for the
membrane plate and the membrane to be flush with the surface of the bioreactor which
aides in a laminar flow pattern. In order to remove the membrane plates after use, a tool
had to be designed to push the
them
m up and out of the depression. This tool accesses the
membrane plates through ports in the vacuum chamber which are plugged during testing.
The two-pronged
pronged device shown in Figure 5 b) gently pushes the membrane plate up for
easy removal without disturbi
disturbing the silicone surface containing the cells.

a)

b)

c)

Figure 2.5 System accessories a) Silicone Membrane Plate b) Membrane Plate
removal tool c) Baseplate cover and lid
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When the cells are being cultured, the exposed channels need to be covered to maintain
sterility. A two-part Lexan cover has been designed to cover both the channels and the
culture bar (Figure 5c). The first piece fits the cell culture bar with a lip at the junction
with the cell culture bar. A top cover fits over the lip of the protective plate and the cell
culture bar to maintain sterility. Original 2D CAD drawings for the primary parts of this
system are provided for reference in Appendix A.

2.3 Calibration
The next step for the tensile system was the calibration of the computer interface
with the bioreactor. For calibration, a radial grid with known distances was created in
AutoCAD (Figure 6a) and placed on the rigid loading posts in the simulator. The
provided drawing is not to scale.

a)
b)
Figure 2.6 Calibration of Tensile Strain in Simulator a) Reference Grid System b)
Implementation of reference grid in calibration

A circle was drawn on the silicone membrane drawn on each individual
membrane and the amount that the circle stretches will be directly proportional to the
mechanical elongation. Application of vacuum pressures results in the stretching of the
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silicone. Both static and dynamic calibrations have been examined. For static
calibration, the FlexCell programs for 2.5%, 5%, 7.5%, and 10% strain were applied. For
each case, pictures were taken before, during, and following strain. An example setup of
calibration is shown in Figure 6 b). For dynamic calibration, a regimen of 1 Hz 0-5%
strain was applied and a movie file was collected. ImageJ provided by NIH was used for
imaging processing and calculations. In the case of dynamic simulations, the movie files
were first converted into a series of pictures using the Easy Video Converter and the
maximum and minimum images were evaluated by converting relating known distances
to the number of pixels within the pictures. Using ImageJ, the area of each circle was
calculated. From there, a radius was determined and the actual percentage of elongation
(%E) was determined from:
%E =

r − r0
r0

where r0 is the initial average radius and r is the average radius of the circle while being
stretched.

Calibration Results
Data in Figure 7 represents data of static calibrations over all 6 plates. Static calibration
was repeated over 3 independent trials. The mean value of calibration for the
programmed values of 2.5%: 2.3 ±0.30 SD, 5%: 5.0 ±0.47 SD, 7.5%: 7.3± 0.57 SD, 10%:
10.1± 0.87. Measurements immediately following stretch agreed with initial
measurements, suggesting stress relaxation of the silicone was not significant.
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Static Calibration
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Experimental
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y = 1.032x - 0.265
R2 = 0.9988
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FlexCell Program med values

Figure 2.7 Static calibration comparison of programmed values versus experimentally
determined values

Given the very similar results in static calibration, dynamic calibration of the system was
performed for the regimen of interest of 0-5% strain. Results of dynamic calibration
determined a maximum deformation of 4.43% ± 0.67 SD. Although slightly lower values
were determined, these were within reasonable tolerances of error and compensated for
with slight increases in programmed values.

2.4 Comparison of Experimental Calibration to Solid Modeling Analysis
The design of the tensile application in this work was based upon the principle of the
FlexercellTM strain unit with minimal variations in dimensions. The experimentally
determined strain values were compared to comparable computational analysis within the
FlexercellTM membranes performed by Vande Geest, et. al [169].
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2.4.1 Summarized Methods
In the work by Vande Geest et. al, computational analyses were performed on both the
biaxial and uniaxial membrane configuration, although for this work we were only
interested in comparing the biaxial configuration [169]. To summarize the applied
methods, the finite element solver Abaqus (Version 6.2 Abaqus Inc.) was implemented to
run simulations with vacuum pressures of 20, 40, 60, and 80 kPa applied to the underside
of the membrane. The two surfaces had an applied friction coefficient of 0.03 [170] to
account for the silicone lubricant grease in between the surfaces, which is the same
lubricant applied in our custom setup as well. Boundary conditions with similar
representation to Figure 8 were applied with the loading post being modeled as an
analytic rigid body and the edges of the silicone membrane as fixed, where both
rotational and translation degrees of freedom were assigned a zero value. After
establishing mesh independence, a first order, quadrilateral, reduced integration shell
elements configuration was used for analysis with 5830 elements. Experimental
comparisons in the work of Vande Geest were performed in a similar methodology of
picture and movie capture with the difference being their experimental values were
measured near the center of the loading post.

Loading
Post

Figure 2.8 Representation of applied boundary conditions and vacuum load

66

2.4.2 Results
Theoretical applied vacuum pressures of 20, 40, 60, and 80 kPa corresponds to
approximate theoretical elongation percentages of 2.6, 6.6, 14.1, and 20.65, respectively
according to the Loading Station Conversion Chart from FlexCell provided in Appendix
B. The area where cells should be plated to receive uniform strain is provided by the
following equation in the FlexCell manual:

Radius = (Diameter of Loading Station (1+ (Max%Elongation/100))

For the FlexCell loading post, these areas to receive uniform strain for the respective
elongation values of 2.6, 6.6, 14.1, and 20.65 for the BioFlex and for the custom designed
simulator are provided in Table 1. Diameters for the loading posts BioFlex and custom
vascular mechanics simulator were 25 (12.5 radius) and 22.4 (11.2 radius) mm
respectively.

Table 2.1 Theoretical Uniform Strain Distances along BioFlex and the custom Vascular
Simulator Loading Posts
Applied Vacuum
Elongation
FlexCell radius
Vascular Simulator
(kPa)
(%)
(mm)
radius (mm)
20
2.6
12.18
10.8
40

6.6

11.75

10.4

60

14.1

10.95

9.75

80

20.65

10.35

9.2
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Comparing the geometries of the FlexCell setup to the custom setup demonstrated
minimal geometrical differences. The diameters for the loading posts and membrane for
the Flexcell were 25 and 35 mm, respectively. For the custom setup, the diameters were
22.4 and 33.8 mm, respectively. The resultant outer diameter/inner diameter ratios for
the Flexcell and custom setup vascular simulator were 1.4 and 1.5, respectively. These
values and ratio are similar, with the largest difference being the determinant of the gap
between the fixed edges which is suctioned downward with application of the vacuum
pressure depicted in Figure 9. This value is within 0.75 mm of the FlexCell dimension
and additional effects were considered negligible. The computational values were
directly compared to the experimentally determined values.
Silicone Membrane
Φ= 35mm

Silicone Membrane
Φ= 33.85 mm

Loading Post
Φ= 25mm

Loading Post
Φ= 22.4 mm
5.725 mm

5 mm

a)

b)

Figure 2.9 Comparison of FlexCell membrane to custom simulator membrane setup
a) Flexcell dimensions (mm) b) Vascular Simulator setup dimension (mm)
(Drawings not to scale, black represents area of the static post and the patterned area
represents silicone membrane)
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The experimentally measured % elongation for both dynamic and static measurements in
the work of Vande Geest were found to be within 26% of the manufacturer’s
specifications and 16% of the finite element analysis [169]. The finite element analysis
indicated more uniform patterns of strain along the loading post in cases of lower vacuum
pressures (Figure 10). However, it is important to note that the “0” position indicated in
Figure 10 represented the center of the silicone membrane. Due to geometrical symmetry
of the loading post, only the radius characterization was provided. The contours of
Figure 10 also demonstrated that the radial and circumferential strains were similar in
magnitude over the loading posts, particularly at the lower vacuum pressures of 20kPa
and 40 kPa. Additionally, the guidelines for uniform strain from Table 1 demonstrated
agreement with the strain behaviors along the loading post (Figure 10).

Figure 2.10 Strain contours along x for biaxial membrane (Figure 2 from Vande Geest,
et al., 2004 [169]) Dotted line represents edge of BioFlex loading post
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2.4.3 Discussion
In comparison of our custom system calibration, our measured strain values were
within 11% for both the static and dynamic measurements. During the testing regimens
applied in this work, we were mainly interested on dynamic behaviors from 0-5% at 1 Hz
corresponding to the normal cyclic regimen that is applied to the cells during the duration
of mechanical testing in addition to static behavior of 12% strain applied to simulate
balloon angioplasty. These strain values corresponded to approximate FlexCell applied
vacuum pressures of 33 and 55 kPa. In our setup, the cells are confined for culture to a
diameter of 18.44 mm, or 9.22 mm radius. According to equation 1 and data from Table
1, we are within the limits of cell area to assure a uniform strain profile, particularly with
the strain values applied in this work. In comparison to the strain distribution along the
x-axis of the membrane in Figure 10, strain can be assumed as fairly constant over the
cells at 5% (33 kPa) strain interpolated in between the cases of 20 and 40 kPa.
Interpolation of the case of balloon angioplasty deployments of 12% (55 kPa) would lie
just below the case of 60 kPa, showing some variation along the distribution of cells
within approximately 2% strain. In either case, the % elongation, or strain, can be
assumed fairly uniform over the cells with agreement between theoretical, computational,
and experimental values.

2.4.4 Conclusion
Through the presented design we were able to construct a vascular mechanics
simulator with a biocompatible cell interface to be implemented in the investigation of
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cell response to applied stimuli. We were also able to calibrate the applied strain and
correlate a relationship with the external FlexCell software in addition to visually confirm
fairly uniform strain behavior of the silicone upon deformation. Comparison with a
computational study with a comparable geometry verified the uniform strain behavior
across the cultured location of cells and agreement with experimentally measured values.

71

-CHAPTER 3AIM 2- COMPUTATIONAL CHARACTERIZATION OF VASCULAR
SIMULATOR

3.1 Introduction
The designed vascular mechanics simulator was developed to provide
physiologically significant levels of strain in addition to shear stresses applicable
following a stent strut contact. In order to characterize the resultant wall shear stresses at
the cells associated with this design, Computational Fluid Dynamics (CFD) simulations
were performed using the commercially available FLUENT. FLUENT is frequently used
to study alterations in shear stress within vascular geometries due to stent placement and
atherosclerosis [171-173], making it an optimal tool to investigate the fluctuations in wall
shear stresses due to suction in our custom designed vascular mechanics simulator. The
particular parameters of interest were the wall shear stresses and the fluid velocity
profiles at the location of the cells following suction of the silicone membrane simulating
balloon angioplasty. A two-dimensional approach was used for the modeling with the
assumptions of: fully developed flow at the channel inlet, incompressible flow,
Newtonian fluid flow, no-slip wall conditions, and 2-dimensional flow, since the channel
height was much less than the channel width [174].
3.2 Materials and Methods
Theoretical wall shear stresses were calculated by the following formula where Q
is the volumetric flow rate, w and h are the width and height of the channel respectively,
and µ is the kinematic viscosity of the media.
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τw =

6Q µ
wh 2

Current analysis worked under the assumption of fully developed laminar flow (Re=151160) at the entry into the section. When examining the velocity profile, the two vacuum
suction areas before and after the location of the cells were distinguished as the leading
and lagging edges, respectively.

3.2.1 Steady State Simulations
Two-dimensional meshes were created in GAMBIT with the simplified steady
state geometry of 5.0 cm by 0.635 cm. A triangular mesh was implemented at a spacing
of 0.015, with 5736 and 6194 total elements for the non-suction and suction meshes,
respectively. A denser mesh was implemented at the site of the cells and at the moving
walls. The wall shear stress of the cases of the suction and non-suction model were
compared to the theoretical calculation. In addition, the velocity profile following the
leading edge suction area was examined to verify the fluid profile recovery at the site of
the cells. The inlet velocity was initialized to 1.61 cm/s and the temperature to 37
degrees Celsius, corresponding to in vitro media temperature conditions in addition to
body temperature. A user-defined function (UDF) altered from the FLUENT UDF
manual was incorporated in FLUENT to provide a steady-state velocity profile for the
incoming flow which is provided in Appendix C.
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3.2.2 Unsteady Moving Wall Geometry Dynamic Simulations
A parallel plate geometry was constructed in GAMBIT with increased edge
densities at the cell wall and the 71326 elements. The geometry of the channel used in
simulation was 12.0 cm x 0.635 cm, representative of the physical measurements in the
simulator. The dynamic motion of the wall was defined using a User Defined Function
(UDF) incorporated into the FLUENT software. The dynamic motion was defined using
the DEFINE_CG_MOTION function which is implemented for translational and
rotational motion for a rigid body. The motion was simplified to a plug, or moving wall
deformation motion rather than parabolic deformation to provided initial evidence that
dynamic behavior affects velocity and wall shear stress behavior on surrounding cells.
The movements of the deforming walls were assigned to 1 Hz deformation with two
cases of deformation examined, low deformation of 0.0175 cm, and high deformation of
0.035 cm.
Dynamic simulations were performed using a segregated implicit solver with a small
time step of 0.002 seconds in order to accurately resolve the dynamic mesh in addition to
obtaining refined periodic oscillatory agreement for the applicable number of iterations.
Periodic agreement was demonstrated after 10,000 iterations corresponding to 20 seconds
which was further used for analysis.
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3.2.3 Unsteady Parabolic Dynamic Simulations
To better model the deformation of the silicone membrane, the shape of
deformation was assumed to be parabolic in nature. Therefore, the function of
deformation is based on the equation of a parabola given by:
y=

( x − k )2
+h
4a

where “a” is the distance from the vertex to the focus and k and h are the x and y
coordinates of the vertex of the parabola, respectively. To determine the unsteady
solution of deformation, it was first assumed that the y coordinate of the vertex changes
with time oscillating from -0.016 to 0 cm global positions in the y-direction based upon
experimental measurement during deformation. Boundaries for the x-coordinates of
deformation were based upon assumptions of fixed boundaries where the silicone
interfaced with the rigid Lexan material at the loading post and retaining ring. By
assuming a linear relationship of deformation at time points within one deformation cycle
of 1 second, a function of “h” in relation to the current time of simulation was
determined. The function values of “h” were then implemented to determine functions at
later time points. With “h” determined, and a constant (x,y) coordinates true for all
values (-1.1125,0), “a” was then calculated by:

a=

(x-k) 2
4(y-h)

It is important to note that a higher (4th) order function was implemented because the

simulation can only approach the minimum y position of 0 cm due to the function of “a”.
The minimum deformation the function currently reaches is -0.001875 cm. This
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assumption is valid since it only accounts for approximately 1% of the maximum
deformation. Additionally, it is unlikely that the silicone membrane ever fully reaches the
minimum position point (y=0) in the experimental case due to the high frequency of
oscillation of 1 Hz. Given calculations of both “a” and “h”, the function is then able to
sweep across the nodes on the deforming wall and calculate the corresponding “y”
positions using the original parabola equation. This implemented C source code is
provided in Appendix C.
Having the deforming boundary during simulation requires the use of dynamic
meshing. There are three methods of dynamic meshing used in FLUENT which include:
layering, spring smoothing, and local remeshing. Layering involves the creation and
destruction of cells. This method is available for quad, hex, and wedge mesh elements.
This method was not used in the presented simulation case since it is not available for
triangular mesh element. Spring smoothing allowed the nodes to move as connected by
springs and the connectivity remains unchanged and is generally limited to small
deformations. Local remeshing can be used for larger boundary motions. In local
remeshing, the cells/faces are remeshed according to user specified skewness and size
limits. Both of these methods are used with triangular and tetrahedral mesh elements and
are typically used in conjunction with each other. A combination of the spring smoothing
and local remeshing was implemented in this model and the settings particular to each
method will be refined as needed to optimize the solution.
In order to implement the parabolic deformation function in FLUENT, the use of
a dynamic mesh User-Defined Function (UDF) was applied to the deforming boundary.
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The three UDFs available include: DEFINE_CG_MOTION, DEFINE_GEOM, and
DEFINE_GRID_MOTION. DEFINE_CG_MOTION is generally implemented to
provide translational or rotational motion to a rigid body as previously used in the
simplified case while DEFINE_GEOM is used to project nodes onto a deforming
boundary [175]. DEFINE_GRID_MOTION allows the most control over the deforming
mesh and allows movement of any defined nodes [175]. This function was called at
every time step and was implemented for the application of the deforming silicone
membrane. The implemented code for the deforming zones is available in Appendix C
and pictorial example of deformation is depicted in Figure 1 over the course of one
deformation cycle.
The parallel plate geometry measuring 5.0 cm by 0.635 cm was constructed in
GAMBIT with four different meshes consisting of 8338, 21666, 67614, and 342720
elements, referred to as Mesh 1,2,3 and 4 respectively, in the presented work.
Simulations were run with a time step of 0.005 s and 10000 iterations for simulation time
of 50 seconds. To establish mesh independence, fluid velocities at three points were
charted over time. The velocities also provided insight to the velocity behavior over time
in response to dynamic oscillation. Once the mesh independence was established, the
wall shear stress at the cells over 10 full deformation cycles was compared to ensure
periodic solution independence.
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Figure 3.1 Parabolic function deformation at points over 1 cycle. (a) Original shape of
entire geometry (b) Magnified view at first (leading) edge of deformation of original
geometry (c) Deformation att 0.25 s, h= -0.08
0.08 cm (d) Magnified view of deformed region
at 0.25s (e) Deformation at 0.5 s, h= -0.00018
0.00018 cm (f) Magnified view at 0.5 s (g)
Deformation at 0.75 s, h= -0.08
0.08 cm (h) Magnified view of deformed region at 0.75 s (i)
Deformation at 1.0 s, h= -0.16
.16 cm (j) Magnified view of deformation at 1.0 s
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3.3 Results
3.3.1 Steady State Simulations

The theoretical wall shear stress was calculated to be 0.23 dynes/cm2, using a
kinematic viscosity of 0.018 dynes*s/cm2 which was measured using the Paar Physica
MCR 300 rheometer with a shear rate sweep from 0-750 s-1. The 2D non-suction profile
of wall shear stress in Figure 2(a) was linear, with overlapping values for the bottom and
top walls due to symmetry. There was an average value of 0.23 dynes/cm2, which agreed
with the theoretical value. The 2D suction model in Figure 2(b) displayed a less constant
profile, but resulted in similar shear stress values in the range from 0.23-0.29 dynes/cm2.
The top curve represents the wall shear stress profile across the cells.

(a)

(b)

(c)

(d)

Figure 3.2 Steady State Simulations (a) Minimum deformation velocity profile (cm/s) (b)
Maximum deformation velocity profile (cm/s) (c) Minimum deformation WSS at cell
location (d) Maximum deformation WSS at cell location
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3.3.2 Unsteady State Moving Wall Dynamic Deformation

Minimum velocity profiles in Figure 3-4 (a) fairly resembled laminar profiles.
For the case of high deformation, the wall shear stress tended to range from 0.0-0.8
dynes/cm2 at the site of the cells (Figure 3c-d). For the case of low deformation, the
range was 0.05-0.5 dynes/cm2 at the site of the cells (Figure 4c-d), demonstrating that the
degree of deformation can affect the resultant WSS profile. In the case of high
deformation, there was also some reversed flow vectors at points during simulation.
Oscillatory effects resulted in 2-4 times the maximum WSS of theoretical solution. Mesh
independence was not performed in the deformation of these geometries, but rather used
as a preliminary simplified testing simulation to evaluate effects of deformation. The
results indicated a variation of wall shear stress (WSS) solution values (Figures 3 and 4)
and demonstrated the necessity for a denser initial mesh and refined dynamic meshing
parameters.
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(a)

(b)

(c)

(d)

Figure 3.3 Unsteady Simulation of High Level of Deformation (a) Minimum velocity
profile (b) Maximum velocity profile (c) Minimum deformation WSS at cell location (d)
Maximum deformation WSS at cell location

(a)

(b)

(c)

(d)

Figure 3.4 Unsteady Simulation of Low Level of Deformation (a) Minimum velocity
profile (b) Maximum velocity profile (c) Minimum deformation WSS at cell location (d)
Maximum deformation WSS at cell location.
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3.3.3 Unsteady Parabolic Simulations

Deformation Functionality
The deformation functions were based on a linear peak deformation assumption. Each
cycle was divided into two functions corresponding to the ascending and descending
behavior of the silicone over each full deformation. Maximum deformation was
measured experimentally to be 0.16 cm and used in as the maximum deformation in each
function. Linear patterns of deformation over time were assumed to be the minimum
deformation approaching zero. To verify the deformation function, the y-coordinate
corresponding to the apex of the parabola was documented every 0.25 seconds and
compared according to the point of deformation for each cycle (Table 1) and clarification
of each point of deformation is shown in Figure 5. The average deformation for each
point in the cycle were: P1, P5: -1.597 x 10-1 cm ± 3.156 x 10-4 SD (0.21% from
theoretical), P2: -7.89 x 10-2 cm ± 4.601 x 10-4 SD (1.38 % from theoretical), P3: -7.2766
x 10-6 cm ± 2.384 x 10-6 SD, P4: -7.89 x 10-2 ± 4.72 x 10-4 SD Percentages of the
displacement comparisons versus the theoretical values were: P1, P5 0.21%, P2: 1.38% ,
P4: 1.33%. For the case of P3, ideally the value would zero, making it unable to
determine a percentage difference. However, the difference between the small
deformation to the negative sixth power and the theoretical value of zero was negligible
and validated the function at this point.
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P3

P4

P2

P1, P5
Figure 3.5 Deformation points through cycle for analysis of minimum grid position
corresponding to maximum deformation at apex of parabola

Table 3.1 Descriptive Statistics for Each Point in Cycle Deformation
P1, P5

P2

P3

P4

Theoretical displacement
(cm)
Avg Exp. displacement
(cm)

-0.160

-0.080

0.000

-0.080

-1.60E-01

-7.89E-02

-7.28E-06

-7.89E-02

Standard Deviation

3.16E-04

4.60E-04

2.38E-06

4.72E-04

Maximum

-1.60E-01

-7.97E-02

-9.86E-06

-8.01E-02

Minimum

-1.59E-01

-7.78E-02

-1.21E-06

-7.81E-02

Mean difference (T vs E)

-3.38E-04

-1.11E-03

7.28E-06

-1.07E-03

% Difference (T vs E)

0.21

1.38

NA*

1.33

Velocity Tracking
The three points that were chosen for velocity tracking were a function of the height of
the channel and related to locations above where cells would be cultured (Figure 6). The
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number of nodes for each mesh was: Mesh 1: 8338, Mesh 2: 21666, Mesh 3: 67614, and
Mesh 4: 342720. Point locations of were based upon nodal global positions with slight
deviations between mesh densities. Deviations in positions would result in different
velocity readings at each time point. Coordinates of the nodal positions for the four mesh
densities is shown in Table 2. Differences were minimal and considered negligible.

y=0.00635 m

A

B

3h/4

h/2

h/4

y=0

y

x=0
Location of cells

x

Figure 3.6 Relative velocity tracking points over geometry

Table 3.2 Global Coordinates of Nodes for Reference Velocity Readings

Point A
Point B
Point C

x (m)
y (m)
x (m)
y (m)
x (m)
y (m)

Mesh 1
-9.22E-03
1.38E-03
3.57E-05
3.37E-03
9.14E-03
5.12E-03

Mesh 2
-9.25E-03
1.35E-03
3.33E-05
3.48E-03
9.25E-03
5.13E-03

Mesh 3
-9.24E-03
1.34E-03
3.24E-05
3.42E-03
9.25E-03
5.18E-03

Mesh 4
-9.24E-03
1.36E-03
-4.07E-06
3.43E-03
9.24E-03
5.20E-03

The theoretical minimal resonance time for the solution was 3.8 seconds. To verify
convergent solution behavior, no values prior to 18 seconds were considered in
comparative study. Velocities were recorded every 1.5 seconds over the 50 seconds
simulation time to capture velocity readings corresponding to minimum and maximum
deformation with the cycles. Velocities for Point A ranged from 1.5-2.0 x 10-2 m/s with
an average of 0.0177 m/s between the four meshes (Figure 7). Variations between
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meshes were minimal and the averages were within 1.7%. Velocities at Point B were
highest and ranged from 2.2-2.7 x 10-2 m/s with the average being 2.48 x 10-2 m/s
between the four meshes (Figure 8) and the averages were within 0.5% of the average.
Point C velocities were the lowest and ranged from 1.2-1.8 x 10-2 m/s with the mean of
all four meshes as 1.5 x 10-2 m/s with the meshes within 3.3% (Figure 9). For all three
points, the velocities for all three points resulted in lower values corresponding to the
maximum deformation and higher values corresponding to the minimum geometrical
deformation. Given that minimal differences existed between the varying meshes and
discrepancies were under 5%, the solutions were considered independent.
Point A Velocity Mesh Comparison
2.60E-02

Velocity (m/s)

2.40E-02
2.20E-02
Mesh 1

2.00E-02

Mesh 2

1.80E-02

Mesh 3

1.60E-02

Mesh 4

1.40E-02
1.20E-02
1.00E-02
0

10

20

30
time (s)

40

50

(a)

Mesh 1
Mesh 2
Mesh 3
Mesh 4

Mean (m/s) Std. Dev Minimum Maximum
0.0178
0.0021
0.0157
0.0202
0.0177
0.0023
0.0155
0.0201
0.0174
0.0025
0.0149
0.0200
0.0178
0.0024
0.0156
0.0203

b)
Figure 3.7 Point A velocity a) Graphical patterns for the four meshes with dotted line
representing point where values were first considered for analysis b) Descriptive statistics
for respective meshes
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Point B Velocity Mesh Comparison
3.10E-02

Velocity (m/s)

2.90E-02
2.70E-02
Mesh 1

2.50E-02

Mesh 2

2.30E-02

Mesh 3

2.10E-02

Mesh 4

1.90E-02
1.70E-02
1.50E-02
0

10

20

30
time (sec)

40

50

a)

Mesh 1
Mesh 2
Mesh 3
Mesh 4

Mean (m/s) Std. Dev
0.0247
0.0027
0.0247
0.0024
0.0249
0.0024
0.0249
0.0022

Minimum
0.0221
0.0223
0.0225
0.0227

Maximum
0.0275
0.0272
0.0274
0.0271

b)
Figure 3.8 Point B velocity a) Graphical patterns for the four meshes with dotted line
representing point where values were first considered for analysis b) Descriptive statistics
for respective meshes

86

Velocity (m/s)

Point C Velocity Mesh Comparison
2.30E-02
2.10E-02
1.90E-02
1.70E-02
1.50E-02
1.30E-02
1.10E-02
9.00E-03
7.00E-03
5.00E-03

Mesh 1
Mesh 2
Mesh 3
Mesh 4

0

10

20

30
time (s)

40

50

a)

Mesh 1
Mesh 2
Mesh 3
Mesh 4

Mean (m/s) Std. Dev
0.0155
0.0028
0.0153
0.0028
0.0149
0.0028
0.0146
0.0025

Minimum
0.0129
0.0126
0.0123
0.0122

Maximum
0.0184
0.0182
0.0178
0.0172

b)
Figure 3.9 Point C velocity a) Graphical patterns for the four meshes with dotted line
representing point where values were first considered for analysis b) Descriptive statistics
for respective meshes

Velocity Contours
Velocity contours over each deformation cycle indicated local fluctuations in velocities
(Figure 10). Investigation of velocity vectors indicated positive velocities in the xdirection over the location of the cells with the exception of the areas of suction in which
flow tended to move in both directions, particularly during suction.
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P1, P5

P2

a)

b)
P4

P3

c)

d)

Figure 3.10 Velocity Profiles Over Deforming Geometry a) P1 and P5, b) P2 c) P3
d) P4 (All velocities to normalized scales m/s)

Wall Shear Stress (WSS)
After establishing mesh independence through the velocity studies, Mesh 4 was
implemented in further analysis for the characterization of the wall shear stress at the site
of the cultures cells and at the deforming walls. It was desired to establish periodic
independence, or in other words verify that each cycle displayed similar wall shear stress
behaviors. To achieve this, wall shear stresses were compared over 10 cycles from 3040s simulation run time. Wall shear stresses were compared for both deforming walls
and along the cell location as depicted in Figure 11a. An example WSS profile
demonstrated the variation of WSS in the areas of suction (W1 and W3) (Figure 11b) and
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recovery at the site of the cells. Points 1-5 in deformation explained previously (Figure
5) were used in analysis.

W1

W2

W3

Cells

a)
Cycle 5 WSS (35-36s)

WSS (Pa)

a)
W1

-2.00E-02

3.00E-01
2.50E-01
2.00E-01
1.50E-01
1.00E-01
5.00E-02
0.00E+00
-1.00E-02

P1

W2

P2
P3
P4
P5

0.00E+00

1.00E-02

2.00E-02

x Wall Position (m)

b)
Figure 3.11 Wall shear stress deformation along deforming boundaries and cell location
a) Pictorial representation of the geometry b)WSS profiles for one cycle at points of
deformation

For WSS comparison, the averages over the site of the cells were compared at
each point in deformation of the 10 cycles of interest. As Table 3 demonstrates, there
was minimal difference between WSS between cycles at each point. There was variation
in the WSS over the cells at the varying points within each cycle due to variations in
velocity. The average WSS at each point were: P1: 0.164, P2: 0.486, P3: 0.410, P4:
0.099, and P5: 0.164 dynes/cm2. WSS contours over the cells in Figure 12 showing
cycles 1 (30-31s), 5 (34-35s), and 10 (39-40s) demonstrated the differences in WSS due
to the local changes in velocity over the deformation cycle in addition to visually
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demonstrating periodic agreement between cycles. Analysis illustrated that WSS
oscillated from 0.1-0.5 dynes/cm2 compared to the theoretical WSS of 0.3 dynes/cm2,
corresponding to the volumetric flow rate of 400 ml/min. The maximum and minimum
wall shear stresses occurred at P2 and P4, respectively. Comparison in Figure 12 was
limited to the actual cell location during cell culture. Figure 13 incorporates both this
length in addition to the entire wall (W2 from Figure 11a) that extends up to the walls
that are suctioned downward (W1 and W3). Wall shear stresses over the entire wall were
affected within the 2mm space before the cell location (Figure 13). Increased WSS
ranges for this area for each deformation point were: P1, P5: 0.2-0.35 dynes/cm2, P2: 0.5.9 dynes/cm2, P3: 0.4-0.55 dynes/cm2, and P4: 0.1-.25 dynes/cm2. P3 demonstrated a
decrease range of WSS at W3 of 0.4-0.3 dynes/cm2. At each point of deformation, there
were patterns of increased wall shear stresses within this range demonstrating the
importance of limiting the region of cultured cells to obtain uniform distribution at each
point in the deformation cycle.

Table 3.3 Comparison of WSS Over 10 Deformation Cycles
WSS at site of cells (dynes/cm2)
Start (s)

end (s)

P1

P2

P3

P4

P5

Cycle 1

30

31

1.65E-01

4.87E-01

4.13E-01

9.84E-02

1.64E-01

Cycle 2

31

32

1.64E-01

4.87E-01

4.09E-01

9.71E-02

1.63E-01

Cycle 3

32

33

1.63E-01

4.87E-01

4.12E-01

9.73E-02

1.63E-01

Cycle 4

33

34

1.63E-01

4.86E-01

4.10E-01

9.87E-02

1.64E-01

Cycle 5

34

35

1.64E-01

4.87E-01

4.09E-01

9.92E-02

1.64E-01

Cycle 6

35

36

1.64E-01

4.86E-01

4.11E-01

9.89E-02

1.64E-01

Cycle 7

36

37

1.64E-01

4.85E-01

4.09E-01

9.97E-02

1.64E-01

Cycle 8

37

38

1.64E-01

4.84E-01

4.10E-01

9.92E-02

1.64E-01

Cycle 9

38

39

1.64E-01

4.84E-01

4.10E-01

1.01E-01

1.65E-01

Cycle 10

39

40

1.65E-01

4.84E-01

4.09E-01

1.01E-01

1.65E-01
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WSS at Cell Location Cycle 1 (30-31s)

WSS (Pa)
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WSS at Cell Location Cycle 5 (34-35s)
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WSS at Cell Location Cycle 10 (39-40s)

W S S (P a)
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5.00E-03

1.00E-02

x Wall Position (m)

c)
Figure 3.12 WSS Contours over cells at points of deformation a) Cycle 1 (30-31s) b)
Cycle 5 ( 34-35s) c) Cycle 10 (39-40s)
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Figure 3.13 WSS Contours Over Whole Cell Wall (W2) and Restricted Cell Location a)
P1, P5 b) P2 c) P3, d) P4
3.4 Discussion
In summary, the static steady
steady-state case simulations
imulations demonstrated agreement with
theoretical design values and also demonstrated that the suction profile of the silicone
membrane did not interfere with the velocity profile at the site of the cells, but did
however affect the wall shear stress profile. The averages for the theoretical, nonnon
suction, and suction model wall shear stresses were all 0.23 dynes/cm2 at the site of the
cultured cells for the case of 350 ml/min volumetric flow rate
rate. The simplified moving
wall unsteady dynamic simulations indicated that the oscillation of the silicone
membrane resulted in a range WSS from approximately 0.0
0.0-0.7 dynes/cm2 and
an 0.05-5
dynes/cm2 for high and low levels of deformation, respectively over the location of the
cells. This provided an initial basis to pursue the parabolic deformation model for better
characterization behavior.
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Parabolic deformation over the 1 Hz deformation cycle indicated changes in WSS
in dynamic simulations occur due to localized increases/decreases in fluid velocity from
dynamic channel geometry changes. The velocity profiles and wall shear stresses at each
point of deformation suggest local increases in velocity as the silicone membrane ascends
upward to the point of minimum deformation and local decreases in velocity occur as the
silicone membrane is suctioned downward. These alterations result in an oscillating
range of WSS of 0.1-0.5 dynes/cm2, corresponding to the theoretical WSS of 0.3
dynes/cm2. Simulations also illustrated that cells should be cultured to a limited range in
order to be exposed to a fairly constant WSS at each point of deformation.
The presented simulations were limited to a cross-sectional plane across the
center of the channel as designated by the dashed line in Figure 14a. Cells are cultured
over a larger area, so two other cases are briefly addressed here for discussion, a crosssection at the cell culture radius/2 (Figure 14b) and a cross-section at the cell culture
radius (Figure 14c). Only one side is considered due to symmetry. The width of
deformation gaps for each of these cases increases moving away from the centerline and
the length of the loading post wall decreases (Table 3).
Loading Post

Gap

Loading Post

Gap

R/2

Loading Post

Gap

R

z
Cell Culture Area

x

a)

b)

c)

Figure 3.14 Reference for cross-sectional analysis a) Centerline r= 0 b) r= R/2 c)
r= R (R=radius of cell culture area)

94

Table 3.4 Comparison of Reference Planes
r= 0
r= R/2
r= R

Post (cm) (radial) Gap (cm)
1.10
0.58
1.01
0.63
0.65
0.80

Ratio
1.89
1.59
0.81

Wall shear stress analysis illustrated that distances between the edge of the
loading post and the cell location were subject to increased wall shear stresses
comparative to the area of the cells (Figure 14). Application of this principle to cells in
the z-direction in Figure 15 suggests implications for the decreased ratio of the post
distance to the gap near the outer limits of the cultured cells. At r= R/2, the ratio is fairly
similar and would demonstrate minimal effects without large peaks in WSS. However, at
the outer boundary of r=R, the gap length is greater than the wall length and would result
in non uniform WSS profiles and peaks of increased wall shear stresses. These could be
areas of concern; however, these areas are minimal relative to the entire area of cell
culture. The area of the circle between Radius/2 and R is 0.17 cm2 compared to the
whole circular cell culture area of 3.84 cm2. Multiplying this area by 2 due to symmetry
of the circle indicates that less than 10% of the area is possibly subject to high and
variable shear stresses.

3.5 Conclusion

Computational analysis characterized the effect of cyclic deformation on resultant
local changes in velocity within the geometry and the resultant wall shear stress which
the cultured cell are subjected to. This 2D analysis not only showed oscillating wall
shear stresses over each cycle of deformation, but also a fairly uniform strain distribution
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over the length of the cultured cells. Computational characterization of the mechanical
environment assists to better correlate the observed responses of cells to the applied
stimuli.
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-CHAPTER 4AIM 3- ACUTE SMC RESPONSE FROM CONCURRENT TENSILE AND
SHEAR FORCES FOLLOWING IN VITRO BALLOON ANGIOPLASTY

4.1 Introduction

In order to study Smooth Muscle Cell response in vitro, a concurrent shear and
tensile forces simulator has been developed to provide clinically significant levels of
strain and shear stresses in addition to simulating forces similar to those during balloon
angioplasty. In this acute study (8 hours), rat aortic SMC demonstrated significant cell
proliferation following applied increased tensile forces of angioplasty injury and shear
exposure when compared to lower levels of tensile exposure similar to a normal
physiologic level with an average of 75% increase in the number of cells of the injury
group compared to the normal dynamic group. The smooth muscle cells exposed to
balloon angioplasty injury and concurrent shear and tensile mechanical forces resulted in
a decreased expression of the contractile phenotypic marker SM α-actin. These findings
demonstrate the efficacy of the developed model for in-vitro angioplasty and the
simulated mechanical environment to the cells. This model provides an in vitro model to
isolate the effects of concurrent mechanical forces and could also potentially act as a
preliminary step toward use in pharmaceutical research for reduction or prevention of
SMC proliferation due to altered mechanical forces during endovascular procedures.
With this model, the mechanical forces can be isolated from the biochemical
signals and their influence on the SMC response to injury. The use of this
model/simulator allows the acquisition of data that can act as a preliminary step in
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pharmaceutical manipulation of SMC, and research into the reduction, and eventually the
prevention, of SMC hypertrophy and proliferation following endovascular procedures.

4.2 Materials and Methods

An equibiaxial strain profile was applied along the silicone membrane using
vacuum similar to the technology implemented by Flexcell International (Hillsborough,
NC). The Flexcell 3000 software was used to control strain and regulate vacuum
pressure. Others have shown that approximately the outer 20% of the silicone
membranes located over the static post in the Flexcell system does not follow constant
radial and circumferential strain profiles [169]. Since the designed system utilized in this
study implemented a similar static post geometry, cells were confined to the center of the
membrane to promote constant radial and circumferential strain at the site of the cultured
cells during mechanical testing by using a Teflon ring with an inner cross sectional area
of 2.75 cm2 and an approximate height of 1.75 cm centered onto the silicone surface over
the center Lexan post during the period of cell culture. This Teflon ring was removed
prior to mechanical testing and only acted to confine the cells during cell culture.

Cell Culture

Rat aortic smooth muscle cells (RASMC) (Passage 11-14) obtained from VEC
Technologies were maintained with Dulbecco’s Modification of Eagle Medium (DMEM)
(Mediatech, Inc., 10-013-CV, Herndon, VA) supplemented with 10% heat inactivated
Fetal Bovine Serum (FBS) (Sigma-Aldrich, F-4135, St. Louis, MO) and 1% Antibiotic-
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Antimycotic (Sigma-Aldrich, A5955, St. Louis, MO). Cells were trypsinized with 0.25%
Trypsin with 0.2 mg/mL EDTA (Sigma Chemical Company, E6511, St. Louis, MO).

Cell Seeding for Mechanical Testing

Silicone membranes (5.25 cm in diameter) for each station were cut from biomedical
grade silicone sheets (Lot SM04106803, Specialty Manufacturing, Inc. Saginaw, MI) of
.015" thickness and 40 durometer. These were sonicated in deionized water and
assembled with the designed station plates. The assembled plates were steam sterilized
(Tuttnauer Brinkmann, 3870M, Jerusalem, Isreal) at 121 degrees Celsius for 30 minutes
and then placed into the simulator apparatus over approximately 0.2 cc of Silicone
lubricant (Loctite Corporation, 51360, Rocky Hill, CT). The lubricant was distributed
using a sterile silicone stopper and application of 5% mechanical strain from the
FlexerCell strain system (FlexCell International). The assembled system was then UV
sterilized for 3 hours. Following sterilization, sterile Teflon rings were centered onto the
silicone surface. The center area of silicone encompassed by the Teflon rings was
collagen coated with Type I Collagen (Vitrogen 100, 3mg/ml, Cohesion Tech, Palo Alta,
CA) diluted with sterile water to 50.0 µg/mL and allowed to dry for 72 hours in a sterile
laminar flow hood according to Cohesion Tech protocol for formation of a thin collagen
film. Prior to cell seeding, the membranes were rinsed with 1.0 ml of Dulbecco’s
Phosphate Buffered Saline (DPBS) (Media Tech, Inc., 21-031 CM,168). Cells were
counted using a hemocytometer and Trypan Blue and were seeded at a density of 7.5 x
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104 cells/mL and incubated for 48 hours. One additional milliliter of media was
supplemented after 24 hours.

Simulation Experiment Groups

Two experimental groups simulating in vivo conditions were investigated in this
study in addition to a control group where cells where not exposed to shear or tension.
The injury model (IM) group consisted of cells exposed to high strains generated during
balloon angioplasty followed by concurrent shear and tensile exposure. These cells
represented the smooth muscle cells that are directly exposed to blood flow upon the
denudation of the endothelial monolayer. The cyclic tension group (CT) simulated a
physiological control where cells are cyclically strained from 0 to 4% and not directly
exposed to flow. Unloaded static controls (U) were used as adhesion and phenotypic
behavior controls. Adhesion controls (A), which were fixed and counted prior to testing,
assisted in determining problems of adhesion due to exposure of mechanical forces.

Mechanical Testing

Prior to mechanical testing, confluency was assessed by microscopy of the unloaded
static controls. The media with 10% FBS was removed and the RASMC were
maintained in quiescent media consisting of DMEM without FBS supplementation for
the duration of mechanical testing. Media without FBS supplementation is commonly
used in dynamic testing to investigate effects of changes in proliferation. During the
application of mechanical testing, both dynamic experimental groups were first subject to
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a preconditioning regimen of 0-4% cyclic strain for 2 hours at gradually increasing
frequencies of 0.1 Hz (30 min), 0.5 Hz (30 min), and 1.0 Hz (60 min). Following this
preconditioning regimen, the CT group (n=6) was subject to 0-4% cyclic strain for 8
hours, and the IM group (n=6) was subject to two 12% static circumferential static
stretches held for 75 seconds each with a 30 second interval between stretches as
commonly performed during balloon angioplasty procedure. Following simulated balloon
deployment, shear flow was resumed at 350 ml/min and cyclic strain was applied at 0-4%
for 8 hours. The flow rate of 350 mL/min provided low wall shear stress (0.25
dynes/cm2) to promote cell proliferation. Static Unloaded (U) samples which were not
subject to dynamic force exposure served as a control (n=6) and adhesion controls (A)
(n=6) which were fixed prior to dynamic testing served to determine the number of cells
lost to problems of cellular adhesion.

Evaluation of Cellular Response
Cell Proliferation

Each experimental group allowed for six samples. Cell proliferation was assessed
using a quantitative (n=3) and a qualitative (n=3) method. The quantitative approach
involved staining of cell nuclei with 4',6-diamidino-2-phenylindole (DAPI) (Molecular
Probes, D-1306, Eugene, OR). For this method, cells were rinsed with DPBS following
mechanical testing and fixed with 100% ethanol for 30 minutes and rinsed again with
DPBS. Samples were covered with 0.5 ml DAPI solution for 10 minutes and rinsed with
DPBS. Samples were imaged with fluorescent microscopy (Nikon Inc., Diaphot 300,
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Melville, NY) at ten locations distributed throughout the sample. ImagePro Plus
Analysis software (Media Cybernetics, Inc., Version 5.1, Silver Spring, MD) was used to
quantify the number of cells present.
The qualitative analysis involved the use of Cell Titer 96 AQueous ONE Solution
Cell Proliferation Assay (MTS) (Promega Corporation, G-3580, Madison, WI) in which
1.25 mL was added to each well and incubated for 3 hours. The supernatant was
collected individually, dispensed into cuvettes, and gently vortexed to promote sample
uniformity. Four 125µL samples from each supernatant were placed into a 96-well UV
spectrophotometer plate. The Optical Density was determined at 490 nm (Beckman
Instruments, Inc., Model# DU 640B, Fullerton, CA).

Phenotypic Marker

SM α−actin as a marker cellular phenotype [2] was assessed in cell extracts using
standard western blotting techniques. The expression of GAPDH was also evaluated and
was used as a normalization and control of protein loading. Cells were removed from the
silicone membrane and lysed using an extraction buffer consisting of 0.5% Triton X-100
(Sigma-Aldrich, T-9284, St. Louis, MO), 1% Sodium dodecyl sulfate (Sigma-Aldrich, L4522, St. Louis, MO), 20 mM Tris (BIORAD, 161-0716, Hercules, CA), and 10 µL/mL
protease cocktail inhibitor (Sigma-Aldrich, P8340, St. Louis MO). The BCA Protein
Assay Kit (Pierce, 23225, Rockford, IL) was then used to determine the total protein
content of each sample. These samples were then diluted to 10 µg/µL using sample
buffer consisting of β-mercaptoethanol, 0.5 M Tris-HCl, 10% SDS, 0.5% Bromophenol
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Blue, glycerol and distilled water. Each sample was normalized to 1 µg/µL. Prior to gel
electrophoresis, the samples were boiled for 5 minutes to linearize the proteins. A 10%
polyacrylamide gel (BIORAD, 161-0158, Hercules, CA) was used in electrophoresis with
17.5 µL cell solution loaded per lane. Western Blot analysis was performed using
transfer to a PVDF membrane (BIORAD, 162-0184, Hercules, CA). WesternBreeze®
chromogenic Western Blot Immunodetection Kit (Invitrogen, WB7103, Carlsbad, CA)
was used to detect levels of α-actin and GAPDH expression. The WesternBreeze
Chromogenic Immunodetection Protocol was followed with the primary antibody Mouse
monoclonal [SPM332] to alpha smooth muscle Actin (Abcam, ab18460-1, Cambridge,
MA) at a dilution of 1:1000 and with the primary antibody Anti-GAPDH Mouse mAb
(6C5) (Calbiochem, CB1001, San Diego, CA) at a dilution of 1:1500. Densitometry was
performed on the developed Western Blots to evaluate the SM α-actin expression
differences between the Unloaded (U) (n=3), Cyclic Tension (CT) (n=3), and Injury
Model (IM) (n=6) groups. The integrated optical density (IOD) of the bands was
determined using a Imaging Densitometer (BIORAD, GS-700, Hercules, CA ) paired
with Quantity One analysis software version 4.1.1 (BIORAD, 170-9600, Hercules, CA).
The ratios of SM α-actin to GAPDH were evaluated to normalize the data and these
values were used in further statistical analysis.
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Statistical Analysis

An ANOVA statistical analysis paired with Tukey analysis was performed using
SigmaStat (Systat Software, Inc., San Jose, CA) for the statistical analyses examining
data of cell proliferation and SM α-actin with p<0.05 indicating a significant difference.

4.3 Results
Cell Quantification

Acute studies (8 hours) using rat aortic SMC demonstrated significant cell proliferation
following angioplasty injury and shear exposure (IM group) when compared to
“physiological function” cyclic tensile exposure (CT). DAPI analysis indicated a 75%
increase in the number of cells of the IM group compared to the CT group (p=0.001).
The cell number averages for the DAPI cell count were 3.45 x 104 (± 1.7 x103 SD)
cells/mL for the cyclic tensile (CT) group, 6.07 x 104 (± 5.0x103 SD) cells/mL for the
injury model group (IM), and 10.0 x 104 (± 15.8 x103 SD) cells/mL for the combined
averages of the static unloaded (U) group, and 8.2 x 104 (± 16.1 x103 SD) cells/mL for the
adhesion group (A) as shown in Figure 1 (a). As shown in Figure 1 (b), MTS results
supported the trends of the DAPI results with mean resultant absorbance levels at 490 nm
of 0.062 (± 0.028 SD) for the cyclic tensile (CT), 0.153 (± 0.04 SD) for the injury model
groups (IM), and 0.345 (± 0.034 SD) for the unloaded (U) groups.
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Figure 4.1 Cell proliferation comparison between cyclic tensile (CT), injury model (IM),
unloaded (U), and adhesion (A) (for DAPI only) test groups (a) DAPI cell quantification
indicated significant difference with IM and U being dif
different
ferent from all other groups
(p=0.001) (b) MTS Cell proliferation comparison confirming significant difference
between experimental groups (p<0.001)

Western Blot
Western Blot analysis was performed to detect levels of the contractile phenotype marker
SM α-actin.
actin. Decreased levels of SM α-actin
actin expression would indicate more synthetic
phenotype of the smooth muscle cells. The results of the Western Blot analysis are
shown in Figure 2. The static unloaded (U1
(U1-U3)
U3) samples expressed a normalized SM αactin integrated
ntegrated optical density (IOD) of 1.038 (± 0.103 SD). The normal function
simulation in the cyclic tensile group (CT1
(CT1-CT3)
CT3) demonstrated a 12% increase in SM αactin with IOD levels of 1.162 (± 0.098 SD), however these results were not significantly
different.
rent. Significant differences were observed with the balloon angioplasty injury
(IM1-IM3)
IM3) model with a decreased normalized SM α-actin
actin expression at IOD levels of
0.841 (± 0.046 SD) (p=0.006), a 19% decrease in SM α-actin
actin expression when comparing
the injury
ury model to the static unloaded samples.
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Figure 4.2 Western Blot results for SM α-actin for cyclic tensile (CT), injury model
(IM), and unloaded (U) test groups: (a) Densitometry picture of SM α-actin used to
evaluate integrated optical density to compare expression (b) Densitometry picture of
GAPDH acting as protein loading control (c) Normalization of SM α-actin expression to
loading control GAPDH indicating significant difference of SM α-actin expression in the
injury model (p=0.006).

4.4 Discussion

The effects of individual mechanical forces on smooth muscle cell behavior in an
in vitro setting have been well documented by others. However, the presented model has
been developed with the capability to more accurately represent concurrent mechanical
forces due to the additional injury response from balloon angioplasty deployment on the
reaction of smooth muscle cells in addition to low wall shear stress exposure that
stimulates smooth muscle cell proliferation.
One purpose of the injury model was to simulate increased balloon deployment
forces on cells in comparison to normal levels due to blood vessel expansion due to blood
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flow. During balloon angioplasty, high deployment forces of 5-10 atmospheres can
negatively affect surrounding smooth muscle cells. Often, the procedure of balloon
angioplasty is described as the compression of arterial plaque within the blood vessel to
restore nominal lumen diameter. However, the higher rigidity of the plaque within the
vessel walls compared to surrounding tissue results in greater transfer of the deployment
force to surrounding tissue and smooth muscle cells [51]. Further exposure of the smooth
muscle cells to a physiological tensile dynamic force of 0-4% for less elastic arteries at 1
Hz resembled the normal tensile forces that smooth muscle cells are subjected to in vivo.
The phenotype shift of smooth muscle cells from a contractile to a more synthetic
phenotype has a significant role in intimal hyperplasia following endovascular procedure.
In vivo, normal non-diseased smooth muscle cells reside primarily in the media layer of
the blood vessel and are of a contractile phenotype. Following balloon angioplasty,
medial smooth muscle cells can change from a contractile to a synthetic phenotype [1].
These changes in the cell result in the cellular loss of ability to contract, increased protein
secretion, and increased reaction to autocrine and paracrine growth factors [3-5].
Contractile smooth muscle cells contain relatively more SM α-actin than synthetic
smooth muscle cells which is why it was the chosen marker in this study [2].
Mechanically, the stiffness of contractile smooth muscle cells has been shown to be
higher than synthetic smooth muscle cells proposed to be from an increased amount of
actin within the cell [62].
In vitro cell lines are generally characterized as a synthetic phenotype. When
transferred to static culture, contractile vascular smooth muscle cells tend to change their
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phenotypes to a synthetic state. Increased levels of applied tensile forces (>10%) have
been shown to result in increased smooth muscle cell proliferation in addition to
decreased expression of markers such as SM α-actin [163]. When examining the results
of this study, the static unloaded smooth muscle cells, normal to in vitro culture, served
as a baseline for SM α-actin expression. Even at a short time point of eight hours
following injury, a low level of tensile forces similar to in vivo forces resulted in a higher
level of SM α-actin expression as seen in Figure 3. Although not significant, this
suggests that the application of an applied low level of tensile forces could stimulate
differentiation toward a more contractile phenotype over time. Investigation of increased
time points would be needed to explore this hypothesis. The significant decrease in SM
α-actin expression shown in Figure 3 at the early time point of 8 hours exposure to shear

and tensile forces following in vitro balloon angioplasty provides valuable insight to the
early phenotypic shift due to the applied mechanical forces.
Proliferation results indicated in Figure 2 supported the concept of an early
phenotypic shift. Comparing the dynamic groups of cyclic tensile (CT) and the injury
model (IM), DAPI results indicated a significantly different 75% increase in the number
of cells present in the injury model compared to the CT group simulating normal arterial
function, indicating that the injury and exposure to concurrent shear and tensile forces
resulted in increased proliferation of the injury model. As cell adhesion is a concern
associated with dynamic experiments in the case for both the cyclic tensile (CT) and the
injury model (IM) groups, a direct proliferation comparison of both groups with the static
group is irrelevant. This was supported by the data for the adhesion (A) group indicating
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a significant loss of cells due to dynamic exposure. For this reason, the static unloaded
group (U) was not included in this comparison.
The application of shear force to smooth muscle cells can have various effects on
the cell response. Variations in flow behavior can invoke different responses along with
the magnitude of the shear rate. Shear studies demonstrate the inhibition of in vitro
smooth muscle cell proliferation with high levels of shear stress [143]. In general, shear
stress levels above 10 dyne/cm2 are considered high and atheroprotective [144]. In
contrast, areas of low shear stress (<10 dyne/cm2) promote an atherogenic response and
increased smooth muscle cell proliferation [144]. Alterations in arterial geometry can
result in areas of flow separation, stagnation, and recirculation. These disturbances in the
velocity profile can result in areas of low wall shear stresses, therefore promoting smooth
muscle cell proliferation.
The application of tensile force applied to cells is usually in the form of
circumferential, uniaxial, or biaxial application. The direction applied is usually adjusted
to the application. In the case of vascular cells, they are cyclically deformed from the
dilation and relaxation of the blood vessel, usually represented by either circumferential
or uniaxial testing. The cyclic strain response of vascular cells is important to both
normal and abnormal cell function. It can affect cell proliferation, migration, apoptosis,
morphology, and alignment [154].
Cell differentiation is an important issue in development and in vitro testing.
When transferred to static culture, contractile vascular smooth muscle cells tend to
change their phenotypes to a synthetic state. Cyclic tension has been shown to increase
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the expression of some of the markers of the differentiated state of smooth muscle cells.
In a study by Birukov and collaborators, in addition to h-caldesmon upregulation,
increased proliferation was seen indicating a contradicting synthetic behavior, but the
level of stress on the cells was higher than physiologic stress (15%) which could affect
the proliferation behavior of the cells [162]. Butcher and collaborators demonstrated a
phenotype shift in a 3D collagen construct of RASMC subject to tensile forces
corresponding to 10% strain at 1 Hz for 48 hours using a platen multiaxial strain system
[163]. The strained group results showed increased cell viability, decreased
morphological elongation, decreased α-actin and calponin expression, and increased
vimentin expression compared to the static control. These results suggest a shift from
contractile toward a more synthetic phenotype.
There are different in vitro systems in use to study the effects of applied
mechanical forces. For example, shear stresses are generally fluid induced using a
parallel plate flow chamber based on pressure differences or by a cone on plate rotational
device. In vitro tensile testing is modeled in vitro using devices which apply tensile
forces in unidirectional, bidirectional, and radial/circumferential directions. The
advantage of this system in this study is the combinatory effect of force application
through use of combined principles of radial/circumferential tensile application and
parallel plate shear application.
Although the developed system is an improved in vitro model, there are
limitations of this study that will be addressed in further studies. As previously stated,
the application of mechanical forces can cause a variety of responses such as apoptosis,
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migration, hypertrophy, differentiation, and proliferation. Further studies of cell analysis
will investigate the possible responses of apoptosis, proliferation, and cell hypertrophy.
Additionally, as discussed previously, there are other phenotypic markers that indicate
synthetic or contractile behavior. Investigating other markers in addition to SM α-actin
will assist in better characterization of the differentiation effects of applied mechanical
forces on vascular smooth muscle cells.

4.5 Conclusion

This study presents an in vitro model to simulate in vitro balloon angioplasty
followed by applied tensile and shear forces to exposed smooth muscle cells. The
findings within this study demonstrate the efficacy of the developed model for in-vitro
angioplasty and the simulated mechanical environment to the cells. Additionally, the
significant response at a short point stimulates further investigation for increased forces
and time points for increased smooth muscle cell response.
The clinical significance of this in vitro cell proliferation model is the ability to
mimic clinically relevant mechanical stresses and to apply a more complex applied
regimen to simulate clinical intervention combined with normal exposure. Hopefully this
model could ultimately be implemented for use in early pharmaceutical research for
potential anti-proliferative agents for smooth muscle cells in attempt to prevent
hyperplasia and restenosis following endovascular intervention.
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-CHAPTER 5AIM 4- INCREASED SYNTHETIC PHENOTYPE BEHAVIOR OF SMOOTH
MUSCLE CELLS IN RESPONSE TO IN VITRO BALLOON ANGIOPLASTY
INJURY MODEL

5.1 Abstract

In order to study smooth muscle cell (SMC) response in vitro, a concurrent shear and
tensile forces simulator has been developed to provide clinically significant levels of
strain and shear stresses in addition to simulating forces similar to those exerted during
balloon angioplasty. After 24 hours of force exposure, rat aortic SMC demonstrated
significant synthetic behavior following applied increased tensile forces of angioplasty
injury and shear exposure. These responses included increased proliferation, apoptosis,
and smooth muscle cell hypertrophy when compared to the dynamic control of applied
strain alone. All dynamic groups demonstrated a decrease in contractile protein
expression, although the injury model maintained a significantly greater expression of the
synthetic marker vimentin. These in vitro findings agree with in vivo occurrences and
present a refined dynamic model to be implemented for better understanding of smooth
muscle cell activation and prevention of responses through pharmacological treatment.

5.2 Introduction

Restenosis remains a common problem following balloon angioplasty and stent
placement occurring in 30-60% of cases with balloon angioplasty alone [45] and in 1336% of cases with stent placement [12]. It is characterized by smooth muscle migration
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which can begin immediately after balloon angioplasty followed by smooth muscle
proliferation in the next 24-72 hours for up to two weeks [51]. Increased production of
the extracellular matrix and cellular hypertrophy further increases intimal hyperplasia [9].
These initial events of restenosis can be attributed in part to shifts in behavior of
medial vascular SMCs from a contractile to a synthetic phenotype [1]. Contractile SMCs
are quiescent, morphologically smaller and more elongated, express increased contractile
protein expression, and maintain the ability to contract [2]. In contrast, synthetic SMCs
are marked by higher proliferation, higher cell turnover, increased extracellular matrix
production, increased cell hypertrophy, increased synthetic protein expression, and loss
of the ability to contract [2]. Thus, blocking of SMC phenotype shift may be a useful
way to reduce the incidence of restenosis following balloon angioplasty.
While the exact triggering mechanism is yet unknown, it has been speculated
that changes in the mechanical environment for SMCs due to angioplasty and placement
of stents can result in shifts in SMC phenotype. During balloon deployment, both
atherosclerotic and healthy smooth muscle cells in the medial layer are exposed to higher
radial and circumferential forces followed by normally unseen direct shear forces from
blood flow due to the denudation of the endothelium.
In addition, disturbances in blood flow due to atherosclerotic lesions and stent
struts can cause further smooth muscle cell response. Vascular locations with disturbed
blood flow are more prone to plaque formation, vessel remodeling, and endothelial cell
activation [91, 176-178] and are most frequently associated with intimal thickening
leading to restenosis [51, 91, 179]. Moreover, it has been observed that smooth muscle
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activation is shear and time dependent; studies have shown that intimal thickness results
in areas of high shear at early time points while low wall shear was associated with
advanced intimal thickening, demonstrating negative effects in both cases deviated from
an optimum range [85, 86]. These results were further substantiated by in vitro studies
that demonstrated SMC proliferation decreases when exposed to well-defined steady flow
[153] and increased proliferation when exposed to oscillatory or orbital shear stress
patterns [178, 180, 181].
Cyclic strain due to the dilation and contraction of blood vessels is just as an
important mechanical stimulus as blood flow-induce shear stress to SMC function, such
as cell proliferation, migration, apoptosis, morphology, and alignment [154]. While
numerous studies have investigated the in vitro SMC response to applied cyclic strain, the
results obtained to date are mixed. Responses can vary with different parameters such as
the SMC vascular location, animal species, and the extracellular matrix [154] as well as
with the frequency, amplitude, and time exposed to strain can also affect the response of
cells. For example, cyclic strain has been shown to induce cell arrest in vascular SMCs,
therefore reducing rates of proliferation [155, 156]. Both low (< 5%) and high (>10%)
cyclic strains evoke a more synthetic SMC phenotype while normal physiologic (5-10%)
strain promote a quiescent contractile phenotype [182, 183]. In addition, SMC apoptosis
has been shown to be magnitude dependent with low physiologic strain (5-10%) do not
induce cell apoptosis [155-157], while higher levels (10-15%) induce cell apoptosis [157,
158]. The application of cyclic strain has been shown to increase expression of some
differentiated SMC markers [162, 184]. In the study by Birukov et al., in addition to h-
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caldesmon upregulation, increased proliferation was seen [162], demonstrating how
changes in phenotype marker expression and proliferative response can act independently
of one another.
Previous in vitro studies provided many important findings, however the models
are generally limited to the simulation of either cyclic strain or shear force on SMCs. To
simulate the complex arterial mechanical environment, our lab has designed and
fabricated a novel in vitro vascular intervention model which incorporates concurrent
shear and tensile forces to evaluate the response of SMCs to the mechanics of
endovascular intervention. Using this setup, we previously demonstrated increased
proliferation of SMCs after only 8 hours in response to our concurrent mechanical stimuli
when compared to cyclic strain alone [185]. In addition, our study demonstrated a
significant decrease in the contractile protein marker of SM α-actin expression in the
concurrent mechanical stimuli group compared to both the static and the cyclic strain
groups [185]. Given these results, we hypothesized that the early time point of 24 hour
concurrent force exposure following balloon angioplasty would result in further synthetic
behavior of SMCs. To characterize the phenotype shifts in response to the concurrent
forces applied, the present study focused on evaluating SMC responses of proliferation,
apoptosis, phenotype protein expression, and cell morphological measurements.
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5.3 Materials and Methods
Cell Culture

Rat aortic smooth muscle cells (RASMC) (Passages 4-6) harvested from 10-12 weeks old
male Sprague-Dawley rats were a generous gift from the laboratory of Dr. Anand
Ramamurthi, Department of Bioengineering, Clemson University. The RASMCs were
cultured in Dulbecco’s Modification of Eagle Medium (DMEM) (Mediatech, Inc., 10013-CV, Herndon, VA) supplemented with 10% heat inactivated fetal bovine serum
(FBS) (Sigma-Aldrich, F-4135, St. Louis, MO) and 1% Antibiotic-Antimycotic (SigmaAldrich, A5955, St. Louis, MO) under standard cell culture conditions (37ºC, 5% CO2
with 95% air, humidified environment).

Exposure of RASMCs to Mechanical Stimuli

Our custom-designed, concurrent force, vascular mechanics system was set up and
sterilized as previously described [185]. Prior to cell seeding, collagen (50 µg/ml) coated
silicone membranes were rinsed with 1.0 ml of Dulbecco’s Phosphate Buffered Saline
(DPBS) (Media Tech, Inc., 21-031 CM, Herndon, VA). RASMCs were seeded at a
density of 2.8 x 104 cells/cm2 (P4-6) and incubated for 24 hours in DMEM containing
10% FBS and 1% Antibiotic-Antimycotic. At 24 hours, the medium was changed to
DMEM containing 1% FBS, 1% Antibiotic-Antimycotic, and 1% Dextran for an
additional 24 hours prior to testing. During mechanical stimulation, the RASMCs were
maintained in DMEM with 1% FBS and 1% Antibiotic-Antimycotic; Dextran was added
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to the medium at 1% (w/v) to adjust the media viscosity and resultant wall shear stresses
on the cells at the prescribed level [174].
Three experimental dynamic groups simulating in vivo conditions were
investigated in the present study in addition to a static unloaded (U) control group where
cells where exposed neither to shear nor tensile forces. Prior to the application of
mechanical stimuli of interest, the dynamic experimental groups were subject to a
preconditioning regimen of 0-4% cyclic strain at gradually increasing frequencies of 0.1
Hz (15 min), 0.5 Hz (15 min), and 1.0 Hz (15 min). The cyclic tensile group (CT)
simulated a physiological dynamic control and RASMCs were cyclically strained from 05% at a frequency of 1 Hz for 24 hours. The second group that simulates the clinical
balloon angioplasty (BA) regimen was subjected to simulated in vitro balloon angioplasty
consisting of two 12% static circumferential stretches held for 90 seconds each with a 30
second rest interval between stretches. The injury model (IM) group simulated smooth
muscle cells that are directly exposed to blood flow upon the denudation of the
endothelial monolayer and was exposed to the same balloon angioplasty regimen as BA.
Following simulated balloon angioplasty, shear flow was resumed at 400 ml/min and
cyclic strain was applied at 0-5% for 24 hours. The flow rate of 400 mL/min provided a
theoretical low wall shear stress of 0.3 dynes/cm2. Our own computational simulation of
this flow using a finite volume analysis software package, FLUENT, verified that the
resultant wall shear stress at the cells falls within this range, but oscillates between 0.10.5 dynes/cm2 due to the 1 Hz cyclic straining of the silicone membrane.
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Evaluation of RASMC Response to Applied Mechanical Stimuli

Cell Number Quantification
The number of cells was assessed using the CyQuant Cell Proliferation Assay Kit
according to the manufacturer’s protocols (Molecular Probes, C7026). Briefly, cell
samples of each group (n=6) were rinsed in PBS and incubated with 0.25% trypsin for 10
min at 37ºC. A cell scraper was used to gently lift the cells from the collagen coated
silicone surface and centrifuged at 1500 rpm for 5 minutes. Following aspiration of the
supernatant, the cell pellets were washed with DPBS to remove any remaining phenol red
from the trypsin solution and centrifuged again at 1500 rpm for 5 minutes. The
supernatant was aspirated and the cell pellets were lysed at -80ºC. When thawed, the
samples were each diluted with 400 µL of CyQuant GR dye/cell-lysis buffer. Two
samples of 200 µL were transferred to a black 96-well microplate and fluorescence
intensity was measured at 535 nm using a plate reader (GENios, Tecan, Research
Triangle Park, NC). The two readings were averaged and the number of cells present for
each sample was calculated by comparing to the standard curve prepared at the time of
the assay.

Apoptosis
Apoptosis was evaluated using the DeadEnd Fluorometric TUNEL System (Promega,
TB235). In this process, fragmented DNA of apoptotic cells was stained green with
fluorescein and imaged at 535 nm and the DNA of all cells was stained red with
propidium iodide (Sigma-Aldrich, P486) and was imaged at 620 nm. The percentage of
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apoptotic cells in each group was determined by counting the number of apoptotic
(green) cells and total (red) cells imaged 5-7 fields per sample providing a range of 25-29
fields per experimental group (n=5 samples). For a positive control of apoptosis, cells
were subjected to UV exposure for 30 minutes [186-188]. Negative controls were
performed with rTdT incubation buffer prepared without the rTdT Enzyme according to
the manufacturer’s protocol.

Quantification of Phenotypic Marker Proteins
Protein expressions of SM α−actin, calponin, SM22α, and vimentin in cell lysates were
quantified using standard western blotting techniques and digital image analysis. The
expression of GAPDH was also quantified to ensure equal loading of protein samples in
SDS-PAGE gel. Briefly, cells were removed from the silicone membrane and lysed
using an extraction buffer consisting of 0.5% Triton X-100 (Sigma-Aldrich, T-9284, St.
Louis, MO), 1% Sodium dodecyl sulfate (Sigma-Aldrich, L-4522, St. Louis, MO), 20
mM Tris (BIORAD, 161-0716, Hercules, CA), and 10 µL/mL protease cocktail inhibitor
(Sigma-Aldrich, P8340, St. Louis MO). The BCA Protein Assay Kit (Pierce, 23225,
Rockford, IL) was then used to determine the total protein content of each sample. These
samples were then diluted to 40 µg/µL using sample buffer consisting of a reducing
agent, β-mercaptoethanol, 0.5 M Tris-HCl, 10% SDS, 0.5% Bromophenol Blue, glycerol
and distilled water. Prior to gel electrophoresis, the samples were denatured by boiling
for 5 minutes. A 10% polyacrylamide gel (BIORAD, 161-0158, Hercules, CA) was used
in electrophoresis with 15 µL protein samples loaded per lane. The protein samples
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separated on the SDS-PAGE gel were transferred to a PVDF membrane (Biorad, 1620184) which was incubated with the following primary antibodies with specified
dilutions: SM α-actin (Abcam, ab18460-1, 1:1000), SM22α (Abcam, ab10135-100,
1:500), calponin (Abcam, ab46794, 1:500), vimentin (Abcam, ab7752, 1:750), and
GAPDH (Santa Cruz Biotechnologies, FL-335, 1:250). The blots were then incubated
with appropriate secondary antibodies at 1:5000 dilution and Precision Streptactin-HRP
conjugate (Biorad, 161-0380) at 1:20000 dilution. Chemiluminescent labeling of the
PVDF membranes was performed with Immun-StarTM HRP substrate kit (Biorad, #1705040) according to the manufacturer’s instructions. The western blots were imaged using
the FluorChem SP imager (Alpha Innotech); Densitometry of the bands in the digital
images was performed using the AlphaEaseFC (FluorChem SP) software to evaluate the
protein expression level differences between the U (n=6), CT (n=6), BA (n=6) and IM
(n=6) groups. The Integrated Density value (IDV) expression of the markers was
normalized that of GAPDH and statistically evaluated.

Quantification of Cell Size and Aspect Ratio
At the end of each experiment, the cells were fixed in a 2% paraformaldehyde solution
and the cytoskeletal F-actin and cell nuclei were stained using Rhodamine-Phalloidin
(Invitrogen, R415) and DAPI, respectively. Measurements of the cells including cell
area, length, width, minor axis, major axis, and aspect ratio were performed using
ImagePro Plus Analysis software (Media Cybernetics, Inc., Version 5.1, Silver Spring,
MD). A minimum of 117 cells per group were measured for analysis from random points
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from four samples of each experimental group. The combined number of cells was
statistically compared according to the area and aspect ratio of the cells. Histograms of
each group were also compared to evaluate trends in data.

Statistical Analysis

Analysis of variance (ANOVA) paired with Student-Newman-Keuls (SNK) analysis was
performed using SigmaStat (Systat Software, Inc., San Jose, CA). In the case of failed
normality as determined by SigmaStat, the Kruskal-Wallis One-Way ANOVA on Ranks
was used with Dunn’s Method to detect statistical differences between groups. The
presented data is representative of samples combined from two independent experiments
to provide a minimum of four samples available for comparison per simulation group for
each evaluation technique.

5.4 Results
CyQuant Cell Proliferation Assay

Cell quantification using the CyQuant Assay resulted in CT: 8.35 x 104 cells ± 2.80 x
104 SD, BA: 8.15 x 104 cells ± 1.10 x 104 SD, IM: 12.41 x 104 cells ± 1.16 x104 SD,
and U: 13.10 x 104 cells ± 2.33 x104 SD. ANOVA indicated a significant difference
between samples (p<0.001) and SNK analysis determined that the CT and BA groups
were statistically lower than the IM and U groups (Figure 1).
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Figure 5.1 CyQuant Proliferation Assay for 24 hour cell quantification. From left to
right: U: 13.10 x 104 cells ± 2.33 x104 SD (n=6), IM: 12.41 x 104 cells ± 1.16 x104 SD
(n=6), BA: 8.15 x 104 cells ± 1.10 x 104 SD (n=5), CT: 8.35 x 104 cells ± 2.80 x 104 SD
(n=6). (* indicates statistical significance, p=0.001)

Apoptosis TUNEL assay

The TUNEL assay revealed that a few, but measurable cells were apoptotic after 24 hours
in all experimental groups (Figure 2). The resultant percentage of the ratio of apoptotic
to total cells were: CT: 3.43 ± 3.50 SD (n=29), BA: 5.05 ± 3.156 SD (n=28), U: 6.07 ±
4.32 SD (n=27), and IM: 6.86 ± 3.89 SD (n=25). The IM and U groups contained
significantly (p=0.002) greater percentages of apoptotic cells compared to the CT group
(Figure 3). Data represents a minimum of 25 points distributed over a minimum of four
samples.
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b)

c)

d)

e)

f)
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h)

g)

Figure 5.2 TUNEL assay images at 100x magnification a) CT apoptosis b) CT
Propidium iodide c) BA apoptosis d) BA Propidium iodide e) IM apoptosis f) IM
Propidium iodide g) U apoptosis h) U Propidium iodide; arrows indicate apoptotic cells

Figure 5.3 Apoptosis comparison using TUNEL assay. Statistical Analysis performed
with Kruskal-Wallis One Way Analysis of Variance on Ranks (p=0.002). Mean values
(% of cells) and standard deviation (SD) for the groups were: U: 6.07 ± 4.32 SD (n=27),
and IM: 6.86 ± 3.89 SD (n=25), BA: 5.05 ± 3.16 SD (n=28), CT: 3.43 ± 3.50 SD (n=29)
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Phenotype markers

Densitometry analysis of western blots demonstrated decreased expression of contractile
proteins (SM22α, SM α-actin, and calponin) for all three dynamic groups compared to
static Unloaded control. The expressions of SM22α (Figure 4b) and SM α-actin (Figure
4c) in CT, IM, and BA groups were significantly lower by approximately 50% compared
to the static (U) cells. Calponin expression indicated the significantly (p=0.001) highest
expression in the U group and the significantly lowest expression in CT group (Figure
4d). The expression of calponin for the dynamic groups was lower by almost 40% for IM
and BA, and about 66% for CT compared to the static control (U). The expression of the
synthetic phenotype marker vimentin (Figure 4e) was significantly (p=0.001) highest in
the static control samples as well.
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U

IM

BA

CT

SM22
SM22α
SM α
α-actin
Calponin
Vimentin
GAPDH

Figure 5.4 Western blot analysis for RASMC phenotype characterization. a)
Representative images for each of the groups for the expression of SM22
SM22α,
α, SM α-actin,
calponin, vimentin, and GAPDH. (b-e)
e) Densitometry results normalized relative to static
control (U), n=6 samples per treatment gro
group,
up, error bars depict standard deviation
d
of
samples ( * indicates a significant difference between groups, p=0.001 for all One-WayOne
ANOVA comparisons)
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Cell Area Measurements
The mean cell areas determined using phalloidin staining of fixed SMCs and ImagePro
software (Figure 5) for the respective groups were: U: 4948
4948µm2 ± 3511 SD (n=126), IM:
4928 µm2 ± 2646 SD (n=117), BA: 3212 µm2 ± 2060 SD (n=146), and CT: 2415 µm2 ±
1730 SD (n=127). ANOVA paired with Dunn’s method indicated that areas of both the
BA and CT groups were both significantly (p=0.001) lower than both U and IM groups
(Figure 6a).

a)

b)

c)

d)

a)
Figure 5.5 Phalloidin staining with DAPI overlay of rat aortic smooth muscle cells used
for cell measurements and aspect ratio at 100x magnification a) Static Unloaded (U) b)
Injury Model (IM) c) Balloon Angioplasty (BA) d) Cyclic tensile (CT)
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d)
d

Figure 5.6 Celll measurement comparison of mean cell area and cell aspect ratio for 24h
experiment groups with error bars representing standard deviation a) Mean cell area U:
4947.8 µm2 ± 3511 SD (n=126), IM: 4928 µm2 ± 2646 SD (n=117), BA: 3212 µm2 ±
2060 SD (n=146), andd CT: 2415 µm2 ± 1730 SD (n=127) (p=0.001) b) Mean cell aspect
ratio: U: 2.71 ± 1.31 SD (n=126), IM: 2.49
2.49± 0.85SD (n=117), BA: 3.15 ± 1.50 SD, and
CT 3.62 ± 1.67 SD (n=127) (p=0.001)

The histogram analysis with 7 bins of cell areas in the ranges of: 00-1000,
00, 1000-2000,
1000
2000-3000, 3000-4000,
4000, 4000
4000-6000, 6000-8000, and >8000 µm2 (Figure 7) provided
further insight to the behavior of these cell groups. The histogram distribution indicated
the majority of cells for U (63.5%) was between 2000
2000-6000 µm2 (Figure 7a)
a) and for IM
(70.1%) between 3000-8000
8000 µ
µm2 (Figure 7b). In contrast, the majority of BA (71.9%)
was between 1000-4000 µm2 (Figure 7c) and for CT (69.3%) between 0-3000
3000 µm2
(Figure 7d). The primary differences between BA and CT were the substantially higher
frequencies of CT cells in the lowest bin of 00-1000 µm2 and the lower percentages of
cells in subsequent bin ranges greater than 2000 µm2 (Figures 7c and 7d). Moreover, the
IM group had greater frequencies at higher area ranges and exhibited a shift toward
higher cell areas compared to the other groups.
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Figure 5.7 Histogram representation distribution of cell area measurements a) U area
histogram b) IM area histogram c) BA area histogram d) CT area histogram

Aspect Ratio Determination
Analysis of smooth muscle cells using Image Pro analysis defined the average aspect
ratios as the ratio of the measurement of the major axis to the minor axis. The aspect
ratios of the U and IM groups were similar with mean values of 2.71 ± 1.31 SD (n=126)
and 2.49 ± 0.85 SD (n=117), respectively. In contrast, both the BA (3.15 ± 1.50 SD) and
CT (3.62 ± 1.67 SD) groups were both significantly (p<0.001) higher from both the U
and IM groups (Figure 6b).
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Figure 5.8 Histogram representation of the aspect ratio in the experiment groups a) U
aspect ratio b) IM aspect ratio c) BA aspect ratio d) CT aspect ratio

The histogram analysis with 7 bins at aspect ratios ranges of: 1-1.5, 1.5-2.0, 2.0-2.5, 2.53.0,3.0-3.5, 3.5-4.0, and >4.0 (Figure 8) provided further insight into the behavior of the
cells. The U group (Figures 8a) exhibited the narrowest range of aspect ratios with the
majority (49.2%) between 1.5 and 2.5. The majorities for both IM (70.1%) and BA
(51.4%) were in the range of 1.5-3.0 (Figure 8a and 8c, respectively). The primary
differences between the aspect ratio distributions of IM and BA was the lower
percentages of the BA cells within the respective range and the high percentage of cells
(21.2%) with aspect ratios greater than 4.0. In this range, BA resembled the behavior of
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CT in which the majority (45.7%) of the aspect ratios for the CT group (48%) (Figure 8d)
was greater than 3.5.

5.5 Discussion

The concurrent force model in the presented study simulates several mechanical
events encountered in clinical settings while maximizing the early synthetic SMC
response following balloon angioplasty. The combinatory model implemented in this
work combined current shear and tensile forces in addition to the increased injury of
balloon angioplasty. Tensile strain of 5% was included to simulate arterial vessel dilation
and a balloon angioplasty regimen including two bouts of high strain was included to
simulate two-staged balloon deployments, which is a common clinical practice [19].
Arterial regions with wall shear stress (WSS) values of about 5 dynes/cm2 are more
prone to restenosis [144, 171, 189]; the much lower oscillating wall shear stress used in
the study (0.1-0.5 dynes/cm2) was integrated to elicit a SMC response. The complex
effects that SMCs are subjected to in vivo have been simulated in vitro for SMC
phenotype characterization in response to mechanical stimuli. More specifically, we
evaluated changes in cell proliferation, apoptosis, phenotype markers, and morphological
measurements.
Increased cell proliferation and apoptosis are characteristics of synthetic
phenotype of smooth muscle cells. The present study resulted in significant increase in
the number of cells in the U and IM groups when compared to smooth muscle cells
exposed to cyclic strain only (CT) at 24 hours (Figure 1). Apoptosis in the U and IM
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groups (Figure 2) was also greater compared to CT and suggests that proliferation of
these groups may be greater due to the greater numbers of cell in U and IM was to
increased proliferation. Increased rates of apoptosis and proliferation suggest a higher
cell turnover rate, a characteristic of synthetic behavior in SMCs; while proliferative
activity of the SMCs may be increased, increased apoptosis decreases the number of total
cells. These results are in agreement with our previous observations of increased
proliferation in the IM group and decreased proliferation in the CT group at 8 hours
[185]. Other in vitro studies also found that SMCs exposed to physiologic strain alone
and demonstrated cell arrest in vascular smooth muscle cells [155, 156] and cyclic stretch
less than 7% did not induce SMC apoptosis [158]. The increase in both cell proliferation
and apoptosis of the injury model SMCs in the present study is in agreement with clinical
occurrences, and further demonstrates that the addition of shear results in proliferative
and apoptotic responses compared to strain alone. Following balloon angioplasty in vivo,
increased SMC proliferation and apoptosis in the artery have been observed [51, 190,
191]. Smooth muscle cells in vivo have been shown to become apoptotic in as little as 30
minutes following balloon angioplasty [191].
The protein expression of the dynamic groups (IM, BA, and CT) in this study
demonstrated a decrease in contractile markers after 24 hours of mechanical stimulation
compared to the static control. The decrease in SM α-actin in the injury model (IM) was
shown to continue beyond 8 hours that was reported in our previous study [185].
Additionally in the previous study, 8 hours of mechanical stimulation did not result in
any changes in SM α-actin expression in CT alone. However, 24 hours of mechanical
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stimulation resulted in a significant decrease of SM α-actin in CT, therefore implying that
the duration of mechanical stimulation has a key role in cell protein expression. In
addition to SM α-actin, other contractile markers of SM22α and calponin were also
decreased in all of the dynamic models. The decrease in these markers associated with
SMC contraction demonstrate the loss of ability to contract, a common characteristic
associated with synthetic SMCs [2].
Changes in the expression of the synthetic marker vimentin were also observed in
this study. Like the expression of the contractile markers, the static U group exhibited
the highest expression of vimentin. High expressions of both contractile and synthetic
markers suggest a general trend of increased protein production and possible variation
within the population of low passage cells. In contrast to U, the lowest expression of
both marker categories was exhibited in CT with an overall trend of decreased protein
expression. Others have found increased synthetic behavior in response to strain alone
characterized by increased cell viability, decreased morphological elongation, decreased
α-actin and calponin expression, and increased vimentin expression compared to the

static control [163]. The IM group which was subjected to balloon angioplasty injury and
concurrent shear and tensile forces expressed increased vimentin demonstrating that the
SMCs exposed to concurrent shear and tensile forces resulted in an increase in the
synthetic marker expression compared to CT. The increase in the synthetic marker
vimentin expression and decrease in contractile markers is in agreement with other
oscillating shear studies [180]. Compared to in vivo conditions, the variation in protein
expression was expected since there is a heterogeneous range of the phenotype of smooth
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muscle cells present in vivo [192-194] and cells are generally not categorized as purely
synthetic or contractile but rather as a spectrum [183].
Cell hypertrophy, as another indicator of SMC phenotypic shift, is one of the
important characteristics of synthetic SMCs, which are generally larger in size and more
rhomboidal in shape compared to contractile SMCs, which are smaller and more
elongated spindle shaped [2]. The present study evaluated the morphological changes
representative of the phenotypic shift of SMCs in response to mechanical stimuli. The
results of the present study provided evidence that cells in the CT group exhibited a
significantly lower cell area compared to both U and IM (Figure 6a) which suggested that
strain alone does not induce a hypertrophy response to smooth muscle cells at 24 hours
exposure to mechanical stimulation, but rather a smaller more elongated cell morphology.
The significantly greater cell area in the BA group compared to the CT group suggested
that the higher strain levels from simulated balloon angioplasty led to early hypertrophic
behavior of SMCs. This response was further amplified with the addition of shear as
represented in the IM group with significant increases in cell size to the identical level of
the static control (U), suggesting the highest hypertrophic effect of the injury model. In
addition to cell area, the aspect ratio (the major vs. minor axes of the cell) provided
additional insight to the phenotypic behavior of the SMCs; a highly synthetic phenotype
of the cell would tend to have a lower aspect ratio, with more of a round and irregular
rhomboidal shape. Our analyses of the aspect ratio (Figures 6b and 8) supported similar
trends as the cell area analyses. The mean aspect ratios (Figure 6b) were significantly
lower for both the U and IM groups compared to CT. Our histogram analyses revealed
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that U and IM groups contained higher percentages of cells in the low aspect ratio range
of 1.5-2.0, suggesting that cells exhibit morphologically a more synthetic phenotype.
Thus, our image-based analysis of smooth muscle cell morphology following dynamic
exposure had a more contractile morphological behavior with strain alone but underwent
a phenotypic shift to become more morphologically synthetic with the addition of balloon
angioplasty and shear.
The results of the present study provide evidence that mechanical stimulation of
smooth muscle cells evokes phenotypic responses in proliferation, apoptosis,
morphology, and protein expression. The comparison of numerous cell responses
between all of the three dynamic testing groups (CT, BA, and IM) and the static group
(U) was important for characterization of the developed injury model incorporating
concurrent shear and tensile forces. Cells exposed to tensile strain only in the CT group
exhibited the lowest proliferation, apoptosis, and cell area and the highest aspect ratio, all
of which are properties indicative of contractile SMCs, but was also characterized by the
lowest expression of contractile and synthetic protein markers. CT was important for
comparison to verify that the cell responses of IM were attributed to the combinatory
force exposure and not simply strain. BA was valuable to show that increased strain
injury of balloon injury may work in part to trigger a SMC response but the additive force
effects of the injury model incorporating shear resulted in the highest synthetic response.
The statically grown U group was essential to demonstrate the differences between the
static and mechanically stimulated groups. All of the groups demonstrated the wide
spectrum of SMC phenotype and how a population of SMCs can possess both contractile
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and synthetic characteristics [192]. For example, CT exhibited the lowest proliferation,
apoptosis, and cell area, and expressed the lowest levels of both the contractile any
synthetic markers while U exhibited higher proliferation, apoptosis, and cell area but also
expressed the highest level of both the contractile and synthetic markers.
The primary objective of this study was to elicit the highest synthetic response
from the injury model (IM) incorporating balloon angioplasty and concurrent shear and
tensile forces. The combination of balloon angioplasty with applied shear in the injury
model demonstrated a synergistic effect of the combination of forces, resulting in not
only a loss of contractile markers unlike the static control, but also in increased synthetic
behavior with high vimentin expression, increased proliferation and apoptosis, and
increased synthetic morphology, therefore providing an improved in vitro model to
further investigate the role of clinical mechanical forces and the relationship to resultant
SMC responses in early stages of restenosis. Apoptosis, cell number, and morphological
measurements were similar between the dynamic injury model (IM) and the static control
(U). However, the morphological histograms demonstrated that the IM group had the
highest range of cell area and a narrower range of aspect ratios. These combined effects
demonstrate the greatest synthetic SMC response. The differences in responses and
mechanisms of the developed injury model demonstrates the need for dynamic
mechanical in vitro testing to investigate SMC responses associated with early stages of
restenosis.
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5.6 Conclusion

The present study has demonstrated that vascular SMCs in vitro exhibit behaviors
similar to clinical occurrences in the simulated model of balloon angioplasty which
accounted for SMC injury and concurrent mechanical forces. SMC responses including
apoptosis, cell proliferation, cell hypertrophy, and the overall synthetic phenotype
behavior were all significantly increased within the simulated injury model (IM). In this
study, varying phenotype responses to the simulated injury occurred independently of
each other, demonstrating the complicated spectrum of smooth muscle cell phenotype
markers. Using the IM in vitro model of smooth muscle cell response following clinical
intervention, early mechanisms of intimal thickening and restenosis may be studied and
treatment methods to promote a healthier smooth muscle cell response may be developed.
Further studies with the concurrent shear and tensile force model with incorporated
balloon injury will provide additional insight into the role of the mechanical regimen of
endovascular intervention and the incorporation of pharmacological agents will enhance
this investigation tool to address treatment or prevention of restenosis.
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-CHAPTER 6AIM 5- THE EFFECTS OF HEPARIN ADMINISTRATION IN CONCURRENT
FORCE INJURY MODEL

6.1 Abstract

Heparin is an anti-coagulant agent commonly administered during vascular
procedures such as balloon angioplasty. Heparin has been shown to also have an antiproliferative effect but does not prevent against long-term restenosis. In this study, the
effect of the administration of heparin on smooth muscle cells (SMCs) after 24 hours was
investigated using a dynamic in vitro balloon angioplasty injury model in which the
SMCs were exposed to higher strains of balloon angioplasty simulation followed by
concurrent shear and tensile force stimulation. A local administration of 100 µg/ml was
compared to a clinically relevant bolus of 10,000 units for 5 minutes prior to balloon
angioplasty followed by 100 µg/ml administration over the course of 24 hours. It was
found that the heparin bolus dynamic group resulted in a decreased number of cells while
the 100 µg/ml administration had no effect. Additionally, heparin was shown to
significantly decrease calponin expression, a calcium binding protein that inhibits the
ATPase activity of myosin in the case of the injury model, and increase calponin
expression in static samples. Significant variations in responses demonstrate the
necessity of using dynamic clinically relevant in vitro models for pharmaceutical agent
testing.
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6.2 Introduction

Heparin and heparan sulfates are glycosaminoglycans and anti-coagulant agents
naturally produced by various cell types. Anti-coagulative and anti-platelet therapies
such as heparin are administered to patients prior, during, and following endovascular
procedures to reduce blood coagulation. A common clinical protocol consists of a three
to five minute IV bolus administration of 10,000 units of heparin applied immediately
prior to balloon angioplasty [195]. In the addition to preventing blood coagulation,
heparin has been shown to affect cell adhesion, differentiation, and cell proliferation
[195, 196]. Heparin has been shown to reduce smooth muscle cell proliferation and
migration [52, 70] by arresting the cell cycle through the G1 mitotic phase [197, 198].
Heparin regulates SMCs through both extracellular and intracellular actions.
There are approximately 100,000 binding sites for heparin on a vascular smooth muscle
cell (VSMC) [199]. Growth arrested SMCs are 100 times more sensitive and can bind
eight times more heparin [200]. Heparin has been shown to be most effective when the
cells are released from growth arrest by stimulation with media containing higher
percentages of heparin [201, 202]. It has been shown to be involved in multiple kinase
cascades including the mitogen activated protein kinase (MAPK) and protein kinase C
(PKC) pathways. Other investigators have found that heparin suppresses extracellular
signal-regulated kinase (ERK) ½ activation in response to agonists of G protein-coupled
receptors [203, 204].
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Although heparin has been shown to have an anti-proliferative effect [52, 70]on
smooth muscle cells in vitro using static cultures, restenosis remains a significant
problem following clinical endovascular procedures. In this study, a dynamic in vitro
injury model [185] was used to compare the effects of both constant and bolus heparin
administration on VSMC proliferation and phenotype marker expression over 24 hours
following simulated balloon angioplasty. Additionally, the role of heparin administration
on ERK ½ pathway was investigated.

6.3 Materials and Methods
Cell Culture

Rat aortic smooth muscle cells courtesy of Dr. Anand Ramamurthi were cultured in
standard culture conditions consisting of Dulbecco’s modification of Eagle’s Medium
(DMEM) (Mediatech, 10-013-CV) supplemented with 10% fetal bovine serum (FBS)
(Sigma Aldrich, F4135) , 1% antibiotic/antimycotic (Mediatech, A5955) and kept in 5%
CO2 humidified incubator.

Heparin Dosage Studies

SMCs (P4-6) were plated on at a concentration of 2.8 x 104 cells/cm2 in 96-well plates or
48-well plates with DMEM supplemented with 10% FBS, 1% antibiotic-antimycotic. At
24 hours, the media was changed to DMEM with 0.5% FBS, 1% Antibiotic-antimycotic,
and 1% dextran. At 48 hours, the media was changed to 2% FBS, 1% antibioticantimycotic, 1% dextran, and dosages of heparin at the values of 0, 1, 5, 10, 50, 75, 100,
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150, 200, 300, and 500 µg/ml with n=4 per dosage. After an additional 24 hours, the
SMC were evaluated using Live/Dead assay (Invitrogen, L-3224), CyQuant Cell
Proliferation assay (Invitrogen, C7026), and DeadEnd Fluorometric TUNEL System
apoptosis assay (Promega, TB235). Dosage studies are representative of 3 independent
experiments across several techniques.

Cell Viability for Heparin dosage

After heparin dosage treatment, cell viability and quantification were evaluated through
the LIVE/DEAD Viability/Cytotoxicity Kit (L-3224), CyQuant cell proliferation assay,
and the TUNEL apoptosis assay. For the LIVE/DEAD assay, SMCs were plated in a
black 96-well cell culture plate and treated as previously described. Following heparin
dosage treatment after 24h, cells were and handled according to the manufacturer’s
protocol for the microplate reader. Briefly, the cells were rinsed in DPBS and incubated
with 100 µl of a 2 µM calcein AM and 4 µM EthD-1 working solution for 30 minutes.
Fluorescence intensity was measured using the fluorescent plate reader (GENios, Tecan,
Research Triangle Park, NC) with excitation/emission at 494/574 nm for calcein to detect
fluorescence levels for live cells, and 528/617 for EthD-1 to detect fluorescence levels for
dead cells.
CyQuant heparin samples were cultured in black 96-well microplates and the
media was removed following heparin treatment. The cell plate was treated according to
the manufacturer’s protocol in which it was frozen at -80 ºC to induce cell lysis. After 48
hours, 200 µL of the CyQuant GR dye/cell-lysis buffer was added to each well of the
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microplate and the fluorescence intensity was measured at 535 nm using a plate reader
(GENios, Tecan, Research Triangle Park, NC). The number of cells present for each
sample was calculated by comparing to the standard curve prepared at the time of the
assay.
SMCs were cultured on 12-well plates to evaluate the effects of heparin on SMC
apoptosis. Apoptosis was evaluated using the DeadEnd Fluorometric TUNEL System
(Promega, TB235). In this process, fragmented DNA of apoptotic cells was stained green
with fluorescein and imaged at 535 nm and the DNA of all cells was stained red with
propidium iodide (Sigma-Aldrich, P486) and was imaged at 620 nm. The percentage of
apoptotic cells in each group was determined by counting the number of apoptotic
(green) cells and total (red) cells imaged 5 fields per sample providing a range of 15
fields per experimental group (n=3 samples). For a positive control of apoptosis, cells
were subjected to UV exposure for 30 minutes [186-188]. Negative controls were
performed with rTdT incubation buffer prepared without the rTdT Enzyme according to
the manufacturer’s protocol.

Exposure of RASMCs to Mechanical Stimuli

A custom-designed, concurrent force, vascular mechanics system was set up and
sterilized as previously described [185]. Biomedical grade silicone sheets (5.25 cm in
diameter) for each station were cut from biomedical grade silicone sheets of .015"
thickness and 40 durometer (Specialty Manufacturing, 70P001-100-015) and were
collagen coated using 665 µl of a 75 µg/ml PureCol (Cohesion Tech, 5409) solution. The
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collagen film was allowed to dry for 48 hours in a sterile laminar hood. Prior to cell
seeding, the films were rinsed and rinsed with 1 ml of Dulbecco’s Phosphate Buffered
Saline (DPBS) (Mediatech, 21-031 CM). RASMCs were seeded at a density of 2.8 x 104
cells/cm2 (P4-6) and incubated for 24 hours in DMEM containing 10% FBS and 1%
antibiotic-antimycotic (Sigma-Aldrich, A5955). At 24 hours, the medium was changed
to DMEM containing 0.5% FBS, 1% antibiotic-antimycotic, and 1% Dextran for an
additional 24 hours prior to testing to promote more quiescent behavior of the smooth
muscle cells. The media used during mechanical testing consisted of DMEM
supplemented with 2% Fetal Bovine Serum, 1% Antibiotic/Antimycotic, 1% Dextran
(Sigma Aldrich, D4876). Heparin (Sigma Aldrich, H3149) was dissolved to the
appropriate concentration in DMEM and filter sterilized. Dextran was added to the
medium at 1% (w/v) to adjust the media viscosity and resultant wall shear stresses on the
cells at the prescribed level [174].
Six testing groups were compared in this experiment. The injury model (IM)
group simulated smooth muscle cells that are directly exposed to blood flow upon the
denudation of the endothelial monolayer following balloon angioplasty [20]. Prior to the
application of mechanical stimuli, the dynamic experimental groups were subject to a
preconditioning regimen of 0-4% cyclic strain at gradually increasing frequencies of 0.1
Hz (15 min), 0.5 Hz (15 min), and 1.0 Hz (15 min). Balloon angioplasty was simulated
by subjecting cells to two 12% static circumferential stretches held for 90 seconds each
with a 30 second rest interval between stretches. Following simulated balloon
angioplasty, cells were subjected to 400 ml/min shear flow and cyclic strain was applied
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from 0 to 5% with a sinusoidal regimen at1 Hz frequency for 24 hours. The flow rate of
400 mL/min provided a theoretical low wall shear stress of 0.3 dynes/cm2. A
computational simulation of this flow using a finite volume analysis software package,
FLUENT, verified that the resultant wall shear stress at the cells falls within this range,
but oscillates between 0.1-0.5 dynes/cm2 due to the 1 Hz cyclic straining of the silicone
membrane. Three groups were subjected to the injury model regimen; the Injury Model
(IM) acted as the dynamic control to evaluate potential effects of heparin. The Injury
Model-Heparin (IMH) group was exposed to the same dynamic regimen but also subject
to constant administration of 100 µg/ml heparin dosage in DMEM following balloon
angioplasty for the duration of 24 hours. The Injury Model-Bolus (IMB) group simulated
a more clinically relevant regimen with 10,000 units of heparin dissolved in DPBS
administered as a bolus for 5 minutes prior to balloon angioplasty followed by
administration of 100 µg/ml heparin dosage in DMEM following balloon angioplasty for
the duration of 24 hours. Three statically grown groups were implemented for
comparison with static Unloaded (U) being cultured under the same culture conditions
without heparin as IM, Unloaded-Heparin (UH) was exposed to DMEM with 100 µg/ml
heparin dosage, and Unloaded-Bolus (UB) was exposed to the bolus heparin in DPBS for
5 minutes followed by 100 µg/ml heparin dosage in DMEM. All experiments were
conducted in triplicate.
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Cell Number Quantification
Following 24 hour testing, the number of cells was assessed using the CyQuant Cell
Proliferation Assay Kit according to the manufacturer’s protocols (Molecular Probes,
C7026). Briefly, cell samples of each group (n=5) were rinsed in PBS and incubated
with 0.25% trypsin for 10 min at 37ºC. A cell scraper was used to gently lift the cells
from the collagen coated silicone surface and centrifuged at 1500 rpm for 5 minutes.
Following aspiration of the supernatant, the cell pellets were washed with DPBS to
remove any remaining phenol red from the trypsin solution and centrifuged again at 1500
rpm for 5 minutes. The supernatant was aspirated and the cell pellets were lysed at 80ºC. When thawed, the samples were each diluted with 600 µL of CyQuant GR
dye/cell-lysis buffer. Three samples of 200 µL were transferred to a black 96-well
microplate and fluorescence intensity was measured at 535 nm using a plate reader
(GENios, Tecan, Research Triangle Park, NC). The three readings were averaged and
the number of cells present for each sample was calculated by comparing to the standard
curve prepared at the time of the assay.

Quantification of Phenotypic Marker Proteins
Expression of phenotype markers SM α−actin, calponin, and vimentin in SMC lysates
were quantified using standard western blotting techniques and digital image analysis.
The expression of GAPDH was also quantified to ensure equal loading of protein
samples in SDS-PAGE gel. Briefly, cells were removed from the silicone membrane and
lysed using an extraction buffer consisting of 0.5% Triton X-100 (Sigma-Aldrich, T-
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9284, St. Louis, MO), 1% Sodium dodecyl sulfate (Sigma-Aldrich, L-4522, St. Louis,
MO), 20 mM Tris (BIORAD, 161-0716, Hercules, CA), and 10 µL/mL protease cocktail
inhibitor (Sigma-Aldrich, P8340, St. Louis MO). The BCA Protein Assay Kit (Pierce,
23225, Rockford, IL) was then used to determine the total protein content of each sample.
These samples were then diluted to 40 µg/µL for phenotype proteins or 80 µg/µL for
p44/42 proteins using sample buffer consisting of a reducing agent, β-mercaptoethanol,
0.5 M Tris-HCl, 10% SDS, 0.5% Bromophenol Blue, glycerol and distilled water. Prior
to gel electrophoresis, the samples were denatured by boiling for 5 minutes. A 10%
polyacrylamide gel (BIORAD, 161-0158, Hercules, CA) was used in electrophoresis with
15 µL protein samples loaded per lane. The protein samples separated on the SDS-PAGE
gel were transferred to a PVDF membrane (Biorad, 162-0184) which was incubated with
the following primary antibodies with specified dilutions: SM α-actin (Abcam, ab184601, 1:1000), calponin (Abcam, ab46794, 1:500), vimentin (Abcam, ab7752, 1:750),
GAPDH (Santa Cruz Biotechnologies, FL-335, 1:250), p44/22 (Cell Signaling
Technologies, 4695, 1:1000), and phos p44/42 (Cell Signaling Technologies, 4370,
1:1000). The blots were then incubated with appropriate secondary antibodies at 1:5000
dilution and Precision Streptactin-HRP conjugate (Biorad, 161-0380) at 1:20000 dilution.
Chemiluminescent labeling of the PVDF membranes was performed with Immun-StarTM
HRP substrate kit (Biorad, #170-5040) according to the manufacturer’s instructions. The
western blots were imaged using the FluorChem SP imager (Alpha Innotech).
Densitometry of the bands in the digital images was performed using the AlphaEaseFC
(FluorChem SP) software to evaluate the protein expression level differences between the
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U (n=3), UH (n=3), UB (n=3), IM (n=3), IMH (n=3), and IMB (n=3) groups. The
Integrated Density value (IDV) expression of the markers was normalized that of
GAPDH and statistically evaluated.

Statistical Analysis

Analysis of variance (ANOVA) paired with Student-Newman-Keuls (SNK) analysis or
the Fisher LSD Method was performed using SigmaStat (Systat Software, Inc., San Jose,
CA) to detect statistical differences between groups.

6.4 Results

Heparin Dosage Studies
The Calcein portion of the LIVE/DEAD assay indicated significant difference between
some of the heparin dosages (p=0.001). The first significant decrease was present at 100
µg/ml compared to the control without heparin (p=0.001) (Figure 1a) with all remaining

higher concentrations also being significantly lower (150 µg/ml: p=0.001, 250 µg/ml:
p=0.001, 500 µg/ml: p=0.034). Fluorescence of EthD-a indicative of dead cells also
demonstrated significant differences across several groups (p=0.001). The concentration
of 500 µg/ml was significantly lower than that all other groups (Figure 1b). Although
there were significant differences, all fluorescence values were low and the intensity at
100 µg/ml was not significantly different from the control 0 µg/ml (p=0.403).
The CyQuant cell proliferation assay (Figure 1c) (n=4) demonstrated decreases in
the number of cells starting around 50 µg/ml with supporting data of the lowest number

147

of cells present at 100 µg/ml. Mean cell numbers of the respective groups are provided in
Table 1. Differences between groups were not significant (p=0.843) due to the high
variability between samples in each group.

Table 6.1 CyQuant Cell Quantification in Heparin Dosage (n=4)
Heparin Concentration
(µg/ml)
0
1
5
10
50
75
100
250
500

Cell Number

Standard Deviation

2.02 x 104
1.96 x 104
1.63 x 104
1.88 x 104
1.32 x 104
1.14 x 104
1.05 x 104
1.27 x 104
1.63x 104 ±

1.54 x 104
1.55 x 104
6.34 x 103
7.00 x 103
9.45 x 103
9.26 x 103
5.10 x 103
2.10 x 103
8.83 x 103

Apoptosis percentages of SMCs due to heparin were not significant (p=0.761) and
were low with all groups having 3.0% or less apoptotic cells (Figure 1d). The 100 µg/ml
concentration (0.8%) was very similar to the control 0 µg/ml concentration (0.6%),
therefore further affirming the relevance of using 100 µg/ml as the testing concentration.
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a)

b)

c)
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d)
EthD Dead
Figure 6.1 Heparin Dosage Cell Viability a) Calcein Live Cell Assay b) EthD-1
Cell Assay c) CyQuant cell proliferation d) TUNEL apoptosis (* indicates statistical
significance, p<0.05) ** not all statistical differences are noted in Figure 1(a-b)
1(a due to
multiple differences aacross several groups.
Cell Quantification in Dynamic Testing
Differences in cell quantification were observed due to clinical heparin effects (p=0.003)
(Figure 2). Mean cell number values for the respective groups are provided in Table 2.

Table 6.2 CyQuant
yQuant Cell Quantification in Heparin Dynamic Studies (n=5)
Testing Group
U
UH
UB
IM
IMH
IMB

Cell Number
7.94 x 104
6.59 x 104
5.49 x 104
7.00 x 104
7.56 x 104
4.63 x 104

Standard Deviation
1.51 x 104
1.39 x 104
1.15 x 104
9.42 x 103 SD
7.14 x 103
1.57 x 104

The decreased number of cells of UH (100
(100µg/ml) and UB (Bolus + 100µg/ml)
µg/ml) indicated
17% and 31% inhibition, respectively, compared to U. In comparison to IM, IMH
(100µg/ml)
g/ml) and IMB (Bolus + 100
100µg/ml) exhibited a -8%
8% and 34% inhibition.
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There were significant differences in IMB compared to both IM and IMH, p=0.032 and
p=0.01 respectively, and in IMB compared to U (p=0.005) (Figure 2).

Figure 6.2 Effect of Heparin on SMC quantification after 24h (n=5) (* indicates
statistical significance p<0.05)
Protein Expression
Mean densitometry values were normalized to the static unloaded (U) expression (Figure
3). A significant decrease in SM α-actin
actin expression for the dynamic injury model groups
(IM, IMH, IMB) was observed when compared to the static groups (U, UH, UB)
(p=0.003,
003, Figure 3b), consistent with previous findings (see Chapter 5).
). Heparin did not
have any apparent effect on the expression of SM α-actin
actin after 24 hours in either the
constant administration or the clinical bolus model. In comparison, calponin levels also
demonstrated significant differences (p=0.036) and decreases in injury model expression
compared to the static groups (Figure 3c). In contrast, the IMB group demonstrated a
significant decreased in calponin expression compared to the static counterp
counterpart
art UB
(p=0.045). Although not significant, an increasing trend of increased calponin expression
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due to heparin in the UH (14%) and UB (24%) groups compared to the U group was
observed. Vimentin expression differences among all groups was not significant
(p=0.802, Figure 3d), although there was an increasing trend (10
(10-15%)
15%) with heparin
administration in both the static and dynamic conditions.

U

UH UB IM

SM α-actin

Calponin

Vimentin

GAPDH
a)

b)
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IMH IMB

c)

d)
Figure 6.3 Western blot protein expression a) Representative western blot images b) SM
α-actin
actin densitometry c) Calponin densitometry d) Vimentin densitometry (* denotes
statistical significance p<0.05)
p44/42 Activity
The ratios of phos p44/42 to total p44/42 representative of p44/42 activity, or ERK ½
activity, were significantly different (p=0.046). Mean densitometry values were
normalized to the basal static unloaded (U) expression and represented in Figure 4.
Theree was a general trend of decreased p44/42 activity in all three of the injury model
groups (IM, IMH, and IMB) compared to the static groups (U, UH, UB). Fisher LSD
method indicated that IMH was different from all of the static groups (U: p=0.01, UH:
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p=0.023,
23, UB: p=0.029). There was also a significant difference between U and IMB
(p=0.025). Overall, there was a general trend of decreased p44/42 activity due to the
dynamic injury model conditions over significant effects of heparin. Decreases in
activity were in the range of around 20% and demonstrated similar trends to decreases in
SM α-actin expression.

U

UH

UB

IM

IMH

IMB

phos p44/42

total p44/42

a)

*

b)
Figure 6.4 Effect of heparin on p44/42 activity a) Western blot images representative of
phos p44/42 (top) and total p44/42 (bottom) b) Densitometry ratio analysis (n=3)
(* indicates a significant difference p<0.05)
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6.5 Discussion

Decreases in SMC proliferation due to heparin exposure as observed by others
both in vivo and in vitro is not surprising since SMCs are naturally exposed to heparan
sulfates produced by endothelial cells in a healthy vessel, but upon denudation of this
endothelial layer, SMC proliferate and cause lesion formation [196, 200]. Although
heparin has been shown to decrease SMC proliferation, varying degrees of inhibition
have been observed depending on the cell type and heparin dosage [200]. Traditionally,
heparin resistant VSMCs are defined by proliferation ≤ 25% in low serum conditions for
48-72 hours followed by presence in high serum conditions (10%) with heparin at 100
µg/ml for 4-5 days [200]. SMCs would be considered heparin sensitive with proliferation

>25% under the same conditions. Based upon previous work conducted by the authors
(reference), these culture conditions were adapted to a shorter time period and a lower
serum concentration to help isolate influences of mechanical forces rather than only
serum evoked reactions.
In this study, anti-proliferative effects of heparin were confirmed after only 24
hours of heparin treatment. Initial dosage studies were performed to verify the
effectiveness of the commonly used 100 µg/ml concentration with adapted serum
conditions without evoking an excessive negative SMC response. Results from the 24h
studies dynamic studies demonstrated an inhibitory effect of the bolus group (IMB)
within the injury model while the low 100 µg/ml administration (IMH) resulted in a slight
increase in the number of cells (Figure 2). This is in contrasts to the inhibitory effect
observed of the static (U) group exposed to heparin (UH). This result suggests that
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exposure to the concurrent mechanical stimuli limited the anti-proliferative effects of
heparin at this administered concentration.
A decreasing trend in the number of cells present demonstrated the effect of the
bolus administration, even if its application lasted for a short duration of 5 minutes. In
the case of static samples (U) the 31% inhibition in UB compared to the 17% inhibition
of UH indicated that exposure to higher concentrations for even a brief time. Injury
model trends support this with the 34% inhibition of the bolus (IMB) compared to the 8% inhibition of IMH. Rinsing of the cells in DPBS following the 5 minutes higher
concentration bolus effect eliminated possibilities of residual heparin remaining in the
presence of the SMCs.
Protein expression results further demonstrated differences due to the dynamic
culture and heparin exposure. In vitro studies have shown that heparin stimulates
differentiation and increases contractile protein expression [205]. A significant decrease
in SM α-actin expression was exhibited in the dynamic injury model as compared to the
static control [185]. No increase in SM α-actin expression due to heparin was observed,
however there was in increase in calponin in the case of the static samples and a decrease
in calponin in the case of the injury model after 24 hours. Heparin treatment has been
shown to increase SM α-actin and calponin expression after 3 days in static in vitro
conditions at 100 U/ml in both myometrial and leiomyomal SMC [206]. Decreases in
SM α-actin and calponin in the cases of the injury model groups (IM, IMH, IMB) is
important because these proteins are associated with the contractile apparatus of SMCs
[207]. This is consistent with other studies in which in vivo balloon angioplasty resulted
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in decreased SM α-actin after 24 hours and that heparin does not prevent the actin
degradation at this timepoint [208]. Increasing trends of the synthetic marker vimentin
expression with heparin exposure would suggest increased synthetic behavior of the
SMCs, so although heparin may decrease proliferation and migration, an increase in the
synthetic marker could partially attribute to restenosis.
The ERK 1/2 pathway is commonly associated with proliferative activity of
SMCs, with activation resulting in increased proliferation. Overall an approximate 20%
decrease in p44/42, or ERK ½, activity due the effect of the injury model was observed
(Figure 4). This decrease in p44/42 activity suggests that other mechanotransductive
pathways must be involved in the increased cell count attributed to the injury model
combining concurrent shear and tensile forces compared to tensile forces alone.
Significant decreases in p44/42 activity were detected after 24 hours in the injury model
heparin groups (IMH, IMB) compared to the static control, but these differences were
more likely attributed to the decrease activity from the mechanical environment rather
than decreased activity from the effects of heparin. Lack of difference suggests other
mechanisms of heparin are involved in the inhibitory mechanism of heparin in both static
and dynamic culture conditions. Heparin has been shown to inhibit activation of ERK1
and ERK2 in response to serum and thrombin [204] [209]. Heparin is also known to
interfere with the protein kinase C (PKC) pathway [202, 210]; the PKC pathway has been
shown to be an ERK-dependent pathway [211]. However, heparin has been shown to
inhibit proliferation through both ERK-dependent and ERK-independent pathways [212,
213]. Differences in these other in vitro findings could be attributed to higher serum
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conditions resulting in higher degrees of activation [201] or the degree of activation could
be time-dependent.
The primary purpose of the presented work was to demonstrate the need for
dynamic in vitro testing for pharmaceutical agents through evoking differing SMC
responses in response to mechanical stimulation versus static culture and to further show
that modeling a clinically implemented regimen in vitro can lead to better understanding
and characterization of SMC behavior and response. In summary, after 24 hours, the
administration of 100 µg/ml demonstrated differing effects compared to the bolus groups
incorporating the higher concentration administration before balloon angioplasty. In
comparison of the static versus dynamic in vitro simulation, proliferation inhibition
effects in the bolus groups (UB and IMB) were similar, but protein expression of
calponin exhibited opposing behaviors, therefore demonstrating the need for dynamic in
vitro conditions which can evoke varying SMC response. Through implementation of the
dynamic in vitro model and clinical bolus administration, we confirmed the antiproliferative effect of heparin for use in endovascular intervention. However, the
implemented model also indicated that the use of heparin could promote some synthetic
activity, such as decreased calponin expression which could be important clinically in the
development of restenosis.

6.6 Conclusion

The presented work has incorporated the use of a clinically used pharmaceutical agent
into the custom designed dynamic concurrent force injury model. Incorporation of a
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clinically relevant bolus administration of heparin followed by administration of
100µg/ml heparin resulted in the largest decrease in cell number and some differing
effects in expression of the contractile marker calponin after 24 hours compared to the
static equivalent. The combination of results represents the need for dynamic in vitro
testing conditions for better SMC characterization and clinically relevant phenotypic
behavior which could lead to better understanding of the mechanotransduction responses
triggered by these effects and the mechanisms of heparin treatment on SMC response.
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-CHAPTER 7AIM 6- EVALUATING THE ROLE OF ERK ½ IN INJURY MODEL PROTEIN
EXPRESSION RESPONSE

7.1 Abstract

Previous work from our lab showed similar patterns of ERK ½ expression and the loss of
contractile markers. In this study we investigated if the loss was directly attributed to the
decrease in ERK ½ activity within our developed injury model and compared to our static
control. We confirmed decreases in ERK ½ activity in the concurrent force injury model
to similar levels as with the ERK ½ inhibitor U01826. The inhibited and uninhibited
injury models resulted in similar expressions of SM22α and SM α-actin. However,
comparison to the inhibited and uninhibited static control (U) demonstrated that the large
differences in ERK ½ activity were not attributed to inhibition. ERK ½ may be partially
involved, but other mechanotransduction pathways must be involved to evoke these SMC
responses.

7.2 Introduction

Mitogen activated protein kinase (MAPK) cascades are important in the
regulation of cell proliferation, cell differentiation, cell movement, and cell death [214].
The MAPK subfamilies are the ERK, JNK/SAPK, and p38 pathways.

Phenotype

modulation and proliferation of smooth muscle cells in controlled in part by the
Extracellular signal-regulated kinase (Erk) pathway [183]. Erk ½, or p44/42, is important
in regulating cell growth and differentiation. This pathway is regulated by Ras and
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proliferation has been shown to be blocked by inhibition of this pathway (Robinson,
1997).
Stress-activated protein kinases (SAPK)/Jun amino-terminal kinases (JNK) have
been shown to play an active role in transmitting transmembrane signals resulting in
cellular apoptosis and cell differentiation [215, 216]. The JNK/SAPK cascade affects
apoptosis in part due to the downstream interaction with p53 [217]. The role of the p53
suppressor gene is to prevent uncontrolled proliferation and to induce apoptosis [218].
Upstream signal activation of the JNK/SAPK is translated by small GTPases of the Rho
family including Rac, rho, and cdc42 [219]. The role of p38 MAPK also suggests a
negative role in regards to proliferation, it plays an active role in apoptosis and the
inhibition of p38 MAPK results in increased proliferation [220].
Although both SAPK/JNK and p38 MAPK play significant roles in cell response,
the work in this study focuses on the role of ERK ½ in SMC response to concurrent force
stimulation. Work by others have shown ERK ½ activation by stretch [221-223]
resulting in cell proliferation. Increased shear-dependant migration of venous SMCs has
been shown to be related to increased ERK ½ phosphorylation after 3-5 days [224].
Higher shear stresses have been associated with decreased ERK ½ phosphorylation while
lower shear stresses were associated with increased ERK ½ phosphorylation [224]
Previous work by the authors demonstrated similar proliferation levels between
the developed injury model and static control after both 8 hours [185], and 24 hours (see
Chapter 5) mechanical stimulation and both demonstrated significantly greater
proliferation compared to samples exposed to strain alone. In those studies, a decrease in
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contractile markers (SM α-actin, calponin, and SM22α) was also observed in both
samples exposed only to strain and the injury model exposed to both shear and strain
compared to the static control. In addition, decreased p44/42 activity was observed in
studies incorporating heparin, with similar behaviors in contractile marker expression. In
this study, we hypothesized that a decreased p44/42 activity is directly correlated to the
differences in contractile protein expression. The ERK ½ inhibitor U0126 (1,4-diamino2,3-dicyano-1,4-bis[2-aminophenylthio] butadiene) was used to test the involvement of
ERK ½ in the protein expression. U0126 and PD98059 are both used MEK 1 and MEK2
inhibitors implemented in ERK ½ pathway inhibition. However, U0126 inhibits both
MEK1 and MEK 2 strongly, while PD98059 has a higher affinity for inhibition of MEK1
over MEK2 [225]. For this reason, U0126 was chosen for use in this study.

7.3 Materials and Methods
Cell Culture

Rat aortic smooth muscle cells (RASMC) (Passages 5-7) harvested from 10-12 weeks old
male Sprague-Dawley rats were a generous gift from the laboratory of Dr. Anand
Ramamurthi, Department of Bioengineering, Clemson University. The RASMCs were
cultured in Dulbecco’s Modification of Eagle Medium (DMEM) (Mediatech, Inc., 10013-CV, Herndon, VA) supplemented with 10% heat inactivated fetal bovine serum
(FBS) (Sigma-Aldrich, F-4135, St. Louis, MO) and 1% Antibiotic-Antimycotic (SigmaAldrich, A5955, St. Louis, MO) under standard cell culture conditions (37ºC, 5% CO2
with 95% air, humidified environment).
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Exposure of RASMCs to Mechanical Stimuli

A custom-designed, concurrent force, vascular mechanics system was set up and
sterilized as previously described [185]. Prior to cell seeding, collagen (50 µg/ml) coated
silicone membranes were rinsed with 1.0 ml of Dulbecco’s Phosphate Buffered Saline
(DPBS) (Media Tech, Inc., 21-031 CM, Herndon, VA). RASMCs were seeded at a
density of 2.8 x 104 cells/cm2 (P4-6) and incubated for 24 hours in DMEM containing
10% FBS and 1% Antibiotic-Antimycotic. At 24 hours, the medium was changed to
DMEM containing 1% FBS, 1% Antibiotic-Antimycotic, and 1% Dextran for an
additional 24 hours prior to testing. During mechanical stimulation, the RASMCs were
maintained in DMEM with 1% FBS and 1% Antibiotic-Antimycotic;
Four groups were investigated in the present study with a static unloaded (U)
control group where cells where exposed neither to shear nor tensile forces. The injury
model (IM) group simulated smooth muscle cells that are directly exposed to blood flow
upon the denudation of the endothelial monolayer. SMCs were first preconditioned for
30 minutes as previously described with increasing frequencies up to 1 Hz and 5% cyclic
strain. Following preconditioning, two balloon deployments were simulated with 10%
static strain for 1.5 minutes each with 30 seconds rest in between deployments.
Following simulated balloon angioplasty applied to IM, shear flow was resumed at 400
ml/min and cyclic strain was applied at 0-5% for 24 hours. The flow rate of 400 mL/min
provided a theoretical low wall shear stress oscillating between 0.1-0.5 dynes/cm2 due to
the 1 Hz cyclic straining of the silicone membrane verified in our lab using a finite
volume analysis software package, FLUENT. The two remaining groups consisted of
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p44/42 inhibited groups for U and IM referred to as Uinh and IMinh. Samples in these
groups were pretreated for 1.5 hours with U0126 (Cell Signaling Technologies, 9903, 10
µM) and then rinsed prior to application as in the case of the uninhibited counterparts.

Quantification of Phenotypic Marker Proteins
Expression of phenotype markers SM α−actin, SM22α, and vimentin in SMC lysates
were quantified using standard western blotting techniques and digital image analysis.
The expression of GAPDH was also quantified to ensure equal loading of protein
samples in SDS-PAGE gel. Briefly, cells were removed from the silicone membrane and
lysed using an extraction buffer consisting of 0.5% Triton X-100 (Sigma-Aldrich, T9284, St. Louis, MO), 1% Sodium dodecyl sulfate (Sigma-Aldrich, L-4522, St. Louis,
MO), 20 mM Tris (BIORAD, 161-0716, Hercules, CA), and 10 µL/mL protease cocktail
inhibitor (Sigma-Aldrich, P8340, St. Louis MO). The BCA Protein Assay Kit (Pierce,
23225, Rockford, IL) was then used to determine the total protein content of each sample.
These samples were then diluted to 80 µg/µL using sample buffer consisting of a
reducing agent, β-mercaptoethanol, 0.5 M Tris-HCl, 10% SDS, 0.5% Bromophenol Blue,
glycerol and distilled water. Prior to gel electrophoresis, the samples were denatured by
boiling for 5 minutes. A 10% polyacrylamide gel (BIORAD, 161-0158, Hercules, CA)
was used in electrophoresis with 15 µL protein samples loaded per lane. The protein
samples separated on the SDS-PAGE gel were transferred to a PVDF membrane (Biorad,
162-0184) which was incubated with the following primary antibodies with specified
dilutions: SM α-actin (Abcam, ab18460-1, 1:2000), SM22α (Abcam, ab10135-100,
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1:1000), vimentin (Abcam, ab7752, 1:750), GAPDH (Santa Cruz Biotechnologies, FL335, 1:500), p44/42 (Cell Signaling Technologies, 4695, 1:1000), phos p44/42 (Cell
Signaling Technologies, 4370, 1:1000) . The blots were then incubated with appropriate
secondary antibodies at 1:5000 dilution and Precision Streptactin-HRP conjugate (Biorad,
161-0380) at 1:20000 dilution. Chemiluminescent labeling of the PVDF membranes was
performed with Immun-StarTM HRP substrate kit (Biorad, #170-5040) according to the
manufacturer’s instructions. The western blots were imaged using the FluorChem SP
imager (Alpha Innotech); Densitometry of the bands in the digital images was performed
using the AlphaEaseFC (FluorChem SP) software to evaluate the protein expression level
differences between the U (n=3), Uinh (n=3), IM (n=3), and IMinh (n=3) groups. The
Integrated Density value (IDV) expression of the markers was normalized that of
GAPDH and statistically evaluated.

Statistical Analysis

Analysis of variance (ANOVA) paired with Student-Newman-Keuls (SNK) analysis was
performed using SigmaStat (Systat Software, Inc., San Jose, CA) to detect statistical
differences between groups.

7.4 Results
p44/42 Activity of the Dynamic and Static Groups

The ratio of phos p44/42 to p44/42 indicated a significant decrease of all other groups
(Uinh, IM, IMinh) compared to static control (U) without inhibitor (p=0.005) (Figure 1b).
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Inhibition of phos p44/42 was not decreased further due to the inhibitor in the case of the
IM group. Overall, the mechanical forces in the injury model induced a similar amount
of decrease in p44/42 activity as the induced inhibitor (p=0.893). To verify that the
inhibitor affected only the phos p44/42 and not the total p44/42, the ratio of total p44/42
to GAPDH was compared. There was not a significant difference between any of the
groups (p=0.129) also ensuring equal protein loading per lane. Protein expression was
normalized to the static sample (U) and densitometry results indicated inhibition of 35%
in the presence of an inhibitor (Uinh) and inhibition around 20% for injury model both
with and without the inhibitor (IM and IMinh) (Figure 1).
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U

Uinh

IM

IMinh

phos p44/42
Total p44/42
GAPDH
a)

b)
Figure 7.1 Western blot phos p44/42 and p44/42 expression in dynamic and static
conditions in addition to the presence of p44/42 inhibitor a) Images of phos p44/42,
p44/42, and GAPDH b) p44/42 activity indicated by ratio of phos p44/42 to total p44/42
(n=3) (* denotes a statistical significance determent by ANOVA with p<0.05)

Phenotypic Protein expression

Results supported significant decreases in SM22α expression with the injury model
(p=0.001) (Figure 2b). Inhibition of p44/42 did not result in significant differences
between U and Uinh (p=0.171) or between IM and IMinh (p=0.526) although about a
20% decrease in activity was consistent between both cases. There were no statistical
differences between testing groups in the case of SM α-actin (p=0.05) (Figure 2c). A
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25% decrease in the expression of alpha actin in the case of the injury model was
observed. Inhibited samples resulted in a 33% increase of alpha actin for Uinh compared
to U and 17% increase of IMinh compared to IM. Vimentin expression indicated a
significant decrease in the case of the inhibited groups (p=0.002) (Figure 2d). However,
there are other mechanisms contributing to vimentin production given that the IM group
maintained the same levels of vimentin expression compared to U, compared to the
decreased expression of both the inhibitor groups (Uinh and IMinh). Although IM data
showed a significant decrease in p44/42 activity within similar levels of the inhibitor, the
increased vimentin expression suggests other signaling mechanisms were activated for
vimentin production.

U

Uinh

SM22α
Vimentin
SM α-actin
GAPDH

b)
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IM

IMinh

c)

d)
Figure 7.2 Western Blot protein Expression in dynamic and static conditions in addition
to the presence of ERK ½ inhibitor a) Images of protein expression for SM22α,
Vimentin, SM α-actin, and GAPDH b) SM22α densitometry (n=3) c) SM α-actin
densitometry (n=3) d) Vimentin densitometry (n=3) (* denotes a statistical significance
determined by ANOVA with p<0.05)

7.5 Discussion

Investigation of p44/42, or ERK ½, activation was hypothesized to be associated with
alterations in SMC protein expression in this study. As in previous work, decreases in
contractile markers were observed [185] in addition to decreased p44/42 activity within
the injury model compared to the static control (see Chapter 4) after 24 hours. p44/42
activity was significantly inhibited with U0126 MEK ½ inhibitor compared to the static
control (U) which demonstrated basal levels of p44/42 conditions (Figure 1).
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Suppression of p44/42, or ERK ½, activity somewhat contradicts other mechanical
environment findings when applied to vascular cells. Cyclic strain of 10% has also been
shown to activate ERK, JNK, and p38 pathways strain exposure in both SMCs and
endothelial cells [226, 227]. Nonlaminar shear stress has been shown to result in ERK ½
activation [180, 228]. This ERK ½ activation through shear stress has also been
associated with the protein kinase C (PKC) pathway [229]. PKC has been shown to be
required for ERK ½ activation in response to shear stress in endothelial cells as well
[230]. Strain (0-7%) in bovine aortic SMCs showed increased PKC activity [160].
Although several in vitro studies have been linked to increased ERK ½ activation, these
studies are short term duration. For example, stretch induced activation of ERK, JNK,
and p38 in SMCs over 2 hours exhibited expression returning to the prestretch levels
[231]. Results from this study are after 24 hours mechanical stimulation and incorporate
shear and tensile forces together, conditions that are more physiologically relevant and
very different from the studies that have been referred above. Decreases in ERK ½
activity after 24 hours may likely be a functional effect of the concurrent force
stimulation, further emphasizing the need to verify the contribution of individual forces.
Phenotypic protein expression results provided further insight into the possible
influences of ERK ½. Data did not show a significant decrease in SM α-actin in the
injury model (IM) compared to the static unloaded (U), however, a similar decrease of
around 20% SM α-actin expression due to the influence of the injury model was
observed. Although there was not a significant difference between any of the groups,
another interesting trend present in SM α-actin expression was evident. In the case of the
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inhibited static group (Uinh) there was a 25% increase in SM α-actin expression. This
would imply that inhibitory activity of p44/42 by the onset of the mechanical forces of
the injury model is not directly associated with the opposing effect of the decreased SM
α-actin expression attributed to the injury model. In response to circumferential

mechanical strain, degradation of α-actin filaments in venous SMCs has been shown to
be attributed in part to the role of p38 MAPK and not ERK ½ [232], supporting that
decreased SM α-actin expression of IM is not attributed to decreased p44/42, or ERK ½
activity.
The significant decrease in SM22α expression in IM compared to U was identical
in behavior to previous findings reported by the authors (see Chapter 4). Treatment of
the samples with inhibitory agents in the cases of Uinh and IMinh resulted in slight
decreases in SM22α to their respective comparison groups, however differences were
negligible when compared to differences attributed to exposure of the mechanical forces.
Decreases in contractile marker in the injury model were not shown to be primarily
attributed to inhibition of p44/42 activity since the expression behavior of the inhibited
static samples (U) did not mimic the injury model (IM) expression even though the
percentage of inhibition was very similar between these groups.
Protein expression results of vimentin introduced other factors for consideration.
Both static and dynamic groups (Uinh and IMinh) treated with the U0126 inhibitory
agent resulted in significantly lower vimentin expression compared to U and IM,
implying inhibition of p44/42 activity results in decreased vimentin expression.
However, the IM group which resulted in decreased p44/42 activity had a higher
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vimentin expression comparable to U, which has been shown in previous studies as well
(see Chapter 3). If vimentin is suppressed by inhibitory agents, then again there must be
additional signaling mechanisms occurring to result in an increase in the synthetic marker
vimentin expression. ERK ½ is involved in differentiation and has been shown to affect
other proteins such as h-caldesmon [233], so these influences in protein expression by
ERK ½ assist to better characterize SMC phenotype.
ERK ½ is one of the important MAPK to study, which greatly influence SMC
response both in vitro and in vivo in considering atherosclerosis and restenosis.
Atherosclerotic lesions have been shown to demonstrate hyperexpression and increased
activation of ERK ½ emphasizing the importance of ERK ½ activation in cell
proliferation during atherosclerosis [234]. In vivo studies have indicated a sustained
increase in ERK 2 and JNK both immediately following balloon angioplasty and up to 14
days following angioplasty [235]. In vivo SMC migration has also been shown to be
mediated in part through increased ERK ½ [222, 224]. Enhanced ERK, JNK, and p38
MAPK has been exhibited following balloon injury in rat carotid arteries [235-237]. In
this work, there was actually a decrease in ERK ½ activity at 24 hours concurrent force
mechanical stimulation. Protein phenotypic expression was affected by the onset of
mechanical force as described in previous work. However, further investigation with
additional time points would be advantageous for better characterization of ERK ½
expression and of the resultant effect on phenotypic protein expression of SMCs exposed
to balloon angioplasty and concurrent shear and tensile forces.
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7.6 Conclusion

We have shown that after 24 hours of mechanical stimulation through the custom
developed injury model exposing SMCs to concurrent oscillating shear and tensile forces,
there was a decrease in p44/42, or ERK ½, activity. The observed decreased ERK ½
activity is contradictory to some of the synthetic phenotypic attributes previously
observed by others in different conditions. ERK ½ inhibition exhibited differing degrees
of effect in different protein expression of the cells in both the static and injury model,
again suggesting additional signaling mechanisms should be investigated, particularly
those which influence cell differentiation, proliferation, and apoptosis, such as the other
MAPK pathways (JNK/SAPK and p38) and upstream signaling targets such as PKC
which can influence these cell responses as well. Through this work we have shown that
the resultant changes in protein expression after 24 hours exposure to the developed
injury model was not attributed to ERK ½ inhibition, therefore providing further insight
into the characterization of the complicated SMC response to mechanical stimuli.
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CONCLUSION

The hypothesis of this project was that balloon angioplasty endovascular
intervention exposing vascular smooth muscle cells to an altered mechanical environment
would evoke a cell phenotype change. The exposure of smooth muscle cells to
concurrent shear and tensile forces following balloon angioplasty did result in a more
synthetic phenotype behavior marked by such characteristics as increased synthetic
morphology, increased proliferation, increased apoptosis and decreased expression of
contractile markers. Each aim of this project greatly contributed to this work. Through
the system design and CFD channel characterization (Aims 1 and 2), a six-independentchannel system providing low oscillating wall shear stress (WSS) was manufactured to
apply concurrent shear and tensile forces with uniform strain and WSS profiles over the
cell location.
Implementation of the system verified SMC response over 8 hours, with
variations in cell proliferation and SM α-actin expression of the developed injury model
(Aim 3). Extension of testing to 24 hours further demonstrated effects of the concurrent
force injury model with increased SMC hypertrophy, decreased contractile protein
expression, increased synthetic protein expression, and increased apoptosis (Aim 4).
Incorporation of heparin within the model within a clinical bolus regimen resulted in
promotion of a contractile behavior with decreased proliferation and a contradictory
synthetic promotion of decreased calponin expression (Aim 5). Heparin did not
significantly affect ERK ½ activity, suggesting the decreased proliferation after 24h was
not attributed to further decreased ERK ½ activity. Decreases in ERK ½ activity from
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injury model exposure were not directly correlated with the decreased contractile protein
expression (Aim 6).
Clinical implications for this work suggest that physiological regimens should be
incorporated into in vitro studies. We simulated balloon angioplasty through increased
strains and a clinical heparin bolus administration, both of which evoked different SMC
responses compared to controls. SMC response triggered by exposure to the injury
model resembled in vivo reactions following balloon angioplasty. Incorporation of the
dynamic concurrent and shear forces with in vitro testing can lead to better treatment and
prevention of restenosis following endovascular intervention.
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PROJECT RECOMMENDATIONS

1. Expansion of Computational CFD Characterization
Computational CFD characterization was limited to a 2D analysis and primarily
focused on a particular deformation and input velocity. Expansion of this model to
account for effects of higher input velocities, characterization over entire cell culture
area, varying degrees of deformation, and varying frequencies would be useful for a
broader characterization of the system for implemented use. Additionally, development
of a three-dimensional model would be the most advantageous computational
development, although this would result in an increased computational expense requiring
additional computational resources.

2. System Adaptation for Varied Force and Time Exposure for Injury Model
The presented work focused extensively on the 24h response of SMC to
mechanical forces incorporating an extremely low range of oscillating wall shear stresses
(0-0.5 dynes/cm2). Alterations in fluid chamber geometry would be required to expand
the ranges of investigated wall shear stresses. It would be of interest to compare cases of
wall shear stresses around 3-5 dynes/cm2, and at a healthier physiologic amount around
10 dynes/cm2. Additionally, extending dynamic testing time points to 48 and 72 hours
would allow for more points of comparison. Comparison of uni-axial stretching in
comparison to the current bi-axial configuration could also be of significant interest,
requiring minimal geometry adaptation.
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3. Incorporation of Other Cell Types
Cell studies in this work used healthy rat aortic smooth muscle cells. Although
this work provided insight into the synthetic response of surrounding healthy vascular
cells, investigation of the response of other cell types would be of interest, particularly
those of the pathological state. Atherosclerotic cells may demonstrate different or
elevated responses pertinent to restenosis. Additionally, rat SMCs were used in this
work. Ideally, investigation of human SMCs would be of most interest since cell
responses can vary between species. Comparison between atherosclerotic and normal
human SMCs would be clinically relevant.

4. Investigation of Other Clinical Anti-proliferative Agents
Design of this dynamic model was targeted as an improved in vitro testing bed for
pharmaceutical testing. Incorporation of other pharmaceutical agents, both commercially
available and experimental, could be tested within this apparatus. For example,
sirolomus and paclitaxol, common stent coatings, could be investigated within the
dynamic in vitro environment and compared to in vivo documented effects.
The heparin studies could be expanded to investigate the effects of DPBS rinse
versus immediate altered concentration exposure, the rate of bolus delivery, and effects of
varying dosages on SMC response. The investigation of heparin could also incorporate
the natural anti-coagulant as well, rather than only its synthetic form. For this
experiment, plasma would need to be used in place of affected cell proliferation and
protein expression using a clinical bolus regimen similar to what would be administered
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during balloon angioplasty. With an altered model, heparin dosages could be evaluated
to optimize heparin administration to maintain anti-coagulant behavior, and maintain or
promote contractile activity of the SMCs. For this work, SMCs would need to be of the
same species origin as the source plasma.

5. Increased ECM Environment and In-situ Implementation of Vascular Tissue Response
to Endovascular Intervention

For this work, a SMC monolayer cultured on collagen coated silicone was used
for testing. SMC response on variations of collagen content or a gradient of collagen
could be altered and may demonstrate additional insight. SMCs could also be cultured
longer statically to increase the surrounding collagen and other ECM components
produced and released from the cells.
There may be cases where it would be advantageous to take a more in-situ
approach incorporating arterial tissue into testing. For example, porcine or bovine
arterial segments could be bisected and placed flat within the system secured by an
anastomosis on the outer edges to a material. This configuration would allow for
incorporation of the vascular wall to investigate endovascular intervention. The
endothelial wall could be denuded, or partially denuded. Also, wires simulating stent
placement could be placed to investigate the injury response within the wall. Histological
analysis could be used to evaluate the arterial response within the integrated dynamic
model.
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6. Investigation of Signaling Pathways Affecting Dynamic Response
Dynamic testing resulted in decreased sustained ERK ½ activity. The significant
decrease in contractile protein expression was not attributed to this decreased activity,
suggesting the involvement of other signaling mechanisms. To evoke the complicated
SMC responses, it is likely that several pathways are affected. Upstream MAPK targets
should be investigated such as Ras or Rho, in addition to Protein Kinase C (PKC), which
can affect ERK and is involved with its own downstream effects. Additionally, other
time points of expression both in short term and sustained activation should be
investigated. Different pathways could be influenced at different time points by the
dynamic model.
Further evaluation of the mechanisms of heparin inhibition would also be of great
experimental interest. Mitogen-activated kinase phosphatase-1 (MKP-1) would be an
interesting protein of investigation. MKP-1 dephosphorylates ERK and JNK pathways of
MAPK [238, 239]. Strain induced MKP-1 expression at 10% cyclic strain through
Ras/Rac/MAPK pathway [240]. Reduction of MKP-1 is suggested to contribute in part
to SMC proliferation after injury through decrease in dephosphorylation of p44 MAPK
[241], however heparin has been shown to suppress the expression of MKP-1 [242], even
though heparin has an anti-proliferative effect. Comparing these effects in the developed
injury model could allow for better SMC response to injury and the incorporation of
pharmaceutical agents.
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APPENDICES
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Appendix ACAD Drawings

A.1 Top Plate (Dimensions in inches)
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A.2 Baseplate (Dimensions in inches)
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A.3 Membrane Plate (dimensions in inches)
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A.4 Culture Bar and Lid (dimensions in inches)
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Appendix BFlexCell BioFlex 25 mm-%Elongation Conversion
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Plating and View Cells With the Loading StationsTM

It should be noted that the only cells that will receive uniform strain are those attached to
the area of the membrane that is over the post when the membrane is in its fully stretched
position. Therefore, it is best to attempt to plate cells only in the uniformly strained area
or to view or test the cells that are in the uniformly strained area. To determine this area,
the following equation can be used:
Radius= (Diameter of Loading Station)/(1+Max%Elongation/100))
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Appendix CC Source Code for Fluid Velocity Profile and Parabolic Deformation
/***********************************************************************
vprofile.c
UDF for specifying steady-state velocity profile boundary condition
************************************************************************/
#include "udf.h"
DEFINE_PROFILE(inlet_x_velocity, thread, position)
{
/* this will hold the position vector */
real x[ND_ND];
real y;
face_t f;
begin_f_loop(f, thread)
{
F_CENTROID(x,f,thread);
y = x[1];
F_PROFILE(f, thread, position) = 0.0184 - ((y-.003175)*(y.003175))/(.00635*.00635)*0.0184;
}
end_f_loop(f, thread)
}

#include "udf.h"
/***********************************************************************/
/*
UDF to define a wall that is initially a max deformation parabola, but then
oscillates sinusoidally with time. */
/***********************************************************************/

DEFINE_GRID_MOTION(moving_arc, domain, dt, time, dtime)
{
Thread *tf = DT_THREAD (dt);
face_t f;
Node *node_p;

float

a, h, k, x, y;

int n;
/* constant x coordinate of vertex of parabola*/
k= -0.0143002;
/* Set/activate the deforming flag on adjacent cell zone, which
/* means that the cells adjacent to the deforming wall will also be
/* deformed, in order to avoid skewness.
SET_DEFORMING_THREAD_FLAG (THREAD_T0 (tf));

*/
*/
*/

/* Solve for h at new time, generic determined function good for t 0-1 determined from
excel function*/
if (time <= 0.5)
{
/*y =0.00049999999999650300x3 + 0.00029999999999730200x2 + 0.00320000000000079000x 0.00160000000000008000*/
h= -0.000499999999996503*pow(time,3) + 0.000299999999997302*pow(time,2) +
0.00320000000000079*time - 0.00160000000000008;
}
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if (time > 0.5)
{
/*y = 0.00049999999999705800x3 - 0.00119999999999498000x2 0.00230000000000263000x + 0.00140000000000040000*/
h= 0.000499999999997058*pow(time,3) - 0.00119999999999498*pow(time,2) 0.00230000000000263*time + 0.0014000000000004;
}
if (time >= 1.0)
{
/*y = -0.00049999999999950100x3 + 0.00179999999999814000x2 +
0.00110000000000240000x - 0.00400000000000106000*/
h= -0.000499999999999501*pow(time,3) + 0.00179999999999814*pow(time,2) +
0.0011000000000024*time - 0.00400000000000106;
}

if (time > 1.5)
{
/* y = 0.00049999999999972300x3 - 0.00269999999999770000x2 +
0.00159999999999505000x + 0.00200000000000317000*/
h= 0.000499999999999723*pow(time,3) -0.0026999999999977*pow(time,2)
+0.00159999999999505*time + 0.00200000000000317;
}
if (time >2.0)
{
/*y = -0.00049999999999617000x3 + 0.00329999999997366000x2 0.00399999999993997000x - 0.00280000000004536000*/
h= -0.00049999999999617*pow(time,3) + 0.00329999999997366*pow(time,2) 0.00399999999993997*time - 0.00280000000004536;
}

if (time > 2.5)
{
/* y = 0.00049999999999883500x3 - 0.00419999999999199000x2 +
0.00849999999998186000x - 0.00279999999998652000*/
h= 0.000499999999998835*pow(time,3) - 0.00419999999999199*pow(time,2) +
0.00849999999998186*time - 0.00279999999998652;
}
if (time > 3.0)
{
/*y = -0.00049999999999617000x3 + 0.00479999999996217000x2 0.01209999999987580000x + 0.00499999999986443000*/
h= -0.00049999999999617*pow(time,3) + 0.00479999999996217* pow(time,2) 0.0120999999998758*time + 0.00499999999986443;
}
if (time > 3.5)
{
/* y = 0.00049999999999883500x3 - 0.00569999999998849000x2 +
0.01839999999996230000x - 0.01599999999995920000 */
h= 0.000499999999998835*pow(time,3) - 0.00569999999998849*pow(time,2) +
0.0183999999999623*time - 0.0159999999999592;
}
if (time > 4.0)
{
/*y = -0.00049999999999894600x3 + 0.00629999999998621000x2 0.02319999999994000000x + 0.02239999999991310000*/
h=-0.000499999999998946* pow(time,3) + 0.00629999999998621*pow(time,2)0.02319999999994*time + 0.0223999999999131;
}
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if (time > 4.5)
{
/*y = 0.00050000000000149900x3 - 0.00720000000002141000x2 +
0.03130000000010220000x - 0.04060000000016320000 */
h= 0.000500000000001499*pow(time,3) - 0.00720000000002141*pow(time,2) +
0.0313000000001022*time - 0.0406000000001632;
}

if (time > 5.0)
{
/*y = -0.00049999999999894600x3 + 0.00779999999998304000x2 - 0.03729999999990920000x
+ 0.05239999999983820000
*/
h= -0.000499999999998946*pow(time,3)+ 0.00779999999998304*pow(time,2) 0.0372999999999092*time + 0.0523999999998382;
}
if (time > 5.5)
{
/*y = 0.00050000000000149900x3 - 0.00870000000002591000x2 +
0.04720000000014960000x - 0.07960000000028830000*/
h= 0.000500000000001499*pow(time,3) - 0.00870000000002591*pow(time,2) +
0.0472000000001496*time - 0.0796000000002883;
}
if (time > 6.0)
{
/*y = -0.00049999999999894600x3 + 0.00929999999997988000x2 0.05439999999987210000x + 0.09799999999972940000*/
h= -0.000499999999998946*pow(time,3) + 0.00929999999997988*pow(time,2) 0.0543999999998721*time + 0.0979999999997294;
}
if (time > 6.5)
{
/*y = 0.00050000000000149900x3 - 0.01020000000003040000x2 +
0.06610000000020590000x - 0.13600000000046500000*/
h= 0.000500000000001499*pow(time,3) - 0.0102000000000304*pow(time,2) +
0.0661000000002059*time - 0.136000000000465;
}
if (time > 7.0)
{
/*y = -0.00049999999999894600x3 + 0.01079999999997670000x2 0.07449999999982870000x + 0.16219999999958000000*/
h= -0.000499999999998946*pow(time,3) + 0.0107999999999767*pow(time,2) 0.0744999999998287*time + 0.16219999999958;
}
if (time > 7.5)
{
/*y = 0.00050000000000149900x3 - 0.01170000000003490000x2 +
0.08800000000027120000x - 0.21280000000070300000*/
h= 0.000500000000001499*pow(time,3)- 0.0117000000000349*pow(time,2) +
0.0880000000002712*time - 0.212800000000703;
}
if (time > 8.0)
{
/*y = -0.00049999999999883500x3 + 0.01229999999997130000x2 0.09759999999976480000x + 0.24799999999935700000*/
h= -0.000499999999998835*pow(time,3) + 0.0122999999999713*pow(time,2) 0.0975999999997648*time + 0.247999999999357;
}
if (time > 8.5)
{
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/*y = 0.00049999999999883500x3 - 0.01319999999996970000x2 +
0.11289999999973700000x - 0.31299999999924200000*/
h= 0.000499999999998835*pow(time,3) - 0.0131999999999697*pow(time,2) +
0.112899999999737*time - 0.312999999999242;
}
if (time > 9.0)
{
/*y = -0.00049999999999883500x3 + 0.01379999999996780000x2 0.12369999999970400000x + 0.35839999999909200000*/
h= -0.000499999999998835*pow(time,3) + 0.0137999999999678*pow(time,2) 0.123699999999704*time + 0.358399999999092;
}
if (time > 9.5)
{
/*y = 0.00049999999999883500x3 - 0.01469999999996620000x2 +
0.14079999999967300000x - 0.43959999999894800000*/
h= 0.000499999999998835*pow(time,3) - 0.0146999999999662*pow(time,2) +
0.140799999999673*time - 0.439599999998948;
}
if (time > 10.0)
{
/*y = -0.00049999999999883500x3 + 0.01529999999996430000x2 - 0.15279999999963600000x
+ 0.49639999999876200000*/
h= -0.000499999999998835*pow(time,3) + 0.0152999999999643*pow(time,2) 0.152799999999636*time + 0.496399999998762;
}
if (time > 10.5)
{
/*y = 0.00049999999999883500x3 - 0.01619999999996270000x2 + 0.17169999999960200000x 0.59559999999858600000*/
h= 0.000499999999998835*pow(time,3) - 0.0161999999999627*pow(time,2) +
0.171699999999602*time - 0.595599999998586;
}
if (time > 11.0)
{
/*y = -0.00049999999999883500x3 + 0.01679999999996080000x2 - 0.18489999999956100000x
+ 0.66499999999836200000*/
h= -0.000499999999998835*pow(time,3) + 0.0167999999999608*pow(time,2) 0.184899999999561*time + 0.664999999998362;
}
if (time > 11.5)
{
/*y = 0.00049999999999883500x3 - 0.01769999999995920000x2 +
0.20559999999952400000x - 0.78399999999815000000*/
h= 0.000499999999998835*pow(time,3) - 0.0176999999999592*pow(time,2) +
0.205599999999524*time - 0.78399999999815;
}
if (time > 12.0)
{
/*y = -0.00049999999999883500x3 + 0.01829999999995740000x2 0.21999999999948000000x + 0.86719999999788300000*/
h= -0.000499999999998835*pow(time,3) + 0.0182999999999574*pow(time,2) 0.21999999999948*time + 0.867199999997883;
}
if (time > 12.5)
{
/*y = 0.00049999999999883500x3 - 0.01919999999995570000x2 +
0.24249999999943900000x - 1.00779999999763000000*/
h= 0.000499999999998835*pow(time,3) - 0.0191999999999557*pow(time,2) +
0.242499999999439*time - 1.00779999999763;
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}
if (time > 13.0)
{
/*y = -0.00049999999999883500x3 + 0.01979999999995390000x2 0.25809999999939100000x + 1.10599999999732000000*/
h= -0.000499999999998835*pow(time,3) + 0.0197999999999539*pow(time,2) 0.258099999999391*time + 1.10599999999732;
}
if (time > 13.5)
{
/*y = 0.00049999999999883500x3 - 0.02069999999995220000x2 +
0.28239999999934700000x - 1.26999999999703000000*/
h= 0.000499999999998835*pow(time,3) - 0.0206999999999522*pow(time,2) +
0.282399999999347*time - 1.26999999999703;
}
if (time > 14.0)
{
/*y = -0.00049999999999883500x3 + 0.02129999999995040000x2 0.29919999999929500000x + 1.38439999999666000000*/
h= -0.000499999999998835*pow(time,3) + 0.0212999999999504*pow(time,2) 0.299199999999295*time + 1.38439999999666;
}
if (time > 14.5)
{
/*y = 0.00049999999999883500x3 - 0.02219999999994870000x2 +
0.32529999999924800000x - 1.57359999999632000000*/
h= 0.000499999999998835*pow(time,3) - 0.0221999999999487*pow(time,2) +
0.325299999999248*time - 1.57359999999632;
}
if (time > 15.0)
{
/*y = -0.00049999999999883500x3 + 0.02279999999994690000x2 0.34329999999919200000x + 1.70539999999591000000*/
h= -0.000499999999998835*pow(time,3) + 0.0227999999999469*pow(time,2) 0.343299999999192*time + 1.70539999999591;
}
if (time > 15.5)
{
/*y = 0.00049999999999883500x3 - 0.02369999999994520000x2 +
0.37119999999914200000x - 1.92159999999552000000*/
h= 0.000499999999998835*pow(time,3) - 0.0236999999999452*pow(time,2) +
0.371199999999142*time - 1.92159999999552;
}
if (time > 16.0)
{
/*y = -0.00050000000000083300x3 + 0.02430000000004140000x2 0.39040000000068500000x + 2.07200000000378000000*/
h= -0.000500000000000833*pow(time,3) + 0.0243000000000414*pow(time,2) 0.390400000000685*time + 2.072000000003780;
}
if (time > 16.5)
{
/*y = 0.00050000000000061100x3 - 0.02520000000003050000x2 +
0.42010000000050800000x - 2.31700000000281000000*/
h= 0.000500000000000611*pow(time,3) - 0.0252000000000305*pow(time,2) +
0.420100000000508*time - 2.31700000000281;
}
if (time > 17.0)

193

{
/*y = -0.00050000000000083300x3 + 0.02580000000004390000x2 0.44050000000077100000x + 2.4872000000045100000*/
h= -0.000500000000000833*pow(time,3) + 0.0258000000000439*pow(time,2) 0.440500000000771*time + 2.48720000000451;
}
if (time > 17.5)
{
/*y = 0.00050000000000061100x3 - 0.02670000000003240000x2 +
0.47200000000057000000x - 2.76280000000335000000*/
h= 0.000500000000000611*pow(time,3) - 0.0267000000000324*pow(time,2) +
0.47200000000057*time - 2.76280000000335;
}
if (time > 18.0)
{
/*y = -0.00050000000000083300x3 + 0.02730000000004640000x2 0.49360000000086100000x + 2.95400000000532000000*/
h= -0.000500000000000833*pow(time,3) + 0.0273000000000464*pow(time,2) 0.493600000000861*time + 2.95400000000532;
}
if (time > 18.5)
{
/*y = 0.00050000000000061100x3 - 0.02820000000003420000x2 +
0.52690000000063700000x - 3.26200000000395000000*/
h= 0.000500000000000611*pow(time,3) - 0.0282000000000342*pow(time,2) +
0.526900000000637*time - 3.26200000000395;
}
if (time > 19.0)
{
/*y = -0.00050000000000083300x3 + 0.02880000000004890000x2 0.54970000000095600000x + 3.47540000000623000000*/
h= -0.000500000000000833*pow(time,3) + 0.0288000000000489*pow(time,2) 0.549700000000956*time + 3.47540000000623;
}
if (time > 19.5)
{
/*y = 0.00050000000000061100x3 - 0.02970000000003600000x2 +
0.58480000000070700000x - 3.81760000000462000000*/
h= 0.000500000000000611*pow(time,3) - 0.029700000000036*pow(time,2) +
0.584800000000707*time - 3.81760000000462;
}
if (time > 20.0)
{
/*y = -0.00050000000000083300x3 + 0.03030000000005140000x2 0.60880000000105700000x + 4.05440000000724000000*/
h= -0.000500000000000833*pow(time,3) + 0.0303000000000514*pow(time,2) 0.608800000001057*time + 4.05440000000724;
}
if (time > 20.5)
{
/*y = 0.00050000000000061100x3 - 0.03120000000003790000x2 +
0.64570000000078100000x - 4.43260000000536000000*/
h= 0.000500000000000611*pow(time,3) - 0.0312000000000379*pow(time,2) +
0.645700000000781*time - 4.43260000000536;
}
if (time > 21.0)
{
/*y = -0.00050000000000083300x3 + 0.03180000000005390000x2 0.67090000000116200000x + 4.69400000000835000000*/
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h=-0.000500000000000833*pow(time,3) + 0.0318000000000539*pow(time,2) 0.670900000001162*time + 4.69400000000835;
}
if (time >21.5)
{
/*y = 0.00050000000000061100x3 - 0.03270000000003970000x2 +
0.70960000000085900000x - 5.11000000000618000000*/
h=0.000500000000000611*pow(time,3) - 0.0327000000000397*pow(time,2) +
0.709600000000859*time - 5.11000000000618;
}
if (time >22.0)
{
/*y = -0.00050000000000083300x3 + 0.03330000000005640000x2 - 0.73600000000127200000x +
5.39720000000956000000*/
h= -0.00050000000000833*pow(time,3) + 0.0333000000000564*pow(time,2) 0.736000000001272*time + 5.39720000000956;
}
if (time >22.5)
{
/*y = 0.00050000000000061100x3 - 0.03420000000004150000x2 + 0.77650000000094000000x 5.85280000000708000000*/
h = 0.000500000000000611*pow(time,3) - 0.0342000000000415*pow(time,2) +
0.77650000000094*time - 5.85280000000708;
}
if (time >23.0)
{
/*y = -0.00050000000000083300x3 + 0.03480000000005890000x2 - 0.80410000000138700000x +
6.16700000001089000000*/
h= -0.000500000000000833*pow(time,3) + 0.0348000000000589*pow(time,2) 0.804100000001387*time + 6.16700000001089;
}
if (time >23.5)
{
/*y = 0.00050000000000061100x3 - 0.03570000000004340000x2 + 0.84640000000102500000x 6.66400000000806000000*/
h = 0.000500000000000611*pow(time,3) - 0.0357000000000434*pow(time,2) +
0.846400000001025*time - 6.66400000000806;
}
if (time >24.0)
{
/*y = -0.00050000000000083300x3 + 0.03630000000006140000x2 - 0.87520000000150800000x +
7.00640000001234000000*/
h= -0.000500000000000833*pow(time,3) + 0.0363000000000614*pow(time,2) 0.875200000001508*time + 7.00640000001234;
}
if (time >24.5)
{
/*y = 0.00050000000000061100x3 - 0.03720000000004520000x2 + 0.91930000000111300000x 7.54660000000913000000*/
h = 0.000500000000000611*pow(time,3) - 0.0372000000000452*pow(time,2) +
0.919300000001113*time - 7.54660000000913;
}
if (time >25.0)
{
/*y = -0.00050000000000083300x3 + 0.03780000000006390000x2 - 0.94930000000163300000x +
7.91840000001391000000*/
h= -0.000500000000000833*pow(time,3) + 0.0378000000000639*pow(time,2) 0.949300000001633*time + 7.91840000001391;
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}
if (time >25.5)
{
/*y = 0.00050000000000061100x3 - 0.03870000000004700000x2 + 0.99520000000120600000x 8.50360000001029000000*/
h = 0.000500000000000611*pow(time,3) - 0.038700000000047*pow(time,2) +
0.995200000001206*time - 8.50360000001029;
}
if (time >26.0)
{
/*y = -0.00050000000000083300x3 + 0.03930000000006640000x2 - 1.02640000000176000000x +
8.90600000001561000000*/
h= -0.000500000000000833*pow(time,3) + 0.0393000000000664*pow(time,2) 1.02640000000176*time + 8.90600000001561;
}
if (time >26.5)
{
/*y = 0.00050000000000061100x3 - 0.04020000000004890000x2 + 1.07410000000130000000x 9.53800000001154000000*/
h = 0.000500000000000611*pow(time,3) - 0.0402000000000489*pow(time,2) +
1.0741000000013*time - 9.53800000001154;
}
if (time >27.0)
{
/*y = -0.00050000000000083300x3 + 0.04080000000006890000x2 - 1.10650000000190000000x +
9.97220000001744000000*/
h= -0.000500000000000833*pow(time,3) + 0.0408000000000689*pow(time,2) 1.1065000000019*time + 9.97220000001744;
}
if (time >27.5)
{
/*y = 0.00050000000000061100x3 - 0.04170000000005070000x2 + 1.15600000000140000000x 10.65280000001290000000*/
h = 0.000500000000000611*pow(time,3) - 0.0417000000000507*pow(time,2) +
1.1560000000014*time - 10.6528000000129;
}
if (time >28.0)
{
/*y = -0.00050000000000083300x3 + 0.04230000000007140000x2 - 1.18960000000204000000x +
11.120000000019400000002*/
h= -0.000500000000000833*pow(time,3) + 0.0423000000000714*pow(time,2) 1.18960000000204*time + 11.120000000019400000002;
}
if (time >28.5)
{
/*y = 0.00050000000000061100x3 - 0.04320000000005250000x2 + 1.24090000000150000000x 11.85100000001440000000*/
h = 0.000500000000000611*pow(time,3) - 0.0432000000000525*pow(time,2) +
1.2409000000015*time - 11.8510000000144;
}
if (time >29.0)
{
/*y = -0.0005000000000008330x3 + 0.0438000000000739000x2 - 1.2757000000021800000x +
12.3524000000215000000*/
h= -0.0005000000000008330*pow(time,3) + 0.0438000000000739*pow(time,2) 1.27570000000218*time + 12.3524000000215;
}
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if (time >29.5)
{
/*y = 0.00050000000000061100x3 - 0.04470000000005440000x2 + 1.32880000000161000000x 13.13560000001590000000*/
h = 0.000500000000000611*pow(time,3) - 0.0447000000000544*pow(time,2) +
1.32880000000161*time - 13.1356000000159;
}
if (time >30.0)
{
/*y = y = -0.00050000000000083300x3 + 0.04530000000007640000x2 - 1.36480000000233000000x
+ 13.67240000002380000000*/
h= -0.000500000000000833*pow(time,3) + 0.0453000000000764*pow(time,2) 1.36480000000233*time + 13.6724000000238;
}
if (time >30.5)
{
/*y = y = 0.00050000000000061100x3 - 0.04620000000005620000x2 + 1.41970000000172000000x 14.50960000001760000000*/
h = 0.000500000000000611*pow(time,3) - 0.0462000000000562*pow(time,2) +
1.41970000000172*time - 14.5096000000176;
}
if (time >31.0)
{
/*y = -0.00050000000000083300x3 + 0.04680000000007890000x2 - 1.45690000000249000000x +
15.08300000002620000000*/
h= -0.000500000000000833*pow(time,3) + 0.0468000000000789*pow(time,2) 1.45690000000249*time + 15.0830000000262;
}
if (time >31.5)
{
/*y = 0.00050000000000061100x3 - 0.04770000000005800000x2 + 1.51360000000184000000x 15.97600000001940000000*/
h = 0.000500000000000611*pow(time,3) - 0.047700000000058*pow(time,2) +
1.51360000000184*time - 15.9760000000194;
}
if (time >32.0)
{
/*y = -0.00050000000000005600x3 + 0.04830000000000560000x2 - 1.55200000000018000000x +
16.58720000000200000000*/
h= -0.000500000000000056*pow(time,3) + 0.0483000000000056*pow(time,2) 1.55200000000018*time + 16.587200000002;
}
if (time >32.5)
{
/*y = 0.00049999999999972300x3 - 0.04919999999997330000x2 + 1.61049999999914000000x 17.53779999999080000000*/
h = 0.000499999999999723*pow(time,3) - 0.0491999999999733*pow(time,2) +
1.61049999999914*time - 17.5377999999908;
}
if (time >33.0)
{
/*y = -0.00050000000000005600x3 + 0.04980000000000570000x2 - 1.65010000000020000000x +
18.18800000000220000000*/
h= -0.000500000000000056*pow(time,3) + 0.0498000000000057*pow(time,2) 1.6501000000002*time + 18.1880000000022;
}
if (time >33.5)
{
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/*y = 0.00049999999999972300x3 - 0.05069999999997240000x2 + 1.71039999999909000000x 19.19799999998990000000*/
h = 0.000499999999999723*pow(time,3) - 0.0506999999999724*pow(time,2) +
1.71039999999909*time - 19.1979999999899;
}
if (time >34.0)
{
/*y = -0.00050000000000005600x3 + 0.05130000000000590000x2 - 1.75120000000021000000x +
19.88840000000240000000*/
h= -0.000500000000000056*pow(time,3) + 0.0513000000000059*pow(time,2) 1.75120000000021*time + 19.8884000000024;
}
if (time >34.5)
{
/*y = 0.00049999999999972300x3 - 0.05219999999997160000x2 + 1.81329999999903000000x 20.95959999998900000000*/
h = 0.000499999999999723*pow(time,3) - 0.0521999999999716*pow(time,2) +
1.81329999999903*time - 20.959599999989;
}
if (time >35.0)
{
/*y = -0.00050000000000005600x3 + 0.05280000000000610000x2 - 1.85530000000022000000x +
21.69140000000260000000*/
h= -0.000500000000000056*pow(time,3) + 0.0528000000000061*pow(time,2) 1.85530000000022*time + 21.6914000000026;
}
if (time >35.5)
{
/*y = 0.00049999999999972300x3 - 0.05369999999997080000x2 + 1.91919999999897000000x 22.82559999998800000000*/
h = 0.000499999999999723*pow(time,3) - 0.0536999999999708*pow(time,2) +
1.91919999999897*time - 22.825599999988;
}
if (time >36.0)
{
/*y = -0.00050000000000005600x3 + 0.05430000000000620000x2 - 1.96240000000023000000x +
23.60000000000290000000*/
h= -0.000500000000000056*pow(time,3) + 0.0543000000000062*pow(time,2) 1.96240000000023*time + 23.6000000000029;
}
if (time >36.5)
{
/*yy = 0.00049999999999972300x3 - 0.05519999999996990000x2 + 2.02809999999891000000x 24.79899999998690000000*/
h = 0.000499999999999723*pow(time,3) - 0.0551999999999699*pow(time,2) +
2.02809999999891*time - 24.7989999999869;
}
if (time >37.0)
{
/*y = -0.00050000000000005600x3 + 0.05580000000000640000x2 - 2.07250000000024000000x +
25.61720000000310000000*/
h= -0.000500000000000056*pow(time,3) + 0.0558000000000064*pow(time,2) 2.07250000000024*time + 25.6172000000031;
}
if (time >37.5)
{
/*y = 0.00049999999999972300x3 - 0.05669999999996910000x2 + 2.13999999999885000000x 26.88279999998580000000*/
h = 0.000499999999999723*pow(time,3) - 0.0566999999999691*pow(time,2) +
2.13999999999885*time - 26.8827999999858;
}
if (time >38.0)
{
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/*y = -0.00050000000000005600x3 + 0.05730000000000660000x2 - 2.18560000000026000000x +
27.74600000000330000000*/
h= -0.000500000000000056*pow(time,3) + 0.0573000000000066*pow(time,2) 2.18560000000026*time + 27.7460000000033;
}
if (time >38.5)
{
/*y = 0.00049999999999972300x3 - 0.05819999999996830000x2 + 2.25489999999879000000x 29.07999999998460000000*/
h = 0.000499999999999723*pow(time,3) - 0.0581999999999683*pow(time,2) +
2.25489999999879*time - 29.07999999998460;
}
if (time >39.0)
{
/*y = -0.00050000000000005600x3 + 0.05880000000000670000x2 - 2.30170000000027000000x +
29.98940000000360000000*/
h= -0.000500000000000056*pow(time,3) + 0.0588000000000067*pow(time,2) 2.30170000000027*time + 29.9894000000036;
}
if (time >39.5)
{
/*y = 0.00049999999999972300x3 - 0.05969999999996740000x2 + 2.37279999999873000000x 31.39359999998340000000*/
h = 0.000499999999999723*pow(time,3) - 0.0596999999999674*pow(time,2) +
2.372799999998730*time - 31.39359999998340;
}
if (time >40.0)
{
/*y = -0.00050000000000005600x3 + 0.06030000000000690000x2 - 2.42080000000028000000x +
32.35040000000390000000*/
h= -0.000500000000000056*pow(time,3) + 0.0603000000000069*pow(time,2) 2.42080000000028*time + 32.3504000000039;
}
if (time >40.5)
{
/*y = 0.00049999999999972300x3 - 0.06119999999996660000x2 + 2.49369999999866000000x 33.82659999998210000000*/
h = 0.000499999999999723*pow(time,3) - 0.0611999999999666*pow(time,2) +
2.49369999999866*time - 33.8265999999821;
}
if (time >41.0)
{
/*y = -0.00050000000000005600x3 + 0.06180000000000710000x2 - 2.54290000000030000000x +
34.83200000000420000000*/
h= -0.000500000000000056*pow(time,3) + 0.0618000000000071*pow(time,2) 2.5429000000003*time + 34.8320000000042;
}
if (time >41.5)
{
/*y = 0.00049999999999972300x3 - 0.06269999999996580000x2 + 2.61759999999859000000x 36.38199999998070000000*/
h = 0.000499999999999723*pow(time,3) - 0.0626999999999658*pow(time,2) +
2.61759999999859*time - 36.3819999999807;
}
if (time >42.0)
{
/*y = -0.00050000000000005600x3 + 0.06330000000000720000x2 - 2.66800000000031000000x +
37.43720000000450000000*/
h= -0.000500000000000056*pow(time,3) + 0.0633000000000072*pow(time,2) 2.66800000000031*time + 37.4372000000045;
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}
if (time >42.5)
{
/*y = 0.00049999999999972300x3 - 0.06419999999996500000x2 + 2.74449999999852000000x 39.06279999997920000000*/
h = 0.000499999999999723*pow(time,3) - 0.064199999999965*pow(time,2) +
2.74449999999852*time - 39.0627999999792;
}
if (time >43.0)
{
/*y = -0.00050000000000005600x3 + 0.06480000000000740000x2 - 2.79610000000033000000x +
40.16900000000480000000*/
h= -0.000500000000000056*pow(time,3) + 0.0648000000000074*pow(time,2) 2.79610000000033*time + 40.1690000000048;
}
if (time >43.5)
{
/*y = 0.00049999999999972300x3 - 0.06569999999996410000x2 + 2.87439999999845000000x 41.87199999997770000000*/
h = 0.000499999999999723*pow(time,3) - 0.0656999999999641*pow(time,2) +
2.87439999999845*time - 41.8719999999777;
}
if (time >44.0)
{
/*y = -0.00050000000000005600x3 + 0.06630000000000760000x2 - 2.92720000000034000000x +
43.03040000000510000000*/
h= -0.000500000000000056*pow(time,3) + 0.0663000000000076*pow(time,2) 2.92720000000034*time + 43.0304000000051;
}
if (time >44.5)
{
/*y = 0.00049999999999972300x3 - 0.06719999999996330000x2 + 3.00729999999838000000x 44.81259999997620000000*/
h = 0.000499999999999723*pow(time,3) - 0.0671999999999633*pow(time,2) +
3.00729999999838*time - 44.8125999999762;
}
if (time >45.0)
{
/*y = -0.00050000000000005600x3 + 0.06780000000000770000x2 - 3.06130000000036000000x +
46.02440000000550000000*/
h = -0.000500000000000056*pow(time,3) + 0.0678000000000077*pow(time,2) 3.06130000000036*time + 46.0244000000055;
}
if (time >45.5)
{
/*y = 0.00049999999999972300x3 - 0.06869999999996250000x2 + 3.14319999999831000000x 47.88759999997450000000*/
h = 0.000499999999999723*pow(time,3) - 0.0686999999999625*pow(time,2) +
3.14319999999831*time - 47.8875999999745;
}
if (time >46.0)
{
/*y = -0.00050000000000005600x3 + 0.06930000000000790000x2 - 3.19840000000037000000x +
49.15400000000580000000*/
h= -0.000500000000000056*pow(time,3) + 0.0693000000000079*pow(time,2) 3.19840000000037*time + 49.1540000000058;
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}
if (time >46.5)
{
/*y = 0.00049999999999972300x3 - 0.07019999999996160000x2 + 3.28209999999823000000x 51.09999999997280000000*/
h = 0.000499999999999723*pow(time,3) - 0.0701999999999616*pow(time,2) +
3.28209999999823*time - 51.0999999999728;
}
if (time >47.0)
{
/*y =y = -0.00050000000000005600x3 + 0.07080000000000810000x2 - 3.33850000000039000000x +
52.42220000000620000000*/
h= -0.000500000000000056*pow(time,3) + 0.0708000000000081*pow(time,2) 3.33850000000039*time + 52.4222000000062;
}
if (time >47.5)
{
/*y = 0.00049999999999972300x3 - 0.07169999999996080000x2 + 3.42399999999815000000x 54.45279999997090000000*/
h = 0.000499999999999723*pow(time,3) - 0.0716999999999608*pow(time,2) +
3.42399999999815*time - 54.4527999999709;
}
if (time >48.0)
{
/*y = -0.00050000000000005600x3 + 0.07230000000000820000x2 - 3.48160000000040000000x +
55.83200000000660000000*/
h= -0.000500000000000056*pow(time,3) + 0.0723000000000082*pow(time,2) 3.4816000000004*time + 55.8320000000066;
}
if (time >48.5)
{
/*y = 0.00049999999999972300x3 - 0.07319999999996000000x2 + 3.56889999999807000000x 57.94899999996910000000*/
h = 0.000499999999999723*pow(time,3) - 0.07319999999996*pow(time,2) +
3.56889999999807*time - 57.9489999999691;
}
if (time >49.0)
{
/*y = -0.00050000000000005600x3 + 0.07380000000000840000x2 - 3.62770000000042000000x +
59.38640000000700000000*/
h= -0.000500000000000056*pow(time,3) + 0.0738000000000084*pow(time,2) 3.62770000000042*time + 59.386400000007;
}
if (time >49.5)
{
/*y = 0.00049999999999972300x3 - 0.07469999999995910000x2 + 3.71679999999799000000x 61.59159999996710000000*/
h = 0.000499999999999723*pow(time,3) - 0.0746999999999591*pow(time,2) +
3.71679999999799*time - 61.5915999999671;
}
if (time >50.0)
{
/*y = -0.00050000000000005600x3 + 0.07530000000000860000x2 - 3.77680000000044000000x +
63.08840000000750000000*/
h= -0.000500000000000056*pow(time,3) + 0.0753000000000086*pow(time,2) 3.77680000000044000000*time + 63.0884000000075;
}
if (time >50.5)
{
/*y = 0.00049999999999972300x3 - 0.07619999999995830000x2 + 3.86769999999791000000x 65.38359999996500000000*/
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h = 0.000499999999999723*pow(time,3) - 0.0761999999999583*pow(time,2) +
3.86769999999791*time - 65.383599999965;
}
if (time >51.0)
{
/*y = -0.00050000000000005600x3 + 0.07680000000000880000x2 - 3.92890000000046000000x +
66.94100000000790000000*/
h= -0.000500000000000056*pow(time,3) + 0.0768000000000088*pow(time,2) 3.92890000000046*time + 66.9410000000079;

}
if (time >51.5)
{
/*y = 0.00049999999999972300x3 - 0.07769999999995750000x2 + 4.02159999999783000000x 69.32799999996290000000*/
h = 0.000499999999999723*pow(time,3) - 0.0776999999999575*pow(time,2) +
4.0215999999978300*time - 69.32799999996290;
}
if (time >52.0)
{
/*y = -0.00050000000000005600x3 + 0.07830000000000890000x2 - 4.08400000000047000000x +
70.94720000000840000000*/
h= -0.000500000000000056*pow(time,3) + 0.0783000000000089*pow(time,2) 4.08400000000047*time + 70.9472000000084;
}
if (time >52.5)
{
/*y = 0.00049999999999972300x3 - 0.07919999999995660000x2 + 4.17849999999774000000x 73.42779999996070000000*/
h = 0.000499999999999723*pow(time,3) - 0.0791999999999566000*pow(time,2) +
4.17849999999774*time - 73.4277999999607;
}
if (time >53.0)
{
/*y = -0.00050000000000005600x3 + 0.07980000000000910000x2 - 4.24210000000049000000x +
75.11000000000890000000*/
h= -0.000500000000000056*pow(time,3) + 0.0798000000000091*pow(time,2) 4.24210000000049*time + 75.1100000000089;
}
if (time >53.5)
{
/*y = 0.00049999999999972300x3 - 0.08069999999995580000x2 + 4.33839999999765000000x 77.68599999995840000000*/
h = 0.000499999999999723*pow(time,3) - 0.08069999999995580000*pow(time,2) +
4.33839999999765*time - 77.68599999995840000000;
}
if (time >54.0)
{
/*y = -0.00050000000000005600x3 + 0.08130000000000930000x2 - 4.40320000000051000000x +
79.43240000000940000000*/
h= -0.000500000000000056*pow(time,3) + 0.0813000000000093*pow(time,2) 4.40320000000051*time + 79.4324000000094;

}
if (time >54.5)
{
/*y = 0.00049999999999972300x3 - 0.08219999999995500000x2 + 4.50129999999756000000x 82.10559999995600000000*/
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h = 0.000499999999999723*pow(time,3) - 0.082199999999955*pow(time,2) +
4.50129999999756*time - 82.105599999956;
}
if (time >55.0)
{
/*y = -0.00050000000000005600x3 + 0.08280000000000940000x2 - 4.56730000000053000000x +
83.91740000000990000000*/
h= -0.000500000000000056*pow(time,3) + 0.0828000000000094*pow(time,2) 4.56730000000053*time + 83.9174000000099;
}
if (time >55.5)
{
/*y = 0.00049999999999972300x3 - 0.08369999999995410000x2 + 4.66719999999747000000x 86.68959999995350000000*/
h = 0.000499999999999723*pow(time,3) - 0.0836999999999541*pow(time,2) +
4.66719999999747*time - 86.68959999995350;
}
if (time >56.0)
{
/*y = -0.00050000000000005600x3 + 0.08430000000000960000x2 - 4.73440000000055000000x +
88.56800000001040000000*/
h= -0.000500000000000056*pow(time,3) + 0.0843000000000096*pow(time,2) 4.73440000000055*time + 88.5680000000104;
}
if (time >56.5)
{
/*y = 0.00049999999999972300x3 - 0.08519999999995330000x2 + 4.83609999999738000000x 91.44099999995090000000*/
h = 0.000499999999999723*pow(time,3) - 0.0851999999999533*pow(time,2) +
4.83609999999738*time - 91.4409999999509;
}
if (time >57.0)
{
/*y = -0.00050000000000005600x3 + 0.08580000000000980000x2 - 4.90450000000057000000x +
93.38720000001100000000*/
h= -0.000500000000000056*pow(time,3) + 0.0858000000000098*pow(time,2) 4.90450000000057*time + 93.387200000011;
}
if (time >57.5)
{
/*y = 0.00049999999999972300x3 - 0.08669999999995250000x2 + 5.00799999999728000000x 96.36279999994830000000*/
h = 0.000499999999999723*pow(time,3) - 0.0866999999999525*pow(time,2) +
5.00799999999728*time - 96.3627999999483;
}
if (time >58.0)
{
/*y = -0.00050000000000005600x3 + 0.08730000000000990000x2 - 5.07760000000059000000x +
98.37800000001150000000*/
h= -0.000500000000000056*pow(time,3) + 0.0873000000000099*pow(time,2) 5.07760000000059*time + 98.3780000000115;
}
if (time >58.5)
{
/*y = 0.00049999999999972300x3 - 0.08819999999995170000x2 + 5.18289999999719000000x 101.45799999994500000000*/
h = 0.000499999999999723*pow(time,3) - 0.0881999999999517*pow(time,2) +
5.18289999999719*time - 101.457999999945;
}
if (time >59.0)
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{
/*y = -0.00050000000000005600x3 + 0.08880000000001010000x2 - 5.25370000000061000000x +
103.54340000001200000000*/
h= -0.000500000000000056*pow(time,3) + 0.0888000000000101*pow(time,2) 5.25370000000061*time + 103.543400000012;
}
if (time >59.5)
{
/*y = 0.00049999999999972300x3 - 0.08969999999995080000x2 + 5.36079999999709000000x 106.72959999994300000000*/
h = 0.000499999999999723*pow(time,3) - 0.0896999999999508*pow(time,2) +
5.36079999999709*time - 106.729599999943;
}
if (time >60.0)
{
/*y = -0.00050000000000005600x3 + 0.09030000000001030000x2 - 5.43280000000063000000x +
108.88640000001300000000*/
h= -0.000500000000000056*pow(time,3) + 0.0903000000000103*pow(time,2) 5.43280000000063*time + 108.886400000013;
}
if (time > 60.5)
{
/*y = 0.00049999999999972300x3 - 0.09119999999995000000x2 + 5.54169999999699000000x 112.18059999994000000000*/
h = 0.000499999999999723*pow(time,3) - 0.09119999999995*pow(time,2) +
5.54169999999699*time - 112.18059999994;
}

/*Need new a, using reference coordinates of edge of parabola which stays constant (x,y)=
(-0.011125,0)*/
/*double check x coordinate on reference*/
/*a= (x-k)^2/(4(y-h)) */
a= (-0.011125-k)*(-0.011125-k)/(4*(0-h));

/*
/*
/*
/*

Loop over the deforming boundary zone's faces;
inner loop loops over all nodes of a given face;
Thus, since one node can belong to several faces, one must guard
against operating on a given node more than once:

*/
*/
*/
*/

begin_f_loop (f, tf)
{
f_node_loop (f, tf, n)
{
node_p = F_NODE (f, tf, n);
/* Update the current node only if it has not been
*/
/* previously visited:
*/
if (NODE_POS_NEED_UPDATE (node_p))
{
/* Set flag to indicate that the current node's
*/
/* position has been updated, so that it will not be
*/
/* updated during a future pass through the loop:
*/
NODE_POS_UPDATED (node_p);
x

= NODE_X (node_p);

/* equation of parabola*/
y= (1/(4*a))*(x-k)*(x-k)+ h;
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NODE_Y (node_p) = y;
}
}
}
end_f_loop (f, tf);
}
DEFINE_GRID_MOTION(moving_arc2, domain, dt, time, dtime)
{
Thread *tf = DT_THREAD (dt);
face_t f;
Node *node_p;
float

a, h, k2, x, y;

int n;
/* constant x coordinate of vertex of parabola*/
k2= 0.0143002;
/* Set/activate the deforming flag on adjacent cell zone, which
/* means that the cells adjacent to the deforming wall will also be
/* deformed, in order to avoid skewness.
SET_DEFORMING_THREAD_FLAG (THREAD_T0 (tf));

*/
*/
*/

/* Solve for h at new time, generic determined function good for t 0-1 determined from
excel function*/

if (time <= 0.5)
{
/*y =0.00049999999999650300x3 + 0.00029999999999730200x2 + 0.00320000000000079000x 0.00160000000000008000*/
h= -0.000499999999996503*pow(time,3) + 0.000299999999997302*pow(time,2) +
0.00320000000000079*time - 0.00160000000000008;
}
if (time > 0.5)
{
/*y = 0.00049999999999705800x3 - 0.00119999999999498000x2 0.00230000000000263000x + 0.00140000000000040000*/
h= 0.000499999999997058*pow(time,3) - 0.00119999999999498*pow(time,2) 0.00230000000000263*time + 0.0014000000000004;
}
if (time >= 1.0)
{
/*y = -0.00049999999999950100x3 + 0.00179999999999814000x2 +
0.00110000000000240000x - 0.00400000000000106000*/
h= -0.000499999999999501*pow(time,3) + 0.00179999999999814*pow(time,2) +
0.0011000000000024*time - 0.00400000000000106;
}

if (time > 1.5)
{
/* y = 0.00049999999999972300x3 - 0.00269999999999770000x2 +
0.00159999999999505000x + 0.00200000000000317000*/
h= 0.000499999999999723*pow(time,3) -0.0026999999999977*pow(time,2)
+0.00159999999999505*time + 0.00200000000000317;
}

205

if (time >2.0)
{
/*y = -0.00049999999999617000x3 + 0.00329999999997366000x2 0.00399999999993997000x - 0.00280000000004536000*/
h= -0.00049999999999617*pow(time,3) + 0.00329999999997366*pow(time,2) 0.00399999999993997*time - 0.00280000000004536;
}

if (time > 2.5)
{
/* y = 0.00049999999999883500x3 - 0.00419999999999199000x2 +
0.00849999999998186000x - 0.00279999999998652000*/
h= 0.000499999999998835*pow(time,3) - 0.00419999999999199*pow(time,2) +
0.00849999999998186*time - 0.00279999999998652;
}
if (time > 3.0)
{
/*y = -0.00049999999999617000x3 + 0.00479999999996217000x2 0.01209999999987580000x + 0.00499999999986443000*/
h= -0.00049999999999617*pow(time,3) + 0.00479999999996217* pow(time,2) 0.0120999999998758*time + 0.00499999999986443;
}
if (time > 3.5)
{
/* y = 0.00049999999999883500x3 - 0.00569999999998849000x2 +
0.01839999999996230000x - 0.01599999999995920000 */
h= 0.000499999999998835*pow(time,3) - 0.00569999999998849*pow(time,2) +
0.0183999999999623*time - 0.0159999999999592;
}
if (time > 4.0)
{
/*y = -0.00049999999999894600x3 + 0.00629999999998621000x2 0.02319999999994000000x + 0.02239999999991310000*/
h=-0.000499999999998946* pow(time,3) + 0.00629999999998621*pow(time,2)0.02319999999994*time + 0.0223999999999131;
}

if (time > 4.5)
{
/*y = 0.00050000000000149900x3 - 0.00720000000002141000x2 +
0.03130000000010220000x - 0.04060000000016320000 */
h= 0.000500000000001499*pow(time,3) - 0.00720000000002141*pow(time,2) +
0.0313000000001022*time - 0.0406000000001632;
}

if (time > 5.0)
{
/*y = -0.00049999999999894600x3 + 0.00779999999998304000x2 - 0.03729999999990920000x
+ 0.05239999999983820000
*/
h= -0.000499999999998946*pow(time,3)+ 0.00779999999998304*pow(time,2) 0.0372999999999092*time + 0.0523999999998382;
}
if (time > 5.5)
{
/*y = 0.00050000000000149900x3 - 0.00870000000002591000x2 +
0.04720000000014960000x - 0.07960000000028830000*/
h= 0.000500000000001499*pow(time,3) - 0.00870000000002591*pow(time,2) +
0.0472000000001496*time - 0.0796000000002883;
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}
if (time > 6.0)
{
/*y = -0.00049999999999894600x3 + 0.00929999999997988000x2 0.05439999999987210000x + 0.09799999999972940000*/
h= -0.000499999999998946*pow(time,3) + 0.00929999999997988*pow(time,2) 0.0543999999998721*time + 0.0979999999997294;
}
if (time > 6.5)
{
/*y = 0.00050000000000149900x3 - 0.01020000000003040000x2 +
0.06610000000020590000x - 0.13600000000046500000*/
h= 0.000500000000001499*pow(time,3) - 0.0102000000000304*pow(time,2) +
0.0661000000002059*time - 0.136000000000465;
}
if (time > 7.0)
{
/*y = -0.00049999999999894600x3 + 0.01079999999997670000x2 0.07449999999982870000x + 0.16219999999958000000*/
h= -0.000499999999998946*pow(time,3) + 0.0107999999999767*pow(time,2) 0.0744999999998287*time + 0.16219999999958;
}
if (time > 7.5)
{
/*y = 0.00050000000000149900x3 - 0.01170000000003490000x2 +
0.08800000000027120000x - 0.21280000000070300000*/
h= 0.000500000000001499*pow(time,3)- 0.0117000000000349*pow(time,2) +
0.0880000000002712*time - 0.212800000000703;
}
if (time > 8.0)
{
/*y = -0.00049999999999883500x3 + 0.01229999999997130000x2 0.09759999999976480000x + 0.24799999999935700000*/
h= -0.000499999999998835*pow(time,3) + 0.0122999999999713*pow(time,2) 0.0975999999997648*time + 0.247999999999357;
}
if (time > 8.5)
{
/*y = 0.00049999999999883500x3 - 0.01319999999996970000x2 +
0.11289999999973700000x - 0.31299999999924200000*/
h= 0.000499999999998835*pow(time,3) - 0.0131999999999697*pow(time,2) +
0.112899999999737*time - 0.312999999999242;
}
if (time > 9.0)
{
/*y = -0.00049999999999883500x3 + 0.01379999999996780000x2 0.12369999999970400000x + 0.35839999999909200000*/
h= -0.000499999999998835*pow(time,3) + 0.0137999999999678*pow(time,2) 0.123699999999704*time + 0.358399999999092;
}
if (time > 9.5)
{
/*y = 0.00049999999999883500x3 - 0.01469999999996620000x2 +
0.14079999999967300000x - 0.43959999999894800000*/
h= 0.000499999999998835*pow(time,3) - 0.0146999999999662*pow(time,2) +
0.140799999999673*time - 0.439599999998948;
}
if (time > 10.0)
{
/*y = -0.00049999999999883500x3 + 0.01529999999996430000x2 - 0.15279999999963600000x
+ 0.49639999999876200000*/
h= -0.000499999999998835*pow(time,3) + 0.0152999999999643*pow(time,2) 0.152799999999636*time + 0.496399999998762;
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}
if (time > 10.5)
{
/*y = 0.00049999999999883500x3 - 0.01619999999996270000x2 + 0.17169999999960200000x 0.59559999999858600000*/
h= 0.000499999999998835*pow(time,3) - 0.0161999999999627*pow(time,2) +
0.171699999999602*time - 0.595599999998586;
}
if (time > 11.0)
{
/*y = -0.00049999999999883500x3 + 0.01679999999996080000x2 - 0.18489999999956100000x
+ 0.66499999999836200000*/
h= -0.000499999999998835*pow(time,3) + 0.0167999999999608*pow(time,2) 0.184899999999561*time + 0.664999999998362;
}
if (time > 11.5)
{
/*y = 0.00049999999999883500x3 - 0.01769999999995920000x2 +
0.20559999999952400000x - 0.78399999999815000000*/
h= 0.000499999999998835*pow(time,3) - 0.0176999999999592*pow(time,2) +
0.205599999999524*time - 0.78399999999815;
}
if (time > 12.0)
{
/*y = -0.00049999999999883500x3 + 0.01829999999995740000x2 0.21999999999948000000x + 0.86719999999788300000*/
h= -0.000499999999998835*pow(time,3) + 0.0182999999999574*pow(time,2) 0.21999999999948*time + 0.867199999997883;
}
if (time > 12.5)
{
/*y = 0.00049999999999883500x3 - 0.01919999999995570000x2 +
0.24249999999943900000x - 1.00779999999763000000*/
h= 0.000499999999998835*pow(time,3) - 0.0191999999999557*pow(time,2) +
0.242499999999439*time - 1.00779999999763;
}
if (time > 13.0)
{
/*y = -0.00049999999999883500x3 + 0.01979999999995390000x2 0.25809999999939100000x + 1.10599999999732000000*/
h= -0.000499999999998835*pow(time,3) + 0.0197999999999539*pow(time,2) 0.258099999999391*time + 1.10599999999732;
}
if (time > 13.5)
{
/*y = 0.00049999999999883500x3 - 0.02069999999995220000x2 +
0.28239999999934700000x - 1.26999999999703000000*/
h= 0.000499999999998835*pow(time,3) - 0.0206999999999522*pow(time,2) +
0.282399999999347*time - 1.26999999999703;
}
if (time > 14.0)
{
/*y = -0.00049999999999883500x3 + 0.02129999999995040000x2 0.29919999999929500000x + 1.38439999999666000000*/
h= -0.000499999999998835*pow(time,3) + 0.0212999999999504*pow(time,2) 0.299199999999295*time + 1.38439999999666;
}
if (time > 14.5)
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{
/*y = 0.00049999999999883500x3 - 0.02219999999994870000x2 +
0.32529999999924800000x - 1.57359999999632000000*/
h= 0.000499999999998835*pow(time,3) - 0.0221999999999487*pow(time,2) +
0.325299999999248*time - 1.57359999999632;
}
if (time > 15.0)
{
/*y = -0.00049999999999883500x3 + 0.02279999999994690000x2 0.34329999999919200000x + 1.70539999999591000000*/
h= -0.000499999999998835*pow(time,3) + 0.0227999999999469*pow(time,2) 0.343299999999192*time + 1.70539999999591;
}
if (time > 15.5)
{
/*y = 0.00049999999999883500x3 - 0.02369999999994520000x2 +
0.37119999999914200000x - 1.92159999999552000000*/
h= 0.000499999999998835*pow(time,3) - 0.0236999999999452*pow(time,2) +
0.371199999999142*time - 1.92159999999552;
}
if (time > 16.0)
{
/*y = -0.00050000000000083300x3 + 0.02430000000004140000x2 0.39040000000068500000x + 2.07200000000378000000*/
h= -0.000500000000000833*pow(time,3) + 0.0243000000000414*pow(time,2) 0.390400000000685*time + 2.072000000003780;
}
if (time > 16.5)
{
/*y = 0.00050000000000061100x3 - 0.02520000000003050000x2 +
0.42010000000050800000x - 2.31700000000281000000*/
h= 0.000500000000000611*pow(time,3) - 0.0252000000000305*pow(time,2) +
0.420100000000508*time - 2.31700000000281;
}
if (time > 17.0)
{
/*y = -0.00050000000000083300x3 + 0.02580000000004390000x2 0.44050000000077100000x + 2.4872000000045100000*/
h= -0.000500000000000833*pow(time,3) + 0.0258000000000439*pow(time,2) 0.440500000000771*time + 2.48720000000451;
}
if (time > 17.5)
{
/*y = 0.00050000000000061100x3 - 0.02670000000003240000x2 +
0.47200000000057000000x - 2.76280000000335000000*/
h= 0.000500000000000611*pow(time,3) - 0.0267000000000324*pow(time,2) +
0.47200000000057*time - 2.76280000000335;
}
if (time > 18.0)
{
/*y = -0.00050000000000083300x3 + 0.02730000000004640000x2 0.49360000000086100000x + 2.95400000000532000000*/
h= -0.000500000000000833*pow(time,3) + 0.0273000000000464*pow(time,2) 0.493600000000861*time + 2.95400000000532;
}
if (time > 18.5)
{
/*y = 0.00050000000000061100x3 - 0.02820000000003420000x2 +
0.52690000000063700000x - 3.26200000000395000000*/
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h= 0.000500000000000611*pow(time,3) - 0.0282000000000342*pow(time,2) +
0.526900000000637*time - 3.26200000000395;
}
if (time > 19.0)
{
/*y = -0.00050000000000083300x3 + 0.02880000000004890000x2 0.54970000000095600000x + 3.47540000000623000000*/
h= -0.000500000000000833*pow(time,3) + 0.0288000000000489*pow(time,2) 0.549700000000956*time + 3.47540000000623;
}
if (time > 19.5)
{
/*y = 0.00050000000000061100x3 - 0.02970000000003600000x2 +
0.58480000000070700000x - 3.81760000000462000000*/
h= 0.000500000000000611*pow(time,3) - 0.029700000000036*pow(time,2) +
0.584800000000707*time - 3.81760000000462;
}
if (time > 20.0)
{
/*y = -0.00050000000000083300x3 + 0.03030000000005140000x2 0.60880000000105700000x + 4.05440000000724000000*/
h= -0.000500000000000833*pow(time,3) + 0.0303000000000514*pow(time,2) 0.608800000001057*time + 4.05440000000724;
}
if (time > 20.5)
{
/*y = 0.00050000000000061100x3 - 0.03120000000003790000x2 +
0.64570000000078100000x - 4.43260000000536000000*/
h= 0.000500000000000611*pow(time,3) - 0.0312000000000379*pow(time,2) +
0.645700000000781*time - 4.43260000000536;
}
if (time > 21.0)
{
/*y = -0.00050000000000083300x3 + 0.03180000000005390000x2 0.67090000000116200000x + 4.69400000000835000000*/
h=-0.000500000000000833*pow(time,3) + 0.0318000000000539*pow(time,2) 0.670900000001162*time + 4.69400000000835;
}
if (time >21.5)
{
/*y = 0.00050000000000061100x3 - 0.03270000000003970000x2 +
0.70960000000085900000x - 5.11000000000618000000*/
h=0.000500000000000611*pow(time,3) - 0.0327000000000397*pow(time,2) +
0.709600000000859*time - 5.11000000000618;
}
if (time >22.0)
{
/*y = -0.00050000000000083300x3 + 0.03330000000005640000x2 - 0.73600000000127200000x +
5.39720000000956000000*/
h= -0.00050000000000833*pow(time,3) + 0.0333000000000564*pow(time,2) 0.736000000001272*time + 5.39720000000956;
}
if (time >22.5)
{
/*y = 0.00050000000000061100x3 - 0.03420000000004150000x2 + 0.77650000000094000000x 5.85280000000708000000*/
h = 0.000500000000000611*pow(time,3) - 0.0342000000000415*pow(time,2) +
0.77650000000094*time - 5.85280000000708;
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}
if (time >23.0)
{
/*y = -0.00050000000000083300x3 + 0.03480000000005890000x2 - 0.80410000000138700000x +
6.16700000001089000000*/
h= -0.000500000000000833*pow(time,3) + 0.0348000000000589*pow(time,2) 0.804100000001387*time + 6.16700000001089;
}
if (time >23.5)
{
/*y = 0.00050000000000061100x3 - 0.03570000000004340000x2 + 0.84640000000102500000x 6.66400000000806000000*/
h = 0.000500000000000611*pow(time,3) - 0.0357000000000434*pow(time,2) +
0.846400000001025*time - 6.66400000000806;
}
if (time >24.0)
{
/*y = -0.00050000000000083300x3 + 0.03630000000006140000x2 - 0.87520000000150800000x +
7.00640000001234000000*/
h= -0.000500000000000833*pow(time,3) + 0.0363000000000614*pow(time,2) 0.875200000001508*time + 7.00640000001234;
}
if (time >24.5)
{
/*y = 0.00050000000000061100x3 - 0.03720000000004520000x2 + 0.91930000000111300000x 7.54660000000913000000*/
h = 0.000500000000000611*pow(time,3) - 0.0372000000000452*pow(time,2) +
0.919300000001113*time - 7.54660000000913;
}
if (time >25.0)
{
/*y = -0.00050000000000083300x3 + 0.03780000000006390000x2 - 0.94930000000163300000x +
7.91840000001391000000*/
h= -0.000500000000000833*pow(time,3) + 0.0378000000000639*pow(time,2) 0.949300000001633*time + 7.91840000001391;
}
if (time >25.5)
{
/*y = 0.00050000000000061100x3 - 0.03870000000004700000x2 + 0.99520000000120600000x 8.50360000001029000000*/
h = 0.000500000000000611*pow(time,3) - 0.038700000000047*pow(time,2) +
0.995200000001206*time - 8.50360000001029;
}
if (time >26.0)
{
/*y = -0.00050000000000083300x3 + 0.03930000000006640000x2 - 1.02640000000176000000x +
8.90600000001561000000*/
h= -0.000500000000000833*pow(time,3) + 0.0393000000000664*pow(time,2) 1.02640000000176*time + 8.90600000001561;
}
if (time >26.5)
{
/*y = 0.00050000000000061100x3 - 0.04020000000004890000x2 + 1.07410000000130000000x 9.53800000001154000000*/
h = 0.000500000000000611*pow(time,3) - 0.0402000000000489*pow(time,2) +
1.0741000000013*time - 9.53800000001154;
}
if (time >27.0)
{
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/*y = -0.00050000000000083300x3 + 0.04080000000006890000x2 - 1.10650000000190000000x +
9.97220000001744000000*/
h= -0.000500000000000833*pow(time,3) + 0.0408000000000689*pow(time,2) 1.1065000000019*time + 9.97220000001744;
}
if (time >27.5)
{
/*y = 0.00050000000000061100x3 - 0.04170000000005070000x2 + 1.15600000000140000000x 10.65280000001290000000*/
h = 0.000500000000000611*pow(time,3) - 0.0417000000000507*pow(time,2) +
1.1560000000014*time - 10.6528000000129;
}
if (time >28.0)
{
/*y = -0.00050000000000083300x3 + 0.04230000000007140000x2 - 1.18960000000204000000x +
11.120000000019400000002*/
h= -0.000500000000000833*pow(time,3) + 0.0423000000000714*pow(time,2) 1.18960000000204*time + 11.120000000019400000002;
}
if (time >28.5)
{
/*y = 0.00050000000000061100x3 - 0.04320000000005250000x2 + 1.24090000000150000000x 11.85100000001440000000*/
h = 0.000500000000000611*pow(time,3) - 0.0432000000000525*pow(time,2) +
1.2409000000015*time - 11.8510000000144;
}
if (time >29.0)
{
/*y = -0.0005000000000008330x3 + 0.0438000000000739000x2 - 1.2757000000021800000x +
12.3524000000215000000*/
h= -0.0005000000000008330*pow(time,3) + 0.0438000000000739*pow(time,2) 1.27570000000218*time + 12.3524000000215;
}
if (time >29.5)
{
/*y = 0.00050000000000061100x3 - 0.04470000000005440000x2 + 1.32880000000161000000x 13.13560000001590000000*/
h = 0.000500000000000611*pow(time,3) - 0.0447000000000544*pow(time,2) +
1.32880000000161*time - 13.1356000000159;
}
if (time >30.0)
{
/*y = y = -0.00050000000000083300x3 + 0.04530000000007640000x2 - 1.36480000000233000000x
+ 13.67240000002380000000*/
h= -0.000500000000000833*pow(time,3) + 0.0453000000000764*pow(time,2) 1.36480000000233*time + 13.6724000000238;
}
if (time >30.5)
{
/*y = y = 0.00050000000000061100x3 - 0.04620000000005620000x2 + 1.41970000000172000000x 14.50960000001760000000*/
h = 0.000500000000000611*pow(time,3) - 0.0462000000000562*pow(time,2) +
1.41970000000172*time - 14.5096000000176;
}
if (time >31.0)
{
/*y = -0.00050000000000083300x3 + 0.04680000000007890000x2 - 1.45690000000249000000x +
15.08300000002620000000*/
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h= -0.000500000000000833*pow(time,3) + 0.0468000000000789*pow(time,2) 1.45690000000249*time + 15.0830000000262;
}
if (time >31.5)
{
/*y = 0.00050000000000061100x3 - 0.04770000000005800000x2 + 1.51360000000184000000x 15.97600000001940000000*/
h = 0.000500000000000611*pow(time,3) - 0.047700000000058*pow(time,2) +
1.51360000000184*time - 15.9760000000194;
}
if (time >32.0)
{
/*y = -0.00050000000000005600x3 + 0.04830000000000560000x2 - 1.55200000000018000000x +
16.58720000000200000000*/
h= -0.000500000000000056*pow(time,3) + 0.0483000000000056*pow(time,2) 1.55200000000018*time + 16.587200000002;
}
if (time >32.5)
{
/*y = 0.00049999999999972300x3 - 0.04919999999997330000x2 + 1.61049999999914000000x 17.53779999999080000000*/
h = 0.000499999999999723*pow(time,3) - 0.0491999999999733*pow(time,2) +
1.61049999999914*time - 17.5377999999908;
}
if (time >33.0)
{
/*y = -0.00050000000000005600x3 + 0.04980000000000570000x2 - 1.65010000000020000000x +
18.18800000000220000000*/
h= -0.000500000000000056*pow(time,3) + 0.0498000000000057*pow(time,2) 1.6501000000002*time + 18.1880000000022;
}
if (time >33.5)
{
/*y = 0.00049999999999972300x3 - 0.05069999999997240000x2 + 1.71039999999909000000x 19.19799999998990000000*/
h = 0.000499999999999723*pow(time,3) - 0.0506999999999724*pow(time,2) +
1.71039999999909*time - 19.1979999999899;
}
if (time >34.0)
{
/*y = -0.00050000000000005600x3 + 0.05130000000000590000x2 - 1.75120000000021000000x +
19.88840000000240000000*/
h= -0.000500000000000056*pow(time,3) + 0.0513000000000059*pow(time,2) 1.75120000000021*time + 19.8884000000024;
}
if (time >34.5)
{
/*y = 0.00049999999999972300x3 - 0.05219999999997160000x2 + 1.81329999999903000000x 20.95959999998900000000*/
h = 0.000499999999999723*pow(time,3) - 0.0521999999999716*pow(time,2) +
1.81329999999903*time - 20.959599999989;
}
if (time >35.0)
{
/*y = -0.00050000000000005600x3 + 0.05280000000000610000x2 - 1.85530000000022000000x +
21.69140000000260000000*/
h= -0.000500000000000056*pow(time,3) + 0.0528000000000061*pow(time,2) 1.85530000000022*time + 21.6914000000026;
}
if (time >35.5)
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{
/*y = 0.00049999999999972300x3 - 0.05369999999997080000x2 + 1.91919999999897000000x 22.82559999998800000000*/
h = 0.000499999999999723*pow(time,3) - 0.0536999999999708*pow(time,2) +
1.91919999999897*time - 22.825599999988;
}
if (time >36.0)
{
/*y = -0.00050000000000005600x3 + 0.05430000000000620000x2 - 1.96240000000023000000x +
23.60000000000290000000*/
h= -0.000500000000000056*pow(time,3) + 0.0543000000000062*pow(time,2) 1.96240000000023*time + 23.6000000000029;
}
if (time >36.5)
{
/*yy = 0.00049999999999972300x3 - 0.05519999999996990000x2 + 2.02809999999891000000x 24.79899999998690000000*/
h = 0.000499999999999723*pow(time,3) - 0.0551999999999699*pow(time,2) +
2.02809999999891*time - 24.7989999999869;
}
if (time >37.0)
{
/*y = -0.00050000000000005600x3 + 0.05580000000000640000x2 - 2.07250000000024000000x +
25.61720000000310000000*/
h= -0.000500000000000056*pow(time,3) + 0.0558000000000064*pow(time,2) 2.07250000000024*time + 25.6172000000031;
}
if (time >37.5)
{
/*y = 0.00049999999999972300x3 - 0.05669999999996910000x2 + 2.13999999999885000000x 26.88279999998580000000*/
h = 0.000499999999999723*pow(time,3) - 0.0566999999999691*pow(time,2) +
2.13999999999885*time - 26.8827999999858;
}
if (time >38.0)
{
/*y = -0.00050000000000005600x3 + 0.05730000000000660000x2 - 2.18560000000026000000x +
27.74600000000330000000*/
h= -0.000500000000000056*pow(time,3) + 0.0573000000000066*pow(time,2) 2.18560000000026*time + 27.7460000000033;
}
if (time >38.5)
{
/*y = 0.00049999999999972300x3 - 0.05819999999996830000x2 + 2.25489999999879000000x 29.07999999998460000000*/
h = 0.000499999999999723*pow(time,3) - 0.0581999999999683*pow(time,2) +
2.25489999999879*time - 29.07999999998460;
}
if (time >39.0)
{
/*y = -0.00050000000000005600x3 + 0.05880000000000670000x2 - 2.30170000000027000000x +
29.98940000000360000000*/
h= -0.000500000000000056*pow(time,3) + 0.0588000000000067*pow(time,2) 2.30170000000027*time + 29.9894000000036;
}
if (time >39.5)
{
/*y = 0.00049999999999972300x3 - 0.05969999999996740000x2 + 2.37279999999873000000x 31.39359999998340000000*/
h = 0.000499999999999723*pow(time,3) - 0.0596999999999674*pow(time,2) +
2.372799999998730*time - 31.39359999998340;
}
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if (time >40.0)
{
/*y = -0.00050000000000005600x3 + 0.06030000000000690000x2 - 2.42080000000028000000x +
32.35040000000390000000*/
h= -0.000500000000000056*pow(time,3) + 0.0603000000000069*pow(time,2) 2.42080000000028*time + 32.3504000000039;
}
if (time >40.5)
{
/*y = 0.00049999999999972300x3 - 0.06119999999996660000x2 + 2.49369999999866000000x 33.82659999998210000000*/
h = 0.000499999999999723*pow(time,3) - 0.0611999999999666*pow(time,2) +
2.49369999999866*time - 33.8265999999821;
}
if (time >41.0)
{
/*y = -0.00050000000000005600x3 + 0.06180000000000710000x2 - 2.54290000000030000000x +
34.83200000000420000000*/
h= -0.000500000000000056*pow(time,3) + 0.0618000000000071*pow(time,2) 2.5429000000003*time + 34.8320000000042;
}
if (time >41.5)
{
/*y = 0.00049999999999972300x3 - 0.06269999999996580000x2 + 2.61759999999859000000x 36.38199999998070000000*/
h = 0.000499999999999723*pow(time,3) - 0.0626999999999658*pow(time,2) +
2.61759999999859*time - 36.3819999999807;
}
if (time >42.0)
{
/*y = -0.00050000000000005600x3 + 0.06330000000000720000x2 - 2.66800000000031000000x +
37.43720000000450000000*/
h= -0.000500000000000056*pow(time,3) + 0.0633000000000072*pow(time,2) 2.66800000000031*time + 37.4372000000045;
}
if (time >42.5)
{
/*y = 0.00049999999999972300x3 - 0.06419999999996500000x2 + 2.74449999999852000000x 39.06279999997920000000*/
h = 0.000499999999999723*pow(time,3) - 0.064199999999965*pow(time,2) +
2.74449999999852*time - 39.0627999999792;
}
if (time >43.0)
{
/*y = -0.00050000000000005600x3 + 0.06480000000000740000x2 - 2.79610000000033000000x +
40.16900000000480000000*/
h= -0.000500000000000056*pow(time,3) + 0.0648000000000074*pow(time,2) 2.79610000000033*time + 40.1690000000048;
}
if (time >43.5)
{
/*y = 0.00049999999999972300x3 - 0.06569999999996410000x2 + 2.87439999999845000000x 41.87199999997770000000*/
h = 0.000499999999999723*pow(time,3) - 0.0656999999999641*pow(time,2) +
2.87439999999845*time - 41.8719999999777;
}
if (time >44.0)
{
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/*y = -0.00050000000000005600x3 + 0.06630000000000760000x2 - 2.92720000000034000000x +
43.03040000000510000000*/
h= -0.000500000000000056*pow(time,3) + 0.0663000000000076*pow(time,2) 2.92720000000034*time + 43.0304000000051;
}
if (time >44.5)
{
/*y = 0.00049999999999972300x3 - 0.06719999999996330000x2 + 3.00729999999838000000x 44.81259999997620000000*/
h = 0.000499999999999723*pow(time,3) - 0.0671999999999633*pow(time,2) +
3.00729999999838*time - 44.8125999999762;
}
if (time >45.0)
{
/*y = -0.00050000000000005600x3 + 0.06780000000000770000x2 - 3.06130000000036000000x +
46.02440000000550000000*/
h = -0.000500000000000056*pow(time,3) + 0.0678000000000077*pow(time,2) 3.06130000000036*time + 46.0244000000055;
}
if (time >45.5)
{
/*y = 0.00049999999999972300x3 - 0.06869999999996250000x2 + 3.14319999999831000000x 47.88759999997450000000*/
h = 0.000499999999999723*pow(time,3) - 0.0686999999999625*pow(time,2) +
3.14319999999831*time - 47.8875999999745;
}
if (time >46.0)
{
/*y = -0.00050000000000005600x3 + 0.06930000000000790000x2 - 3.19840000000037000000x +
49.15400000000580000000*/
h= -0.000500000000000056*pow(time,3) + 0.0693000000000079*pow(time,2) 3.19840000000037*time + 49.1540000000058;
}
if (time >46.5)
{
/*y = 0.00049999999999972300x3 - 0.07019999999996160000x2 + 3.28209999999823000000x 51.09999999997280000000*/
h = 0.000499999999999723*pow(time,3) - 0.0701999999999616*pow(time,2) +
3.28209999999823*time - 51.0999999999728;
}
if (time >47.0)
{
/*y =y = -0.00050000000000005600x3 + 0.07080000000000810000x2 - 3.33850000000039000000x +
52.42220000000620000000*/
h= -0.000500000000000056*pow(time,3) + 0.0708000000000081*pow(time,2) 3.33850000000039*time + 52.4222000000062;
}
if (time >47.5)
{
/*y = 0.00049999999999972300x3 - 0.07169999999996080000x2 + 3.42399999999815000000x 54.45279999997090000000*/
h = 0.000499999999999723*pow(time,3) - 0.0716999999999608*pow(time,2) +
3.42399999999815*time - 54.4527999999709;
}
if (time >48.0)
{
/*y = -0.00050000000000005600x3 + 0.07230000000000820000x2 - 3.48160000000040000000x +
55.83200000000660000000*/
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h= -0.000500000000000056*pow(time,3) + 0.0723000000000082*pow(time,2) 3.4816000000004*time + 55.8320000000066;
}
if (time >48.5)
{
/*y = 0.00049999999999972300x3 - 0.07319999999996000000x2 + 3.56889999999807000000x 57.94899999996910000000*/
h = 0.000499999999999723*pow(time,3) - 0.07319999999996*pow(time,2) +
3.56889999999807*time - 57.9489999999691;
}
if (time >49.0)
{
/*y = -0.00050000000000005600x3 + 0.07380000000000840000x2 - 3.62770000000042000000x +
59.38640000000700000000*/
h= -0.000500000000000056*pow(time,3) + 0.0738000000000084*pow(time,2) 3.62770000000042*time + 59.386400000007;
}
if (time >49.5)
{
/*y = 0.00049999999999972300x3 - 0.07469999999995910000x2 + 3.71679999999799000000x 61.59159999996710000000*/
h = 0.000499999999999723*pow(time,3) - 0.0746999999999591*pow(time,2) +
3.71679999999799*time - 61.5915999999671;
}
if (time >50.0)
{
/*y = -0.00050000000000005600x3 + 0.07530000000000860000x2 - 3.77680000000044000000x +
63.08840000000750000000*/
h= -0.000500000000000056*pow(time,3) + 0.0753000000000086*pow(time,2) 3.77680000000044000000*time + 63.0884000000075;
}
if (time >50.5)
{
/*y = 0.00049999999999972300x3 - 0.07619999999995830000x2 + 3.86769999999791000000x 65.38359999996500000000*/
h = 0.000499999999999723*pow(time,3) - 0.0761999999999583*pow(time,2) +
3.86769999999791*time - 65.383599999965;
}
if (time >51.0)
{
/*y = -0.00050000000000005600x3 + 0.07680000000000880000x2 - 3.92890000000046000000x +
66.94100000000790000000*/
h= -0.000500000000000056*pow(time,3) + 0.0768000000000088*pow(time,2) 3.92890000000046*time + 66.9410000000079;

}
if (time >51.5)
{
/*y = 0.00049999999999972300x3 - 0.07769999999995750000x2 + 4.02159999999783000000x 69.32799999996290000000*/
h = 0.000499999999999723*pow(time,3) - 0.0776999999999575*pow(time,2) +
4.0215999999978300*time - 69.32799999996290;
}
if (time >52.0)
{
/*y = -0.00050000000000005600x3 + 0.07830000000000890000x2 - 4.08400000000047000000x +
70.94720000000840000000*/
h= -0.000500000000000056*pow(time,3) + 0.0783000000000089*pow(time,2) 4.08400000000047*time + 70.9472000000084;
}
if (time >52.5)
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{
/*y = 0.00049999999999972300x3 - 0.07919999999995660000x2 + 4.17849999999774000000x 73.42779999996070000000*/
h = 0.000499999999999723*pow(time,3) - 0.0791999999999566000*pow(time,2) +
4.17849999999774*time - 73.4277999999607;
}
if (time >53.0)
{
/*y = -0.00050000000000005600x3 + 0.07980000000000910000x2 - 4.24210000000049000000x +
75.11000000000890000000*/
h= -0.000500000000000056*pow(time,3) + 0.0798000000000091*pow(time,2) 4.24210000000049*time + 75.1100000000089;
}
if (time >53.5)
{
/*y = 0.00049999999999972300x3 - 0.08069999999995580000x2 + 4.33839999999765000000x 77.68599999995840000000*/
h = 0.000499999999999723*pow(time,3) - 0.08069999999995580000*pow(time,2) +
4.33839999999765*time - 77.6859999999584;
}
if (time >54.0)
{
/*y = -0.00050000000000005600x3 + 0.08130000000000930000x2 - 4.40320000000051000000x +
79.43240000000940000000*/
h= -0.000500000000000056*pow(time,3) + 0.0813000000000093*pow(time,2) 4.40320000000051*time + 79.4324000000094;

}
if (time >54.5)
{
/*y = 0.00049999999999972300x3 - 0.08219999999995500000x2 + 4.50129999999756000000x 82.10559999995600000000*/
h = 0.000499999999999723*pow(time,3) - 0.082199999999955*pow(time,2) +
4.50129999999756*time - 82.105599999956;
}
if (time >55.0)
{
/*y = -0.00050000000000005600x3 + 0.08280000000000940000x2 - 4.56730000000053000000x +
83.91740000000990000000*/
h= -0.000500000000000056*pow(time,3) + 0.0828000000000094*pow(time,2) 4.56730000000053*time + 83.9174000000099;
}
if (time >55.5)
{
/*y = 0.00049999999999972300x3 - 0.08369999999995410000x2 + 4.66719999999747000000x 86.68959999995350000000*/
h = 0.000499999999999723*pow(time,3) - 0.0836999999999541*pow(time,2) +
4.66719999999747*time - 86.68959999995350;
}
if (time >56.0)
{
/*y = -0.00050000000000005600x3 + 0.08430000000000960000x2 - 4.73440000000055000000x +
88.56800000001040000000*/
h= -0.000500000000000056*pow(time,3) + 0.0843000000000096*pow(time,2) 4.73440000000055*time + 88.5680000000104;
}
if (time >56.5)
{
/*y = 0.00049999999999972300x3 - 0.08519999999995330000x2 + 4.83609999999738000000x 91.44099999995090000000*/
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h = 0.000499999999999723*pow(time,3) - 0.0851999999999533*pow(time,2) +
4.83609999999738*time - 91.4409999999509;
}
if (time >57.0)
{
/*y = -0.00050000000000005600x3 + 0.08580000000000980000x2 - 4.90450000000057000000x +
93.38720000001100000000*/
h= -0.000500000000000056*pow(time,3) + 0.0858000000000098*pow(time,2) 4.90450000000057*time + 93.387200000011;
}
if (time >57.5)
{
/*y = 0.00049999999999972300x3 - 0.08669999999995250000x2 + 5.00799999999728000000x 96.36279999994830000000*/
h = 0.000499999999999723*pow(time,3) - 0.0866999999999525*pow(time,2) +
5.00799999999728*time - 96.3627999999483;
}
if (time >58.0)
{
/*y = -0.00050000000000005600x3 + 0.08730000000000990000x2 - 5.07760000000059000000x +
98.37800000001150000000*/
h= -0.000500000000000056*pow(time,3) + 0.0873000000000099*pow(time,2) 5.07760000000059*time + 98.3780000000115;
}
if (time >58.5)
{
/*y = 0.00049999999999972300x3 - 0.08819999999995170000x2 + 5.18289999999719000000x 101.45799999994500000000*/
h = 0.000499999999999723*pow(time,3) - 0.0881999999999517*pow(time,2) +
5.18289999999719*time - 101.457999999945;
}
if (time >59.0)
{
/*y = -0.00050000000000005600x3 + 0.08880000000001010000x2 - 5.25370000000061000000x +
103.54340000001200000000*/
h= -0.000500000000000056*pow(time,3) + 0.0888000000000101*pow(time,2) 5.25370000000061*time + 103.543400000012;
}
if (time >59.5)
{
/*y = 0.00049999999999972300x3 - 0.08969999999995080000x2 + 5.36079999999709000000x 106.72959999994300000000*/
h = 0.000499999999999723*pow(time,3) - 0.0896999999999508*pow(time,2) +
5.36079999999709*time - 106.729599999943;
}
if (time >60.0)
{
/*y = -0.00050000000000005600x3 + 0.09030000000001030000x2 - 5.43280000000063000000x +
108.88640000001300000000*/
h= -0.000500000000000056*pow(time,3) + 0.0903000000000103*pow(time,2) 5.43280000000063*time + 108.886400000013;
}
if (time > 60.5)
{
/*y = 0.00049999999999972300x3 - 0.09119999999995000000x2 + 5.54169999999699000000x 112.18059999994000000000*/
h = 0.000499999999999723*pow(time,3) - 0.09119999999995*pow(time,2) +
5.54169999999699*time - 112.18059999994;
}
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/*Need new a, using reference coordinates of edge of parabola which stays constant (x,y)=
(0.01125,0)*/
/*double check x coordinate on reference*/
/*a= (x-k)^2/(4(y-h)) */
a= (0.011125-k2)*(0.011125-k2)/(4*(0-h));

/*
/*
/*
/*

Loop over the deforming boundary zone's faces;
inner loop loops over all nodes of a given face;
Thus, since one node can belong to several faces, one must guard
against operating on a given node more than once:

*/
*/
*/
*/

begin_f_loop (f, tf)
{
f_node_loop (f, tf, n)
{
node_p = F_NODE (f, tf, n);
/* Update the current node only if it has not been
*/
/* previously visited:
*/
if (NODE_POS_NEED_UPDATE (node_p))
{
/* Set flag to indicate that the current node's
*/
/* position has been updated, so that it will not be
*/
/* updated during a future pass through the loop:
*/
NODE_POS_UPDATED (node_p);
x

= NODE_X (node_p);

/* equation of parabola*/
y= (1/(4*a))*(x-k2)*(x-k2)+ h;

NODE_Y (node_p) = y;
}
}
}
end_f_loop (f, tf);
}
/*********************************************************************/
/*
End of the UDF.
/*
*/
/*********************************************************************/

220

*/

Appendix DDextran Media Alteration
Introduction

To increase the viscosity of the media, Dextran has previously been used for cell tests
with endothelial cells up to 20% Dextran [174]. First, the effect of varying percentages
of Dextran on smooth muscle cell response was investigated. Once 1% Dextran solution
was chosen, a smaller study was performed to verify that it would not negatively affect
the smooth muscle cells. With the added component to the cell media, it is important to
first evaluate if the changes in the media affect the cell response and eliminate it as a
possible additional variable during experimental testing.

Materials and Methods
Dextran Effect on Media Viscosity

Dextran (Sigma, D8476, MW 100,000-200,000) was added to Dulbecco’s Modification
of Eagle’s Media (Mediatech, 45000-304) to create solutions of 0%, 5%, 10%, 20%.
Viscosities of the media were tested using a rheometer (Anton Paar, MCR-300) with a
CP-75 measuring system with a sweep of 10-750 s-1 averaged for the viscosity readings.

Cell response of cells to varying viscosity and FBS levels

RASMC (P4) obtained from MUSC were seeded in 96-well polystyrene plates at
a concentration of 2.5 x 104 cells/ml and allowed to reach confluency in DMEM
supplemented with 10% FBS (Sigma-Aldrich, F4135) and 1% antibiotic/antimycotic
(Mediatech, 45000-616). Dextran solutions were prepared by dissolving the dextran in
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deionized water and autoclaving the solution for 45 min at 121 C according to the
manufacturer’s protocol for sterilization in an aqueous solution. DMEM was
supplemented with this solution to create solutions of 0%, 5%, 10%, and 20% Dextran.
After 24 hours, the media was removed from the cells and exchanged with DMEM
supplemented with 0%, 5%, 10%, or 20% Dextran and 0%, 0.5%, or 1.0% FBS. All 12
media groups received supplementation of 1% Antibiotic-Antimycotic. Cells were
evaluated at 24 hours following exposure to DMEM with Dextran. Live/Dead
Viability/Cytoxicity Assay (Invitrogen, L-3224) and CellTiter 96 Aqueous One Solution
Proliferation Assay (Promega, TB245) were performed with n=4 for each sample group.
Cell Titer 96 Proliferation Assay
Cell Titer 96 AQueous ONE Solution Cell Proliferation Assay (MTS) (Promega
Corporation, G-3580, Madison, WI) was used to examine the proliferation activity of the
cells. In this assay, 100 ul was added to each well and incubated for 3 hours. The optical
density was determined at 490 nm (Beckman Instruments, Inc., Model# DU 640B,
Fullerton, CA).

Live/Dead Assay
In the Live/Dead assay, Calcein produces a strong green fluorescence in live cells at an
excitation about 495 nm and emission at 515 nm. Ethidium homodimer-1 (EthD-1)
penetrates cells with damaged membranes and binds to nucleic acids. This produces a
red fluorescence in dead cells with excitation at 528 nm and emission around 615 nm.
The microplate reader protocol for the Live/Dead Viability/Cytotoxicity Kit (Molecular
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Probes, L-3224) was followed according to the manufacturer’s protocol in this
preliminary study. A working solution consisting of approximately 2µM calcein AM and
4 µM EthD-1 was prepared. A black 96-well plate was used for cell culture and readings
to limit fluorescent cross-talk between wells. Cells were washed twice with DPBS
solutions prior to exposure of 100µL of the working solution. The cell plate was then
incubated for 45 min at room temperature. The fluorescence was then read using the
Gemini Plate reader (specs here) at 530 nm and 615 nm for Calcein and EthD-1,
respectively. Wells without cells but with working solution were used as blanks in
analysis. These were subtracted from the fluorescence readings and the relative
fluorescence of each sample group was used for comparison.

Altered 1% Dextran Cell Media on Cell Response

Following the testing of the effect of Dextran on the smooth muscle cells, solution
percentages of Dextran and FBS were chosen based upon the results and usage in
literature [174]. Since 1% Dextran was not specifically tested, an additional experiment
was added. In this study, the experimental media is compared to the normal cell culture
media containing 10% FBS as well. The control media consisted of 10% FBS and 1%
Antibiotic-Antimycotic. The two other groups tested consisted of 1% FBS, 1%
Antibiotic-Antimycotic, and 1% FBS, 1% Antibiotic-Antimycotic, 1% Dextran. In
addition, cell analysis techniques of CyQuant Cell Proliferation Assay for cell
proliferation and TUNEL assay for cell apoptosis were implemented in place of MTS and
live/dead analysis. These are further explained in detail in section 4.3.
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Rat Aortic Smooth Muscle Cells (P6) were seeded on Collagen (50 µg/ml,
PureCol Collagen) coated 12-well plates at a density of 7.5x 104 cells/ml. The cells were
maintained in DMEM with 10% FBS, 1% Antibiotic-Antimycotic for the first 24 hours.
The media switched to experimental groups for 48 hours, with the media being changed
after the first 24 hours. This media regimen is identical and simulates the regimen that
the cells in the 24hour dynamic study are subject to. A One-Way ANOVA statistical
analysis was performed with Student-Newman-Keuls (SNK) Method using SigmaStat.

Results
Viscosity Measurements

Addition of Dextran increased the viscosity of the media with the trend shown in Figure
2. Using the developed equation, the viscosity of 1% media was estimated to be 0.0014
Pa*s. Experimental measurement of the 1% media was measured to be 0.0016 Pa*s,
within 10% of the theoretical estimate.

Viscosity Pa*s

Media Viscosity vs Dextran
0.018
0.016
0.014
0.012
0.01
0.008
0.006
0.004
0.002
0

y = 3E-05x2 + 3E-05x + 0.001
R² = 0.987

0

5

10

15

20

% Dextran

Figure D.1 Effect of Dextran on media viscosity
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Variation of Dextran effect on cells- MTS
MTS readings for each media group are provided in Table 1. These readings represent
the absorbance at 490 nm with the absorbance of media without cell exposure subtracted.
Three samples per media group were measured.

Table D.1. MTS Readings for media groups at 490 nm
Media Combination
Mean Std. Dev.
1
0% FBS 0% Dextran
0.146
0.046137
2
0% FBS 5% Dextran
0.128
0.023415
3
0% FBS 10% Dextran
0.194
0.011442
4
0% FBS 20%Dextran
0.260
0.006994
5
0.5% FBS 0%Dextran
0.161
0.034919
6
0.5% FBS 5%Dextran
0.239
0.010344
7
0.5% FBS 10%Dextran
0.290
0.034664
8
0.5% FBS 20%Dextran
0.264
0.071365
9
1% FBS 0%Dextran
0.161
0.027085
10
1% FBS 5%Dextran
0.236
0.037633
11
1% FBS 10%Dextran
0.340
0.043323
12
1% FBS 20%Dextran
0.258
0.042884

Graphical and statistical comparison of this data can be seen in Figures 3-4. Figure 3
compares the variation of percentages of Dextran (0%-20%) for each value of %FBS.
Figure 3 a) indicated a statistical difference of 20% Dextran compared to both 0% and
5% Dextran for 0% FBS media. For the case of 0.5%FBS, both 10% and 20%
demonstrated significantly increased absorbance compared to the 0% Dextran media. In
the case of 1% FBS, significant differences were detected between 5% and 10% Dextran,
and between 0%, 10%, and 20%. The general trend of the data in Figure 3 suggests that
10% and 20% significantly increase the proliferation of the smooth muscle cells. Values
up to 5% do not seem to significantly affect proliferation rates.
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Effect of %Dextran with 0%FBS
0.30

0.4

Effect of %Dextran with 0.5%FBS

*
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*

Effect of %Dextran with 1%FBS
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*

0.4
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0.0
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b)

5%

10%

20%

c)

Figure D.2 Comparison of MTS Proliferation Assay for varying percentages of Dextran
with absorbance readings at 490 nm. Statistical comparison performed with One-way
ANOVA with SNK analysis, * represents a significant difference between samples a) 0%
FBS: p=0.008 b) 0.5% FBS: p= 0.007 c) 1% FBS: p<0.001

Figure 4 compares the effect of the three FBS percentages added to the media.
Figures a) and d) did not show a significant difference in MTS absorbance in the cases of
0% and 20% dextran, respectively. Figures b) and c) representing 5% Dextran and 10%
Dextran demonstrated significant differences for the case of 0% FBS compared to 0.5%
and 1% FBS. This data suggest that FBS values of 0.5% and 1% did not show significant
differences in proliferation for all of the tested percentages of Dextran.
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0.5%

0%

1.0%

a)
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*
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Figure D.3 Comparison of MTS Proliferation Assay for %FBS for each %Dextran with
absorbance readings at 490 nm. Statistical comparison performed with One-way
ANOVA with SNK analysis, * represents a significant difference between samples a) 0%
Dextran: p= 0.797 b) 5 % Dextran: p= 0.015 c) 10% Dextran: p< 0.001 d) 20%Dextran
(p=0.540)

Dextran effect on cells- Live/Dead Assay
Calcein corresponding to live cell readings at 515 nm exhibited the following
fluorescent readings given in Table 2.
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Table D.2 Calcein Readings for live cells at 515 nm
Media Combination
Mean Std. Dev.
1
0% FBS 0% Dextran
43.04
12.70
2
0% FBS 5% Dextran
28.83
18.75
3
0% FBS 10% Dextran
49.44
25.66
4
0% FBS 20%Dextran
36.78
16.23
5
0.5% FBS 0%Dextran
30.78
7.43
6
0.5% FBS 5%Dextran
49.32
6.03
7
0.5% FBS 10%Dextran
52.92
15.94
8
0.5% FBS 20%Dextran
20.02
10.33
9
1% FBS 0%Dextran
43.60
11.42
10
1% FBS 5%Dextran
60.69
15.17
11
1% FBS 10%Dextran
36.22
5.56
12
1% FBS 20%Dextran
32.19
7.12

Graphical and statistical comparisons for the calcein fluorescence for varying percentages
of Dextran are shown in Figures 5-6. For 0% FBS, no significant differences were seen
between the variations in %Dextran as shown in Figure 5 a). For the case of 0.5% shown
in Figure 5 b), significantly less cells were detected for the case of 20% cells compared to
both 5% and 10% Dextran. For 1%FBS shown in Figure 5 c), significantly lower number
of cells were shown comparing 10% and 20% compared to 5% Dextran solution.
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Figure D.4 Comparison of calcein for live cells as part of the Live/Dead microplate assay
for varying percentages of Dextran with fluorescence readings at 515nm. Statistical
comparison performed with One-way ANOVA with SNK analysis, * represents a
significant difference between samples a) 0% FBS: p=0.486 b) 0.5% FBS: p=0.003
c) 1% FBS: p= 0.011
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Comparing the different solutions with variations in live cell expression only when
comparing 5% Dextran between 0% and 1% FBS shown in Figure 6 b).
70
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Figure D.5 Comparison of live cells as part of the Live/Dead microplate assay for
comparison of effect of %FBS at varying percentages of Dextran with fluorescence
readings at 515nm. Statistical comparison performed with One-way ANOVA with SNK
analysis, * represents a significant difference between samples a) 0% Dextran: p= 0.217
b) 5% Dextran: p=0.034 c) 10% Dextran: p=0.410 d) 20% Dextran: p=0.174

The EthD-1 readings of fluorescence represent the readings of dead cells. A summary of
the fluorescence values in provided in Table 3.
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Table D.3 EthD-1 Readings for dead cells at 617 nm
Media Combination
Mean Std. Dev.
1
0% FBS 0% Dextran
0.44
0.18
2
0% FBS 5% Dextran
1.02
0.30
3
0% FBS 10% Dextran
1.72
0.17
4
0% FBS 20%Dextran
1.85
0.05
5
0.5% FBS 0%Dextran
0.76
0.16
6
0.5% FBS 5%Dextran
1.29
0.22
7
0.5% FBS 10%Dextran
1.74
0.32
8
0.5% FBS 20%Dextran
1.97
0.30
9
1% FBS 0%Dextran
1.08
0.19
10
1% FBS 5%Dextran
1.30
0.39
11
1% FBS 10%Dextran
1.47
0.30
12
1% FBS 20%Dextran
2.33
0.18

Figures 7-8 represent the number fluorescence readings for the varying percentages at
each level of %FBS. Figure 7 a) for 0% Dextran demonstrated significant difference
between all groups except 10% and 20% Dextran, with both higher %Dextran expressing
higher fluorescence than the other values. For 0.5%FBS, 0% and 5%Dextran were not
significantly different and represents lower expression of dead cells. For the case of 1%
FBS in Figure 7 c), 20% Dextran was the only significantly higher expression of dead
cells.
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Figure D.6 Comparison of dead cells as part of the Live/Dead microplate assay for
varying percentages of Dextran with fluorescence readings at 617 nm. Statistical
comparison performed with One-way ANOVA with SNK analysis, * represents a
significant difference between samples a) 0% FBS: p<0.001 b) 0.5% FBS: p<0.001 c)
1% FBS: p< 0.001

When comparing the %FBS at the four percentages of Dextran, 1%FBS was significantly
higher than 0%FBS for 0%Dextran and 20%Dextran as shown in Figure 8 a) and d). For
5% and 10% Dextran, no significant differences were seen in comparison of the FBS
percentages.
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Figure D.7 Comparison of dead cells as part of the Live/Dead microplate assay for
comparison of effect of %FBS at varying percentages of Dextran with fluorescence
readings at 617 nm. Statistical comparison performed with One-way ANOVA with SNK
analysis, * represents a significant difference between samples a) 0% Dextran: p=0.002
b) 5% Dextran: p=0.396 c) 10% Dextran: p=0.345 d) 20% Dextran: p=0.023

Media Verification study with 1% FBS, 1% Dextran
CyQuant assay

The control media consisting of 10% FBS, 1% Antibiotic-Antimycotic resulted in 1.89
x105 ± 3.06 x104 SD cells. The experimental medias of 1% FBS, 1% AntibioticAntimycotic and 1% FBS, 1% Dextran, 1% Antibiotic-Antimycotic resulted in cell
counts of 1.09 x105 ±1.51 x104 SD cells and 1.31 x105 ± 1.30 x104 SD cells. ANOVA
and SNK analysis indicated a significant difference in the 10% FBS media (p=0.002).
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These results can be seen in Figure 8 a). No difference was seen between the two 1%
FBS medias even with the addition of Dextran.

Media Cell Count (CyQuant assay)

2.00E+05

%Apoptotic/total cells

Cell number

2.50E+05

*

1.50E+05
1.00E+05
5.00E+04
0.00E+00
10% FBS

Apoptotic Cells with Experimental Media

1% 1FBS

1% FBS 1%Dex

2.00%
1.50%
1.00%
0.50%
0.00%
10% FBS

1% FBS

1%FBS 1%Dex

(a)
(b)
Figure D.8 Control and experimental media a) CyQuant assay results (p=0.002) b)
TUNEL assay results (p=0.863)

TUNEL Apoptosis assay

Results from the TUNEL apoptosis assay indicated no significant difference
between the three medias as shown in Figure 8 b). ANOVA indicated a p value of 0.863.
Results represent n=9 points of imaging. As a control for apoptosis, samples were
exposed to UV for 30 minutes which has been shown to cause cell apoptosis [187]. This
control allowed ease in imaging to separate background staining from the localized green
fluorescence in the nuclei of apoptotic cells. Reduced serum and added Dextran did not
result in increased apoptotic response.

Discussion of Altered Media

The measurements of the viscosity of the media disagreed slightly with the value
determined in Aim 2. Fairly large percentages of Dextran are required to significantly
affect the viscosity of the media. The measured value of media without Dextran
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supplementation was slightly lower in the measurement in this case 0.001 Pa*s versus
0.0015 Pa*s measured in Aim 2. Supplementation with 1% Dextran increased the
viscosity to 0.0016 Pa*s. Compared to the 0% measured in this aim, it resulted in an
approximate 50% increase in viscosity, but only about a 7% increase in viscosity
compared to the previously determined viscosity. These differences could be due to
changes in the measuring system of the rheometer or other possible differences in testing.
Results from the MTS for 0, 5, 10, and 20% Dextran in 0%, 0.5%, and 1% FBS
media solutions suggested that the addition of Dextran can have an effect on cell activity.
MTS results suggested that up to 5% Dextran would not affect the metabolic proliferative
activity of cells compared to media without Dextran. Higher percentages of 10% and
20% Dextran suggested higher metabolic activity of cells. Differences due to alterations
in FBS were not as apparent. For the live/dead assay, there were general trends of
increased expression of EthD-1 representing dead cells with increased percentages of
Dextran. The fluorescent expression of Calcein did not present general trends in
statistical behavior and had increased variability of testing. The Calcein expression did
show that addition of Dextran resulted in similar expression of fluorescence representing
live cells, particularly when comparing lower addition of Dextran expression.
The first cell study acted as a platform to choose a media combination used for
testing. Since lower amounts of Dextran did not seem to significantly change the cell
response, a 1% Dextran 1% FBS solution was implemented. To verify this assumption,
this media was compared to control cell culture media and media without Dextran
supplementation. Apoptosis and CyQuant Cell Proliferation were implemented in place
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of the Live/Dead and MTS assay for reliability and consistency with analysis techniques
implemented in the 24 hour dynamic study. The increased proliferation using the 10%
compared to the 1% FBS medias was expected since low percentages FBS media are
documented and implemented as lower proliferation media and used to reduce cell
responses due to FBS.

Conclusion of Altered Media

Dynamic in vitro testing is important when trying to model the mechanical forces
present in the arterial system. In order to investigate the effects of alterations in
parameters such as shear stresses on cells, alterations of the viscosity of the media are
needed. The use of Dextran to increase viscosity for shear testing has been tested on
endothelial cells1, but not to smooth muscle cells. This study demonstrates that high
percentages of Dextran can affect smooth muscle cell response but low percentages may
be a viable option. Although the low addition of 1% may not dramatically increase the
viscosity of the media and therefore the applied wall shear stresses as originally intended,
the viscosity agrees more with previously determined values and does slightly increase
the wall shear stresses on the cells. This presented work represents the first phase of
determining in static in vitro conditions which levels of Dextran can be implemented in
dynamic studies without compromising the viability of the cells.
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